Patent Grant
11154398
The present invention relates to a stent for the positioning and anchoring of an endoprosthesis in an implantation site in the heart of a patient. Specifically, the present invention relates to an expandable stent for an endoprosthesis used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency.
The present invention also relates to an endoprosthesis that includes a stent for positioning and anchoring of the prosthesis at the implantation site in the heart of a patient. Specifically, the present invention also relates to a collapsible and expandable prosthesis incorporating a stent that can be delivered to the implant site using a catheter for treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency.
The expression “narrowing (stenosis) of a cardiac valve and/or cardiac valve insufficiency” is intended to include a functional defect of one or more cardiac valves, which is either genetic or has developed. A cardiac defect of this type might affect each of the four heart valves, although the valves in the left ventricle (aortic and mitral valves) are affected much more often than the right-sided part of the heart (pulmonary and tricuspid valves). The functional defect can result in narrowing (stenosis), inability to close (insufficiency) or a combination of the two (combined vitium). This invention relates to an endoprosthesis that includes an expandable stent capable of being implanted transluminally in a patient's body and enlarged radially after being introduced percutaneously for treating such a heart valve defect.
In the current treatment of severe narrowing of a cardiac valve and/or cardiac valve. Insufficiency, the narrowed or diseased cardiac valve is replaced with an endoprosthesis. Biological or mechanical valves models, which are typically surgically sewn into the cardiac valve bed through an opening in the chest after removal of the diseased cardiac valve, are used for this purpose. This operation necessitates the use of a heart-lung machine to maintain the patient's circulation during the procedure and cardiac arrest is induced during implantation of the prosthesis. This is a risky surgical procedure with associated dangers for the patient, as well as a long post-operative treatment and recovery phase. Such an operation can often not be considered with justifiable risk in the case of polypathic patients.
Minimally-invasive forms of treatment have been developed recently which are characterized by allowing the procedure to be performed under local anesthesia. One approach provides for the use of a catheter system to implant a self-expandable stent to which is connected a collapsible valvular prosthesis. Such a self-expandable endoprosthesis can be guided via a catheter system to the implantation site within the heart through an inguinal artery or vein. After reaching the implantation site, the stent can then be unfolded.
To this end, it is known that a stent may be comprised of, for example, a plurality of self-expanding longitudinal stent segments, the segments being articulated relative to one another. In order to anchor the stent securely in position in an appropriate blood vessel dose to the heart, anchoring barbs are frequently used to engage with the vascular wall.
An expandable stent for the fastening and anchoring of an endoprosthesis is known from printed publication DE 10 010 074 A1, whereby the stent is essentially formed from wire-shaped, interconnected segments. DE 10 010 074 A1 proposes a stent for fastening and anchoring an endoprosthesis, the stent having different arched elements which assume the function of fastening and supporting the valvular prosthesis at the site of implantation. Specifically, three identically-configured positioning arches spaced 120° from one another respectively are used. These positioning arches are connected to one another by means of solid body articulations.
In addition to the positioning arches, complementary curved retaining arches serve to anchor the endoprosthesis by pressing radially against the vascular wall following the unfolding of the stent.
However, there is a risk of inexact or incorrect implantation of an endoprosthesis using the solutions described above. Expressed in another way, there is a need for exact positioning and longitudinal alignment of an implanted endoprosthesis. In particular, it is only possible using great skill on the part of the attending surgeon or cardiologist—if at all—to position a stent sufficiently precisely, in both a lateral and longitudinal direction, to ensure that the associated endoprosthesis is located in the correct area of the patient's diseased heart valve.
Among other things, inexact implantation of a sub-optimally positioned endoprosthesis can lead to leakage or valvular insufficiency which results in considerable ventricular stress. For example, if an endoprosthesis is implanted too far above the plane of the native heart valve, this can lead to closure or blocking of the coronary artery ostia (inlet orifice of coronaries) and thus to fatal coronary ischemia and myocardial infarction.
Therefore, for the optimal treatment of a narrowed cardiac valve or a cardiac valve insufficiency, it is necessary to position a stent, to which a valvular prosthesis is affixed, as precisely as possible at the site of implantation of the cardiac valve to be treated.
An endoprosthesis for treating aortic valve insufficiency is known from printed publication DE 20 2007 005 491 U1. The endoprosthesis comprises a valvular prosthesis and a stent to position and anchor the endoprosthesis at the implantation site in the patient's heart. A stent having several (multiple, normally three, but two in case of bicuspid valve) positioning arches is employed in this endoprosthesis. In the implanted state of the stent, these positioning arches extend radially and serve to engage in the pockets of the native (diseased) cardiac valve to be treated. The valvular prosthesis affixed to the stent can then self-position into the plane of the cardiac valve. Retaining arches abut against the vascular wall of the aorta in the implanted state of the endoprosthesis, form a force-fit connection and are used to anchor the endoprosthesis.
While the positioning arches enable optimal positioning of the stent of this endoprosthesis at the site of implantation in the patient's heart, what cannot be ensured is that the valvular prosthesis attached to the lower end section of the stent is actually also positioned in the plane of the cardiac valve. In particular, substantial forces act on the endoprosthesis during the filling phase of the heart cycle (diastole), which can lead to the endoprosthesis displacing longitudinally relative the stent. Due to this longitudinal displacement of the implanted endoprosthesis, which occurs in the heart and blood vessels especially because of the peristaltic motion of the heart, the implanted endoprosthesis may no longer be able to provide a secure seal.
Moreover, there is the danger that, because of the longitudinal displacement of the valvular prosthesis relative to the stent occurring with the peristaltic motion, the threads or sutures used to fasten the valvular prosthesis to the stent may chafe against the stent. It can therefore not be excluded that the fastening threads may fray over the course of time and thus lose their fastening function. This would result in at least a partial separation of the valvular prosthesis from the stent, which in turn can lead to leakages, an inappropriate positioning or even complete detachment of the valvular prosthesis.
On the basis of the problems outlined above, certain embodiments of the present. Invention address the issue of providing a self-expandable endoprosthesis for treating a narrowed cardiac valve or a cardiac valve insufficiency which realizes optimum positioning accuracy and anchoring of an endoprosthesis to be implanted. In addition, the treatment of the narrowed cardiac valve or cardiac valve insufficiency should be by way of a simple procedure to enable routine treatment of narrowed cardiac valve or cardiac valve insufficiency without major stress to the patient.
In this regard and as it will be described later in detail, the invention provides an expandable stent for the positioning and anchoring of an endoprosthesis in an implantation site in the heart of a patient in the treatment of a narrowed cardiac valve or a cardiac valve insufficiency, wherein the stent comprises a plurality of positioning arches configured to be positioned within a plurality of pockets of the patient's native heart valve and positioned on a first side of a plurality of native heart valve leaflets, and a plurality of retaining arches configured to be positioned on a second side of the plurality of native heart valve leaflets opposite the first side.
As it will be described in detail later on, in some embodiments of the present invention, the expandable stent may further include at least one auxiliary arch interspaced between two adjacent retaining arches, wherein the at least one auxiliary arch includes a first arm connected at a first end thereof to a first retaining arch and a second arm connected at a first end thereof to a second retaining arch, and wherein the first and second arms of the at least one auxiliary arch each include respective second ends connected to one another at a joint that includes at least one fastening hole configured to receive a suture.
In addition or instead of the at least one auxiliary arch, the stent according to the present invention may further comprise at least one radial arch substantially circumferentially aligned with at least one of the plurality of positioning arches.
Otherwise, it is conceivable that the stent according to the present invention is further provided with a plurality of auxiliary arches, each of said plurality of auxiliary arches being interspaced between two adjacent retaining arches and including a first arm connected at a first end thereof to a first retaining arch and a second arm connected at a first end thereof to a second retaining arch.
Furthermore, the stent according to the present invention may also be provided with a plurality of extra arches, each of said plurality of extra arches being interspaced between a first retaining arch and an adjacent second retaining arch.
Preferably, the stent according to the present invention further comprises a plurality of leaflet guard arches, each interspaced between the two arms of one of the plurality of positioning arches.
A further task of certain embodiments of the present invention lies in specifying an endoprosthesis for the treatment of a stenosed cardiac valve or a cardiac valve. Insufficiency, whereby the endoprosthesis can be anchored securely at the site of implantation in the patent's heart. In addition, certain embodiments of the present invention also address the issue of substantially preventing displacement of an implanted endoprosthesis from its ideal site of implantation in spite of the forces acting on the endoprosthesis during the filling phase of the heart cycle.
The present invention is also directed to an endoprosthesis constituted by a stent as defined in the claims on the one hand and a valvular prosthesis affixed to the stent.
As described herein, stents may be radially expandable intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. The stents may be configured to be placed in a native diseased valve of a patient, such as a native stenotic aortic or pulmonary valve, using a minimally-invasive approach, such as a beating heart transapical procedure or a retrograde transaortic procedure. Although stents can be introduced into the body of the patient via any number of access points, a transvascular approach by femoral access or by transapical access for the aortic valve is preferred. However, this invention is not limited to these approaches.
A “native aortic valve” may be a tricuspid (with three leaflets) or congenitally bicuspid (with two leaflets).
An endoprosthesis may include an implant which (together with a stent to which the valvular prosthesis is affixed) functions as a check valve, opening to permit forward blood flow and dosing to prevent retrograde flow. A valvular prosthesis may consists of at least two and preferably of three leaflets and a valve skirt on which the leaflets are connected.
From one aspect, an expandable stent of a collapsible and expandable prosthesis is proposed in accordance with certain embodiments of the present invention, the stent comprising at least one fastening portion by means of which a valvular prosthesis is connected to the stent. In addition, the stent comprises positioning arches and retaining arches. At least one positioning arch of the stent is connected with at least one retaining arch of the stent by a first connecting web. Additionally, the stent further comprises at least one auxiliary arch which interconnects the arms of respective retaining arches.
The at least one fastening portion extends along the longitudinal axis of the stent and comprises a plurality of fastening holes distributed in a longitudinal direction at discrete positions along the length of the at least one fastening portion. Thread or thin wire may be guided through each fastening hole to secure the valvular prosthesis to the stent. The advantage of this feature is that longitudinal displacement of the valvular relative to the stent is substantially minimized once implanted and so the prosthesis is not unduly disturbed or weakened as a result of the heart's peristaltic motion.
In addition to fastening holes, the fastening portion may include one or more notches to assist the seating and retaining of suture material. The notches also assist with even attachment of the prosthesis to the stent and, similarly to the fastening holes, minimize longitudinal displacement of the prosthesis.
Extending from and between a pair of fastening portions is a fastening arch, over which valve tissue is laid. In the expanded and implanted state of the stent and the valvular prosthesis affixed thereto, the fastening arch of the stent abuts against the vessel wall at least at the lower section of the stent in order to seal against leakage. Furthermore, with the fastening arch, the prosthesis tissue is separated and held away from positioning and retaining arches, thereby reducing the likelihood of these arches chaffing the tissue which, in turn may result in damage and weakening of the prosthesis. The fastening arch serves to anchor the lower edge of the valvular prosthesis and to tension the material so the prosthesis is effective as a valve. By having a fastening portion and fastening arches, the prosthesis is fully supported and anchored within the boundary of the stent. The combination of the two fastening mechanisms also provides a failsafe should one fastening mechanism fail. This is of particular relevance with suturing since a poorly sutured prosthesis will not be as effective as it should due to additional stresses and strains imparted to the prosthesis by the sutures. Thus, the arches allow fastening of the prosthesis in a manner that does not rely solely on suturing.
In an implanted configuration, the at least one positioning arches of the stent extends from the circumference of the stent in a generally radial direction. These positioning arches are designed to engage in the pockets of the native (diseased) cardiac valve that is being replaced which, in turn allows accurate positioning of the stent. Furthermore, on implantation, a positioning arch sits between the vascular wall and a leaflet of the native heart valve. The positioning arch then co-operates with a corresponding retaining arch resulting in clipping of the native leaflet between the two arches. In this way, the positioning and retaining arches together hold the stent in position and substantially eliminate axial rotation of the stent.
In a preferred embodiment (cf. the stent according to the eighteenth embodiment), the positioning arch may be shaped to have a substantially convex shape. In other words, the end of the arch that is positioned in the native valve leaflet may be curved towards the inside of the stent or towards the longitudinal axis of the stent. In this way, the shape of the each positioning arch provides an additional clipping force against the native valve leaflet.
The at least one retaining arch is connected to a positioning arch by a connecting web. The retaining arch extends radially in the implanted state of the stent such that the at least one retaining arch presses against the wall of the blood vessel in which the stent is deployed with a radially-acting tensioning force. In situ, the ends of each retaining arch also fits underneath the aortic valve annulus, providing further means for locating and anchoring the stent. In addition to the at least one retaining arch, certain embodiments of the invention provide for the stent to further comprise at least one auxiliary arch which interconnects the respective arms of the at least one retaining arch connected to the at least one positioning arch. As with the at least one retaining arch, the at least one auxiliary arch also protrudes radially in the expanded state of the stent such that the at least one auxiliary arch also presses against the wall of the blood vessel in which the stent is deployed with a radially-acting tensioning force.
The stent of a collapsible and expandable prosthesis may also include radial arches positioned between each positioning arch, with each radial arch extending upwards towards the upper end section of the stent. The radial arches provide additional means by which the stent may be retained within a catheter before and during implantation, and provide means by which the stent may be recaptured after implantation. The arches also add radial strength to the upper end section of the stent.
In the at least one fastening portion of the stent, by means of which the tissue component(s) of the overall prosthesis can be fastened to the stent, a plurality of fastening holes and optionally one or more notches is provided. These fastening holes and notches are longitudinally distributed at given positions on the fastening portion and guide at least one thread or thin wire to fasten the tissue component(s) of the valvular prosthesis to the stent, thereby enabling a precise positioning of the tissue component(s) of the overall prosthesis on the stent. Each individual fastening hole and notch provided in the at least one fastening portion thereby serves to guide a thread or thin wire with which the tissue component(s) of the valvular prosthesis is affixed or sewn to the fastening portion of the stent.
The means provided for fastening the tissue component(s) of the valvular prosthesis to the fastening portion of the stent (thread or thin wire) is guided by way of the fastening holes and notches so that a longitudinal displacement of the valvular prosthesis relative to the stent is substantially minimized. This also allows exact positioning of the valvular prosthesis relative the stent.
The secure and defined fixing of the tissue component(s) of the valvular prosthesis to the at least one fastening portion of the stent moreover effectively prevents the means used to fasten the tissue component(s) to the stent (threads or thin wires) from rubbing against the stent and thus degrading after a longer period of use.
In order to configure the plurality of fastening holes and any notches in the fastening portion, the at least one fastening portion is preferably configured as—in comparison to the respective arms of the positioning arch, retaining arch and auxiliary retaining arch—a widened segment. Thus, the fastening portion is a stent segment which comprises a relatively large amount of material, facilitating movement and position analysis when the stent is being implanted. For example, when fluoroscopy (cardiac catheterization=LHK) or ultrasound (trans-esophageal echocardiogram=TEE) is used to monitor the insertion procedure, the fastening portion of the stent is particularly distinguishable.
A preferred realization of the stent according to a particular embodiment the invention provides for a fastening portion to be configured within each arm of the stent's retaining arch.
In order to reinforce the respective retaining arches of the stent, the auxiliary arch as already mentioned above is provided. The auxiliary arch extends from the lower ends of the fastening portion and connects the respective arms of two neighboring retaining arches.
In manufacturing the stent used in the valvular prosthesis according to a particular embodiment of the invention, it is conceivable for the stent to exhibit a structure integrally cut from a portion of tube, in particular from a metal tube, which incorporates the positioning arches, retaining arches and auxiliary retaining arches as well as the at least one fastening portion with defined fastening holes and notches. It is also conceivable that the stent is cut out of a relatively large tube, i.e. a tube having a diameter which is larger compared with the diameter of the final stent in its collapsed configuration. For example, a tube having a diameter of approximately 10 mm may be used for cutting a specific stent pattern into this tube. Then the cut pattern will be different, as it will become necessary to crimp the stent to something smaller than what it was originally cut from. In particular, with this procedure it is possible to remove material during cutting and processing in a defined manner thereby enhancing the functionality of the final stent.
Specifically, it is conceivable to use a laser to cut the stent structure from a metal tube, whereby the structure is thereafter subject to an applicable shaping and thermal treatment process so that the stent can transform from a collapsed state during implantation into an expanded state at the site of implantation. This shaping and thermal treatment process is advantageously performed gradually in order to prevent damage to the stent structure.
Particularly preferred is for the stent to exhibit a structure integrally cut from a metal tube in which each positioning arch is allocated one retaining arch, and in which each upper end portion of the positioning arch towards the upper end of the stent is connected with the upper end portion of the associated retaining arch via a first connecting web. The at least one fastening portion, in which the plurality of fastening holes is provided, is thereby preferably configured within an arm of the retaining arch.
The stent preferably exhibits an integrally-formed structure which can transform from a first predefinable shape into a second predefinable shape, whereby the stent exhibits a first predefinable shape (collapsed shape) during insertion into the patient's body and a second predefinable shape (expanded shape) once implanted.
Because of the stent's design, during the transition of the stent from the first predefinable shape into the second predefinable shape, the positioning arches, retaining arches and auxiliary arches are radially expanded as a function of the cross-sectional expansion of the stent. The stent's second shape is thereby preferably selected such that when the stent is expanded, the retaining arch and the auxiliary arch abut against the wall of the blood vessel in which the stent is deployed. In addition, the ends of the retaining arches are positioned beneath the native valve annulus, thereby providing additional anchoring of the stent.
To achieve a secure anchoring of the stent at the site of implantation, both the retaining and auxiliary arches should press against the wall of the vessel with a radial force, whereby this radial force can be set by subjecting the stent structure to a suitable shaping and thermal treatment process.
It is to be understood that the term “upper” refers to the stent when viewed in its. implanted state. In other words, the term “upper” refers to the upper end section of the stent which, when implanted, is sited away from the heart. Similarly, use of the term “lower” refers to a proximal position on the stent which is located towards the ventricle side of the heart when the stent is viewed in its implanted position.
A preferred embodiment (cf. the eighteenth embodiment) of the stent according to the invention provides for the positioning arches and the associated retaining arches as well as auxiliary arches each to exhibit an essentially U-shaped, T-shaped or V-shaped structure which is closed toward the lower end of the stent. It is particularly preferred for each positioning arch to be cut from the material portion of a metal tube from which the essentially U-shaped, T-shaped or V-shaped structure of the associated retaining arch was taken. The respective auxiliary arches are preferably cut from a material portion of the metal tube situated between the essentially U-shaped, T-shaped or V-shaped retaining arch structures.
This preferred embodiment of the stent structure thus provides for the respective retaining and auxiliary arches of the stent to form the lower region of the endoprosthesis, whereby the positioning arches are configured symmetrically to the retaining arches although preferably disposed somewhat further toward the upper region of the endoprosthesis.
The respective upper ends of the positioning arches are connected to the respective upper ends of the associated retaining arches by means of a first connecting web in the upper region of the endoprosthesis. The fastening portions are configured in the respective arms of the retaining arch. In the expanded state of the stent, both the lower region with the fastening portions, as well as the connecting web disposed at the upper end of the stent between the respective positioning and retaining arches, spread out so that a radially-acting force is exerted on the blood vessel wall from both the lower region of the stent as well as the upper end of the stent, thereby enabling secure anchoring of the stent at the site of implantation.
In a preferred embodiment, the stent exhibits in its first shape (collapsed shape) an outer diameter of approximately 4 to 8 mm and a length of between 30 mm and 42 mm. More precisely, the stent may exhibit in its first shape (collapsed shape) an outer diameter of approximately 4.0 to 8.0 mm, preferably of approximately 5.0 mm, more preferably of approximately 6.0 mm, and a length of between 33.0 mm and 40.0 mm, preferably between 34.0 mm and 40.0 mm, and more preferably between 34.0 mm and 39.0 mm. This allows a prosthesis including the stent to be inserted easily into the patient's body, for example with a 21F delivery system, and to be used with an endoprosthesis having a diameter of between 19 mm and 28 mm. The afore-mentioned length specifications are the dimensions currently preferred, based on which the stent becomes suitable for the majority of patients to be treated.
In order to achieve a particularly secure anchoring of the implanted the stent with the stretched valvular prosthesis affixed thereto, it is further conceivable for the stent to be subject to a shaping and thermal treatment process during its manufacture such that the finished stent exhibits a slightly concave configuration.
For example, the finished stent may exhibit a slightly concave configuration tapering toward its upper end section in its implanted and fully expanded state. When the stent together with a valvular prosthesis affixed thereto is in its implanted and fully expanded state, the largest diameter of the lower end section of the stent is positioned below the annulus and tries to assume a larger diameter than the upper end section of the stent even though the upper end section of the stent spreads out a little larger, thereby providing larger radial forces to anchor the stent and the valvular prosthesis affixed thereto in the implanted state. This enables a secure hold of the stent in the blood vessel without damaging the arterial wall. This configuration also provides secure anchoring that is able to withstand the peristaltic motion of the heart and the arterial wall and reliably seal the prosthesis against the arterial wall. It is of course also conceivable to design the concave configuration of the stent in its second shape to be of greater or lesser concavity.
Preferably, the stent diameter at the lower end section of the stent should be able to accommodate a range of annulus diameters around the target diameter. Within this range the forces applied due to the stiffness of the expanded and implanted stent to the vessel wall shall be adequate to prevent migration of the implanted stent, but not too great to cause annular rupture or AV node block. At the upper end section of the stent, it is desirable that the stent does not vary in diameter significantly to minimize the impact to the valve coaptation or opening performance even when the annulus diameter is not exactly at the target diameter.
It is preferable for the lower end area of the stent, when in its second shape, to exhibit a diameter of between 22 mm and 33 mm, preferably between 25 mm and 31 mm. It is conceivable for the stent to exhibit two or more differently dimensioned sizes whereby the optimal stent size can be selected depending upon specific patient. In addition, exact and patient-specific dimensions of the stent—starting from a given stent size—can be realized by appropriately curing the stent, in particular by a thermal treatment process.
In a particularly preferred realization, the stent comprises a valvular prosthesis, preferably a biological or pericardial valvular prosthesis, wherein the tissue component(s) of the valvular prosthesis is/are attached to the at least one fastening portion of the stent by means of a thread or the like.
A shape memory material is preferably used as the material for the stent, the material being designed such that the stent can transform from a temporary shape into a permanent shape under the influence of an external stimulus. The temporary shape is thereby the stent's first shape (i.e. the collapsed state of the stent), while the permanent shape is assumed in the stent's second shape (i.e. in the expanded state of the stent). In particular, use of a shape memory material such as Nitinol, i.e. an equiatomic alloy of nickel and titanium, allows for a particularly gentle implantation procedure when implanting the stent.
It is conceivable of course that other shape memory materials, for example shape-memory polymers, are used as the material for the stent. At least parts of the stent may be formed by using, for example, a polymer composite exhibiting a crystalline or semi-crystalline polymer network having crystalline switching segments. On the other hand, an amorphous polymer network having amorphous switching segments is also conceivable.
When manufacturing the stent preferably made from a shape memory material, the stent structure is preferably shaped after it has been cut from a tube. It is conceivable that the stent is cut out of a tube having a diameter which is larger compared with the diameter of the final stent in its collapsed configuration. Then, the laser-processed tube is crimped thereby achieving the diameter of the stent in its collapsed configuration. Once the desired shape has been formed, this shape is “fixed”, this process being known as “programming”. Programming may be effected by heating the stent structure, forming the stent into the desired shape and then cooling the stent. Programming may also be effected by forming and shaping the stent structure at lower temperature, this being known as “cold stretching.” The permanent shape is thus saved, enabling the stent to be stored and implanted in a temporary, non-formed shape. If an external stimulus then acts on the stent structure, the shape memory effect is activated and the saved, permanent shape restored.
A particularly preferred embodiment provides for the external stimulus to be a definable switching temperature. It is thus conceivable that the stent material needs to be heated to a higher temperature than the switching temperature in order to activate the shape memory effect and thus regenerate the saved permanent shape of the stent. A specific switching temperature can be preset by the relevant selection of the chemical composition of the shape memory material.
It is particularly preferred to set the switching temperature to be in the range of between 10° C. and the patient's body temperature and preferably in the range of between 10° C. and room temperature. Doing so is of advantage, especially with regard to the medical device being used as an implant in a patient's body. Accordingly, all that needs to be ensured in this regard when implanting the stent is that the stent is warmed up to room temperature or the patient's body temperature (37° C.) at the site of implantation to activate the shape memory effect of the stent material.
The following will make reference to the included drawings in describing preferred embodiments of the stent according to the present invention in greater detail.
Shown are:
Both the right and left halves of the human heart consist of a ventricle and an atrium. These cavities are separated by the septum of the heart, divided into the atrial septum (septum interatriale) and the ventricular septum (septum interventriculare).
Blood can only flow in one direction through the chambers of the heart due to the cardiac valves situated between the atria and ventricles and in the arteries connected to the ventricles which function like mechanical valves. The superior and inferior vena cava (vena cava superior et inferior) flow into the right atrium. They supply the oxygen-depleted (venous) blood from the systemic circulation to the heart. The tricuspid valve which, like a mechanical valve, prevents a reverse flow of blood into the atrium upon ventricular contraction (systole) is situated between the right atrium and the right ventricle. It comprises three segments, also called leaflets, which are affixed like flaps to the ventricular musculature by ligaments (hence also called the “flap valve”). The two pulmonary arteries depart the right ventricle of the heart via a common trunk (truncus pulmonalis). There is also a valve between the ventride and the pulmonary trunk, the so-called pulmonary valve. This type of valve is also called a semilunar valve due to its shape. The pulmonary arteries supply the oxygen-depleted blood to the pulmonary circulation.
Oxygen-rich (arterial) blood then usually flows through four pulmonary veins from the pulmonary circulation to the left atrium. From there, it reaches the left ventride through a further flap valve, the mitral valve. The outflow is carried by the aorta which, like the pulmonary artery, has a semilunar valve (aortic valve).
During a heart cycle, the atria fill first while the ventricles concurrently disgorge the blood into the arteries. When the ventricular musculature relaxes, the flap valves open due to the drop in pressure in the ventricle and the blood flows in from the atria (auricular systole). This is supported by a contraction of the atria. Ventricular contraction follows: the ventricular musculature contracts, the pressure rises, the flap valves close and the blood can now only flow into the arteries through the now-opened semilunar valves. A reverse blood flow from the arteries during the relaxation phase (diastole) is prevented by the closing of the semilunar valves such that the direction of flow is determined solely by the valves.
The four cardiac valves work like mechanical valves in the heart and prevent a reverse flow of blood in the wrong direction. Each half of the heart has a flap valve (atrioventricular valve) and a semilunar valve. The atrioventricular valves are situated between the atrium and the ventricle and are called the bicuspid/mitral valve and the tricuspid valve. The semilunar valves are situated between the ventricle and the vascular outflow and are called the pulmonary valve and the aortic valve respectively.
A valve defect; i.e. a dysfunction of a cardiac valve's function, can affect any of the four cardiac valves, although the valves on the left side of the heart (aortic and mitral valves) are affected considerably more frequently than those on the right side of the heart (pulmonary and tricuspid valves). Dysfunction can encompass constriction (stenosis), insufficiency or a combination of the two (combined vitium).
In medicine, the term “aortic valve insufficiency”, or “aortic insufficiency” for short, refers to the defective closing of the heart's aortic valve and the diastolic reverse flow of blood from the aorta into the left ventricle as a result. Depending on the severity of the aortic insufficiency and the extent of resistance to aortic depletion, the volume of reverse flow can be up to two thirds of the left ventricle's ejection volume (normal cardiac output 40 to 70 ml). This results in characteristically high blood pressure amplitude. This regurgitate blood flow increases the diastolic filling of the left chamber and leads to a volume overload of this section of the heart, a consequence of which is eccentric hypertrophy.
Aortic valve stenosis is a valvular heart disease caused by the incomplete opening of the aortic valve. When the aortic valve becomes stenotic, it causes a pressure gradient between the left ventricle and the aorta. The more constricted the valve, the higher the gradient between the left ventricle and the aorta. For instance, with a mild aortic valve stenosis, the gradient may be 20 mmHg. This means that, at peak systole, while the left ventricle may generate a pressure of 140 mmHg, the pressure that is transmitted to the aorta will only be 120 mm Hg.
In individuals with aortic valve stenosis, the left ventricle has to generate an increased pressure in order to overcome the increased after load caused by the stenotic aortic valve and eject blood out of the left ventricle. The more severe the aortic stenosis, the higher the gradient is between the left ventricular systolic pressures and the aortic systolic pressures. Due to the increased pressures generated by the left ventricle, the myocardium (muscle) of the left ventricle undergoes hypertrophy (increase in muscle mass).
Angina in the setting of aortic valve stenosis is secondary to the left ventricular hypertrophy that is caused by the constant production of increased pressure required to overcome the pressure gradient caused by the aortic valve stenosis. While the myocardium (i.e. heart muscle) of the left ventricle gets thicker, the arteries that supply the muscle do not get significantly longer or bigger, so the muscle may become ischemic (i.e. doesn't receive an adequate blood supply). The ischemia may first be evident during exercise, when the heart muscle requires increased blood supply to compensate for the increased workload. The individual may complain of exertional angina. At this stage, a stress test with imaging may be suggestive of ischemia.
Mitral valve insufficiency (also called mitral insufficiency) is a frequent cardiac valve defect in human medicine and also in at least some animal species. It involves a closing defect or “leakage” of the heart's mitral valve which leads to reverse blood flow from the left ventricle into the left atrium during the ejection phase (systole).
The mitral valve functions like a mechanical valve between the left atrium and the left ventricle of the heart. It opens during the filling phase of the ventricle (diastole) and thus enables the inflow of blood from the atrium. At the beginning of the ejection phase (systole), the sudden increase in pressure in the ventricle leads to the closing of the valve and thus to a “sealing” of the atrium. In so doing, a pressure of only about 8 mmHg prevails in the atrium, while at the same time the systolic pressure of about 120 mmHg in the ventricle forces the blood along its usual path into the main artery (aorta).
In cases of severe mitral insufficiency, however, the regurgitation opening is larger than 40 mm2 and the regurgitation volume greater than 60 ml, which can lead to serious and at times life-threatening changes.
In the acute stage, with a normal size to the left ventricle and the left atrium, there is a considerable increase of the pressure in the atrium and thus also in the pulmonary veins. This can be up to 100 mmHg which, given a normal condition to the pulmonary vessels, leads to immediate pulmonary oedema. The then predominantly reverse blood flow can result in insufficient outflow into the aorta and thus decreased blood flow to all the organs.
To treat a severe narrowed cardiac valve or cardiac valve insufficiency, it is necessary for an endoprosthesis to perform the valve function of the narrowed or diseased cardiac valve. Essential in this respect is that the endoprosthesis is securely positioned and anchored in the implantation site in the heart; i.e. in the plane of the (diseased) cardiac valve to be replaced, so that the endoprosthesis is not displaced or shifted despite the, at times considerable, forces acting on it. Also, an effective seal during systole is important for the mitral valve and during diastole for the aortic valve.
The present invention relates to an expandable stent for an endoprosthesis used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve. Insufficiency. Furthermore, the present invention relates to a collapsible and expandable prosthesis incorporating a stent that can be delivered to the implant site using a catheter for treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency. Although the inventive stent and the valvular prosthesis affixed thereto can be used for replacing any of the four different heart valves, in particular the pulmonary valve and the aortic valve, the application of the invention for treatment of a diseased aortic valve is described in the following only for reasons of simplification.
A cardiac valve stent 10, to which the valvular prosthesis 100 is appropriately affixed, is employed in accordance with at least certain embodiments of the invention to position and anchor said endoprosthesis. A medical device for the treating of a narrowed cardiac valve or a cardiac valve insufficiency consisting of a cardiac valve stent 10 and a valvular prosthesis 100 affixed to the stent 10 will be referred to herein simply as endoprosthesis 1.
The following description will make reference to the drawings to describe preferred embodiments of the present invention in detail. The cardiac valve stent 10 according to certain embodiments of the invention (hereinafter referred to simply as “stent”) exhibits an expandable structure which is able to transform from a first predefinable shape in which the stent 10 is in a collapsed state into a second predefinable shape in which the stent 10 is in an expanded state.
In the two embodiments, the stent 10 together with a valvular prosthesis affixed thereon is introduced in a minimally-invasive fashion into the body of a patient in its first shape (cf.
Upon reaching the site of implantation in the patient's heart, the stent 10 transforms, through increments, into its expanded shape in which also the valvular prosthesis 100 affixed to the stent 10 also unfolds and expands. The expanded shape of the stent 10 is a permanent shape that has been set by programming. The completely expanded stent 10 according to the first/second embodiment of the invention with the likewise completely unfolded and expanded valvular prosthesis 100 affixed thereto is shown in
The following will initially make reference to
The stent 10 according to the first embodiment exhibits a structure integrally cut from a portion of tube, in particular a metal tube. The cutting pattern used to form the design of the stent is depicted in a two-dimensional projection in
In detail, the stent 10 has three positioning arches 15a, 15b, 15c which assume the function of self-positioning the stent into the plane of the pulmonary valve (valva trunci pulmonalis) or aortic valve (valva aortae). The positioning arches 15a, 15b, 15c exhibit a rounded head portion 20 which engages in the pockets T of the (diseased) cardiac valve to be treated during positioning of the stent 10 at the site of implantation in the heart (cf.
As well as providing a symmetry that matches that of the native valve, the provision of three positioning arches 15a, 15b, 15c also provides rotational accuracy, symmetry and stability. The stent 10 is of course not limited to the use of a total of three positioning arches.
The head portions 20 of the positioning arches 15a, 15b, 15c, respectively pointing towards the lower end 2 of the stent 10, are rounded so that the vascular wall will not be damaged when the positioning arches 15a, 15b, 15c engage in the pockets T of the cardiac valve H to be replaced. To improve movement and position analysis during the implanting of the stent 10 reference markers 21 are provided on or within the head portions 20 of the positioning arches 15a, 15b, 15c. Radio opaque markers or markers which can be activated by infrared or ultrasound lend themselves particularly well hereto.
The positioning arches 15a, 15b, 15c respectively exhibit an essentially U-shaped or V-shaped structure which is closed to the lower end of stent 10. Accordingly, each positioning arch 15a, 15b, 15c has a total of two arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ respectively extending from the head portion 20 of the associated positioning arch 15a, 15b, 15c towards the upper end 3 of stent 10. By doing so, each two adjoining arms of two neighbouring positioning arches are connected to one another via a connecting portion 22.
For implanting and explanting the stent 10 together with a valvular prosthesis affixed thereto with a suitable catheter system, the stent 10 comprises catheter retaining means 23 at its upper end 3. The connecting portions 22 are respectively connected to catheter retaining means 23 via a connecting web 25. The connecting webs 25 will hereinafter be referred to as “second connecting web 25”.
The catheter retaining means 23 comprise oval-shaped heads which each comprise a corresponding oval-shaped eyelet 24. The shape of the catheter retaining means 23 complements a crown on the tip of a catheter of a catheter system used to implant/explant stent 10. The crown on the catheter tip has protruding elements that are configured as a negative of the catheter retaining means 23. Alternatively, the protruding elements are shaped to be complementary to the eyelets 24 and are configured as catheter retaining heads. This realization enables the protruding elements of the crown to form a releasable engagement with the upper area 3 of stent 10 to allow releasable attachment of the stent 10 to the tip of the catheter. A first connecting web 17 extends essentially in the longitudinal direction L of stent and has an upper end portion 17d and a lower end portion 17p. The upper end portion 17d opens into connecting portion 22 between the two arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of two neighboring positioning arches 15a, 15b, 15c, in addition to the previously-mentioned second connecting web 25. As can be seen in
In between each positioning arch 15 and retaining arch 16 is a fastening arch 19. As is shown particularly clearly in
This stent design achieves an axially symmetrical structure, whereby each positioning arch 15a, 15b, 15c is allocated one fastening arch 19a, 19b, 19c and one retaining arch 16a, 16b, 16c. The stent 10 of the first embodiment depicted in
In the state of the stent 10 shown in
Reference is made to
A comparison of
Even when a certain anchoring of the stent 10 together with a valvular prosthesis affixed thereto is achieved at the site of implantation in the heart due to the positioning arches 15a, 15b, 15c already protruding radially from stent 10 in the expanded state of the stent 10, it is noted that the contact force acting on the vascular wall from the positioning arches 15a, 15b, 15c is insufficient to securely anchor the stent 10 at the site of implantation. The previously-mentioned retaining arches 16a, 16b, 16c, which form the lower end 2 of stent 10, are provided for this reason. The retaining arches 16a, 16b, 16c protrude radially from the circumference of the stent 10 in its expanded state such that the retaining arches 16a, 16b, 16c press against the wall of the blood vessel in which the stent is deployed with a radially-acting contact force. In addition, the closed ends of the retaining arches 16a, 16b, 16c flare outwards, protruding radially still further from the circumference of the stent 10. This shape allows the ends of the retaining arches 16a, 16b, 16c to be positioned below the native valve annulus or to be positioned at least on the native valve annulus, thereby providing additional anchoring for the stent 10 together with a valvular prosthesis affixed thereto.
In addition to retaining arches 16a, 16b, 16c, the stent 10 further comprises auxiliary arches 18a, 18b, 18c, which likewise exert a radially-acting contact force against the wall of the blood vessel in the implanted state of stent 10, thereby further improving anchoring of stent 10 and a valvular prosthesis affixed thereto at the site of implantation.
As can be seen from
In a top plan view of the lower end region 2 of the expanded stent 10 (cf.
To recapitulate, providing retaining arches 16a, 16b, 16c on the one hand and auxiliary arches 18a, 18b, 18c on the other results in a radial force being exerted on the vascular wall by the respective lower end portions of these arches. This ensures both a secure seal of a valvular prosthesis 100 affixed to stent 10 relative the vascular wall, as well as a secure anchoring of the stent 10, at the site of implantation in the heart.
In addition to the contact force exerted on the vascular wall by way of the retaining arches 16a, 16b, 16c and auxiliary arches 18a, 18b, 18c, it is conceivable for the upper end region 3 of stent 10 to expand radially 10% to 25% more—in the fully expanded but not implanted state of stent 10—compared to the lower end region 2.
This gives the stent 10 a slight concave structure which tapers towards the lower end region 2. However, in its fully expanded and implanted state, the upper end section 3 of the stent 10 may not be expanded radially 10% to 25% more compared to the lower end region 2 because the shape of the stent in its implanted state is limited by the anatomy in the implantation side. However, the upper end section 3 of the stent tends to spread radially somewhat relative to the annular diameter of the constrained lower end section 2 of the stent 10. This ensures secure anchoring of the stent 10 within the vessel by the upper end region 2 of the stent 10 pressing against the vascular wall.
To ensure that minimal longitudinal displacement of a valvular prosthesis affixed to stent 10 can occur relative stent 10, even during the peristaltic movement of the heart and the blood vessel in which stent 10 together with a valvular prosthesis affixed thereto is deployed, the embodiment of the inventive stent 10 depicted in the drawings provides for the stent 10 to comprise a plurality of fastening portions 11 extending in the longitudinal direction L of stent 10, by means of which the tissue component(s) of a valvular prosthesis 100 is affixed to the stent 10. Reference is made to
It will be appreciated that the valvular prosthesis may be made from any suitable material, including biological valves removed from animals such as pigs and horses, man-made biological valves created from connective tissue such as pericardium, tissue grown from cell cultures, and man-made materials and fabrics such as nitinol.
In detail, the first connecting webs 17 of stent 10 connect with connecting portions 22 via their upper ends 17d and with the upper ends 13 of fastening portions 11 via their lower ends 17p. The respective lower ends 14 of the fastening portions which are connected to one and the same connecting web 17 are thereby connected together via an essentially U-shaped or V-shaped auxiliary arch 18a, 18b, 18c which is closed towards the lower end 2 of stent 10.
Specifically, the first embodiment of the inventive stent 10 is shown in
As can be seen from
Both components constituting the endoprosthesis 1, namely the stent 10 and the valvular prosthesis 100, may be connected together prior to the surgical procedure. The so constructed endoprosthesis 1 can be stored in its expanded shape for a long period of time without structural deterioration in the tissue of the valvular prosthesis 100. The endoprosthesis 1 shall be compressed and brought into its collapsed shape directly prior to the surgical procedure. Then, the endoprosthesis 1 is ready for being inserted into a catheter system which is used for implanting the endoprosthesis 1.
It is conceivable of course that both components constituting the endoprosthesis 1, namely the stent 10 and the valvular prosthesis 100, are not connected together until directly prior to the surgical procedure. Then, the stent 10 shall be stored in its second shape; i.e. in the expanded state, and not brought into its first (collapsed) shape until directly prior the surgical procedure.
It can be noted from
The cross-sectional shape to the fastening holes 12 may also be adapted to the cross-sectional shape of the thread 101 or wire used to fasten the valvular prosthesis 100. This allows fixing of the valvular prosthesis 100 to the stent 10 at a precise predefined position relative to the stent 10. By providing of a plurality of fastening holes 12 to anchor the valvular prosthesis 100 to the stent 10, precise positioning of the valvular prosthesis on stent 10 is achieved.
Because the fastening holes 12 are adapted to the thickness and/or the cross-sectional shape of the thread 101 or wire used to affix the valvular prosthesis 100 to the stent 10, relative movement between the stent 10 and the valvular prosthesis 100 due to the peristaltic motion of the heart can be effectively prevented when the endoprosthesis 1 is implanted. In the fully expanded and implanted state of the endoprosthesis 1, the valvular prosthesis 100 is thus fastened to the stent 10 with minimal play, based on which friction-Induced wear of the thread 101 or wire used to affix the valvular prosthesis is minimized. As shown in the figures the fastening holes 12 have a circular cross-sectional shape.
Although the valve tissue, i.e. the tissue component(s) of the valvular prosthesis 100, shall be securely fastened to the stent 10, it is necessary that the valve tissue must be capable of deforming without damage to allow for the stent lengthening when collapsed.
As already mentioned, the fastening holes 12 configured in the respective fastening portions 11 may be of different diameters, numbers or cross-sectional shapes (oval, square, etc) according to the diameter of a thread 101 used for affixing the tissue component(s) of the valvular prosthesis 100 to the stent 10, and/or according to the sewing technique utilized for affixing the valvular prosthesis 100 to the stent 10. The diameter, number and/or cross-sectional shape of at least one of the fastening holes 12 may also serve as an indication of the type of the endoprosthesis 1, i.e. the medical device used in the treatment of a narrowing of a cardiac valve and/or a cardiac valve insufficiency. In this respect, the diameter, number and/or cross-sectional shape of the at least one fastening hole 12 may be used for identification to differentiate between different sizes or types of valvular prostheses 100 adapted to be fixed on the stent 10, or may be used for identification to differentiate between different sizes or types of endoprostheses 1, if a valvular prosthesis 100 is already fixed to the stent 10. For example, a small-sized stent 10 having a small-sized valvular prosthesis 100 fixed thereto or a small-sized stent 10 adapted and configured for carrying a small-sized valvular prosthesis 100 could have circular fastening holes 12 whilst a large-sized stent 10 having a large-sized valvular prosthesis 100 fixed thereto or a large-sized stent 10 adapted and configured for carrying a large-sized valvular prosthesis 100 may have triangular fastening holes 12. This allows the surgeon/cardio staff to easily and visually tell different valve sizes, stent types and/or types of the valvular prosthesis apart without the need to measure.
In the first embodiment depicted in
As described in detail with respect to the sixteenth and seventeenth embodiments of the present invention, however, the retaining arches together with the fastening portions provided in the respective arms of the retaining arches may also be configured such that they do change their shape when the stent 10 is compressed. In detail, according to the sixteenth and seventeenth embodiments of the inventive stent design, the retaining arches are curved in the expanded state of the stent, but relatively straight when the stent is collapsed.
A stent 10 in accordance with a second embodiment is depicted in
A difference to be seen is in the configuration of the catheter retaining means 23 provided at the upper end section 3 of stent 10. In contrast to the first embodiment of the inventive stent 10, heads of an essentially round configuration are used as catheter retaining means 23 in the second embodiment, in each case provided with essentially oval eyelets 24. Due to the round configuration of the heads the risk of producing injury or damage is lowered. Hence, an essentially round configuration of the heads is more atraumatic.
As already indicated, the stent 10 according to certain embodiments of the present invention preferably exhibits a structure integrally cut from a portion of tube, and in particular from a metal tube. A fastening arch 19a, 19b, 19c and a retaining arch 16a, 16b, 16c is allocated to each positioning arch 15a, 15b, 15c, and each retaining arch 16a, 16b, 16c is connected to a neighboring retaining arch by means of an auxiliary arch 18a, 18b, 18c. A fastening portion 11 with a specific number of fastening holes 12 is configured in each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of retaining arch 16a, 16b, 16c.
In addition to its retaining arches 16a, 16b, 16c, the stent 10 further comprises auxiliary arches 18a, 18b, 18c which enable a particularly secure anchoring of stent in the site of implantation in the heart.
A stent 10 according to a third embodiment of the invention also has a one-piece structure cut from a portion of a tube, in particular from a metal tube. The cutting pattern used to form the stent design is shown in a two-dimensional projection in
The differences between the third embodiment of the stent and the first or second embodiments can be seen by referring to the two-dimensional cutting pattern shown in
The stent 10 is made from Nitinol and positioning arches 15a, 15b, 15c are programmed during manufacture, by a suitable heat treatment of the positioning arches 15a, 15b, 15c, so that, in the stent's expanded state, i.e. when the permanent shape has been assumed after exceeding the switching temperature, the positioning arches not only spread apart in a radial direction, as illustrated in
In addition, the convex curvature of the positioning arches 15a, 15b, 15c enables an especially secure support of the stent 10 at the implantation site since the positioning arches 15a, 15b, 15c are better adapted to the anatomy of the pockets T of the native heart valves H and their surroundings.
As in a stent 10 according to the first and second embodiment (see for example
As with the stent 10 of the first or second embodiment, the retaining arches 16a, 16b, 16c and auxiliary arches 18a, 18b, 18c serve to secure radial fixing of the stent at the implantation site and for stretching a valvular prosthesis fastened to the stent by way of fastening arches 19a, 19b, 19c. No further discussion is needed to explain that the retaining arches 16a, 16b, 16c and the auxiliary arches 18a, 18b, 18c of this embodiment of the stent also function to seal an implanted valvular prosthesis. Similarly, the retaining arches 16a, 16b, 16c and positioning arches 15a, 15b, 15c clamp the native heart valve H like a paperclip and consequently contribute to the secure anchoring of the stent 10 at the implantation site in the heart.
Stent 10 according to the third embodiment differs from the first and second embodiments in that the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of each retaining arch 16a, 16b, 16c extend from the fastening portion 11 to the lower end 2 of the cardiac valve stent and are connected together by means of a connecting portion 30. The connecting portion 30 has a different shape when compared with the U-shaped or V-shaped connecting portions 30 in the embodiments according to
Looking at
The alternative shape of the connecting portion 30 further increases the effective contact area between the lower end of the retaining arch 16a, 16b, 16c and the vessel wall, when the stent is positioned at the implantation site in its expanded state. Because of this, an improved seal can be obtained between the stent with the valvular prosthesis attached to it and the vessel wall. Furthermore, the radial forces acting in the expanded state of the stent, which are transmitted via the retaining arches 16a, 16b, 16c to the vessel wall, are distributed over a discrete contact area, thereby counteracting the occurrence of load peaks. The risk of damage from the retaining arches 16a, 16b, 16c to the vessel wall is also reduced.
Each connecting portion 30′ which connects the two arms 19a′, 19a″, 19b′, 19b″, 19c′, 19c″ of a fastening arch 19a, 19b, 19c has a more angular shape that assists with anchoring of a valvular prosthesis 100 to the stent 10.
The alternative shapes of the closed ends of the retaining and fastening arches (16, 19) accommodates the enlarged heads 31 of shortened auxiliary arches 18a, 18b, 18c. The enlarged head 31 enables the auxiliary arches to be used to support the valve material 100, as well as providing additional radial force. The heads 31 include fastening holes 12 for additional attachment of the prosthetic valve 100 which further stabilizes the prosthetic valve 100 attached to the stent. The additional fastening holes 12 also reduce the likelihood of miss-aligning the valve 100 within the stent 10 and minimize any longitudinal movement of the valve 100 once the endoprosthesis 1 has been implanted. In addition and as already discussed in relation to the retaining arches 16a, 16b, 16c, an enlarged contact area is provided with the widened head portions 31, which improves the anchorage of the stent 10 at the implantation site while minimizing the risk of damage to the vessel wall.
As can be seen from the cutting pattern of
A yet further difference between the stent of the third embodiment and the stents of the first and second embodiments is the inclusion of notches 26. As shown in
To accommodate the notches 26, the auxiliary arches 18a, 18b, 18c extend from the fastening portion 11 mid-way along the length of the fastening portion 11, rather than from the lower end of the fastening portion 11. This provides each auxiliary arch 18a, 18b, 18c with sufficient flexibility that would otherwise be lacking from a shorter auxiliary arch.
The fourth embodiment of the stent 10 is similar to the third embodiment. However, the stent of the fourth embodiment includes additional fastening holes 12a provided for fastening a valvular prosthesis. Specifically, the additional fastening holes 12a are at the lower end 17p of the first connecting webs 17. The additional fastening holes 12a are configured as eyelets on the first connecting webs 17 between the fastening portion 11 and the connecting portion 22. It is of course conceivable that the additional fastening holes 12a are not configured as eyelets but are directly formed in the first connecting webs. The additional fastening holes 12a enable the upper region of a valvular prosthesis to be additionally secured to the stent 10.
The size of the additional fastening holes 12a may be adapted to the thickness of particular thread or wire used to fasten the valvular prosthesis to the stent 10. The cross-sectional shape of the additional fastening holes 12a may also be adapted to the cross-sectional shape of the thread or wire used for fastening the valvular prosthesis. Due to the presence of a number of additional fastening holes 12a for fixing the valvular prosthesis to the cardiac valve stent, the fastening position of the valvular prosthesis to the cardiac valve stent can be precisely defined.
As an alternative to fastening holes 12a, the same region of the stent 10 may be provided with one or more additional notches. These notches perform the same function as the fastening holes 12a and assist with additional anchoring of a prosthetic valve within the stent 100.
A stent 10 according to the fifth embodiment of the invention is shown in
The stent 10 according to the fifth embodiment is comparable in structural and functional respect to the stent of the third embodiment. In particular, the stent 10 of the fifth embodiment similarly has a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent 10 in the plane of the valve of the pulmonary valve or the aortic valve. As in other embodiments of the stent 10, the positioning arches 15a, 15b, 15c have a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent 10 at the implantation site in the heart (see
A total of three retaining arches 16a, 16b, 16c and three fastening arches 19a, 19b, 19c are also provided.
The fifth embodiment stent 10 differs from the stent of the third embodiment in that further notches 26a are provided in addition to the fastening holes 12 in the fastening portion 11. As can be seen in
It is conceivable of course that the additional notches 26a are adapted to the thickness of the suture thread or wire. In particular, the additional notches 26a may be radiused to minimize damage to the suture thread or wire.
The fifth embodiment of the stent 10 also includes radial arches 32a, 32b, 32c extending from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent 10. As is shown most clearly in
As can be seen in particular in the cutting pattern shown in
This head is not only radiused but also widens at the tip so that the head abuts against the interior wall of the vessel over as large a contact area as possible when the stent 10 is in its expanded and implanted state.
The heads of each radial arch 32a, 32b, 32c also serve as additional means by which the stent 10 may be retained in a catheter before and during implantation and/or to recapture the stent after implantation.
It can be seen from the cutting pattern shown in
In principle, the stent 10 may have more than three radial arches 32 in order to increase the radial contact force further. It is also possible to provide barb elements on all or some of the radial arches 32a, 32b, 32c, for example, to allow a still better anchoring of the stent 10 at the implantation site.
A stent 10 according to a sixth embodiment of the invention is shown in
As in the embodiments previously described, the stent 10 of the sixth embodiment is again configured as a one-piece structure cut from a portion of tube, in particular from a metal tube, the cutting pattern being shown as a two-dimensional projection in
The sixth embodiment of the stent 10 is in principle similar in structure and function with respect to the fifth embodiment. To avoid repetition, reference is therefore made to the above description of the fifth embodiment. In particular, essentially U-shaped or V-shaped radial arches 32a, 32b, 32c are likewise provided to increase the radially acting contact force in the upper region of the stent 10.
The sixth embodiment differs from the fifth embodiment in that fixing bridges 27 with additional fastening portions 11a are provided for additional fastening of the tissue component(s) of the valvular prosthesis. The presence of fixing bridges 27 with additional fastening portions 11a is a particular advantage when a valve constructed from a sheet of biological material, such as pericardium, is used as a valvular prosthesis, i.e. a valvular prosthesis which is made up of several pieces of material.
When pericardial valves are used, care must be taken to ensure that the pericardial material can be securely attached to the stent 10. For this reason, the stent 10 according to the sixth embodiment has a total of three fixing bridges 27 each comprising additional fastening portions 11a. Each fixing bridge 27 is attached to one of the first connecting webs 17 and extends in the direction of the lower end 2 of the stent 10.
The additional fastening portions 11a provided on the fixing bridges 27 have yet more fastening holes 12b and/or other fastening means, for example notches 26b, to anchor a thread or a thin wire which is used to fastened the pericardial material or the valvular prosthesis to the stent 10 allowing minimal, preferably no, movement of the valvular prosthesis. It is of course conceivable to provide fastening holes or fastening eyelets, the diameter of which is adapted to the thickness of the thread or wire used for fastening the valvular prosthesis. In general, the fastening holes 12b or notches 26b should be radiused to minimize wear of the thread or the wire induced by friction so far as is possible.
Reference is made to
The valvular prosthesis 100 comprises at least one leaflet 102 (see
To ensure that minimal longitudinal displacement of the valvular prosthesis 100 affixed to stent 10 can occur relative stent 10, even during the peristaltic movement of the heart and the blood vessel in which stent 10 is deployed, the stent 10 according to the sixth embodiment of the invention comprises a plurality of fastening portions 11 extending in the longitudinal direction L of stent 10. In addition, the stent 100 according to the sixth embodiment is provided with additional fastening portions 11a, each of which is attached to one of the first connecting webs 17 and extends in the direction of the lower end 2 of the stent 10. By means of both the fastening portions 11 and the additional fastening portions 11a the tissue component(s) of the valvular prosthesis 100 is affixed to the stent 10.
In detail, the tissue component(s) of the valvular prosthesis 100 is fastened to the stent 10 by means of a thread 101 or a thin wire which is guided through each respective fastening hole 12, 12b of the fastening portions 11 and the additional fastening portions 11a, respectively. This allows fixing of the valvular prosthesis 100 to the stent 10 at a precise predefined position relative to the stent 10. By providing of a plurality of fastening holes 12 to anchor the valvular prosthesis 100 to the stent 10, precise positioning of the valvular prosthesis 100 on stent 10 is achieved.
Reference is made to
The stent 10 according to the present invention is—as will be described in detail below with reference to the illustrations of
It is important to note that the insertion procedure shown in
In detail, during a first release step, the proximal side K of the delivery portion of the insertion catheter system is manipulated such that the positioning arches 15a-c of stent 10 are released while the remaining parts of the stent 10, in particular the retaining arches 16a, 16b, 16c, the auxiliary arches 18a-c and the radial arches 32a-c are still in their collapsed state (cf.
In the second release step which follows, the proximal side K of the delivery portion of the insertion catheter system is manipulated such that the arches forming the lower end 2 of the stent 10 (auxiliary arches 18a-c and retaining arches 16a, 16b, 16c) are released while the upper end 3 of the stent 10 is however still firmly affixed to the proximal side K of the delivery portion of the catheter system and is not released (cf.
The positioning arches 15a-c disposed on stent 10 and also the retaining arches 16a, 16b, 16c may be curved in convex and arched fashion in the lower direction; i.e. toward the lower end 2 of stent 10, whereby such a rounded form may reduce injuries to the artery as well as facilitate the unfolding during the self-expansion. Such a design may enable an easier insertion of the positioning arches 15a-c into the pockets of the native cardiac valve without correspondingly injuring the neighboring tissue or blood vessels.
In
As shown in
If the functional test shows that the valvular prosthesis 100 satisfactorily functions, the sleeve-like portion P can be pulled back distally so that also the upper end section 3 of stent 10 with the catheter retaining means 23 is fully released (cf.
It can further be seen from the
The annular bead 105 at the lower end of the valvular prosthesis 100 may provide a secure anchoring of the peripheral area of the valvular prosthesis 100 to the blood vessel in the implanted state of the endoprosthesis 1, even given the peristaltic motion, and thus may provide a secure seal relative the vascular wall.
The annular bead 105 at the lower end of the valvular prosthesis 100 may also provide good contact and more uniform structure at the lower end section 2 of the stent 10 to more evenly distribute the radial forces needed to anchor the endoprosthesis 1 in its implanted state. In this regard, sealing and preventing leakage after implantation of the endoprosthesis 1 can be achieved. Over time, tissue growth will further secure the endoprosthesis 1 to prevent any movement relative to the blood vessel in the implanted state of the endoprosthesis 1 or leakage. When implanting the endoprosthesis 1 in a native blood vessel any leakage between the peripheral area of the annular bead 105 and the vascular wall is sealed by a good contact and radial pressure between the endoprosthesis 1 and the diseased native valve annulus. Accordingly, the bead-shaped area 105 provides a secure seal, particularly also during the filling phase of the heart cycle (diastole).
As shown in
As shown in
It can also be noted from
A seventh embodiment of the inventive stent 10 will be described in the following with reference to
Except for the lower end section, the stent 10 according to the seventh embodiment essentially corresponds to the stent according to the sixth embodiment of the present invention described above with reference to
Hence, the stent 10 according to the seventh embodiment has also a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent 10 in the plane of the valve of the pulmonary valve or the aortic valve. As in other embodiments of the stent 10, the positioning arches 15a, 15b, 15c have a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent 10 at the implantation site in the heart (see
A total of three retaining arches 16a, 16b, 16c is also provided. Contrary to the stent design of the sixth embodiment, however, in the stent design according to the seventh embodiment, the two arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of each retaining arch 16a, 16b, 16c are not connected to each other via a connecting portion which has almost an O-shaped configuration. Rather, in the seventh embodiment, the lower end section of each arm of the retaining arches 16a, 16b, 16c merges into an annular collar 40, which will be described in more detail below.
As in the sixth embodiment of the present invention, the stent design according to the seventh embodiment is also provided with fixing bridges 27 with additional fastening portions 11a for additional fastening of the tissue component(s) of a valvular prosthesis or parts of a valvular prosthesis. Each fixing bridge 27 is attached to one of the first connecting webs 17 and extends in the direction of the lower end 2 of the stent 10. The additional fastening portions 11a provided on the fixing bridges 27 have yet more fastening holes 12b and notches 26b to anchor a thread or a thin wire which is used to fastened the pericardial material or the tissue component(s) of the valvular prosthesis to the stent 10 allowing minimal, preferably no, movement of the valvular prosthesis it is of course conceivable to provide fastening holes or fastening eyelets, the diameter of which is adapted to the thickness of the thread or wire used for fastening the tissue component(s) of the valvular prosthesis.
The seventh embodiment of the stent 10 also includes radial arches 32a, 32b, 32c extending from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent 10. As is shown most clearly in
Since in the implanted state of the endoprosthesis 1, substantial forces act on the valvular prosthesis 100 during the filling phase of the heart cycle (diastole), which are transmitted to the stent affixed with the valvular prosthesis 100, the secure anchoring of the stent 10 with the valvular prosthesis 100 affixed thereto at the site of implantation may of distinct importance. The seventh to eleventh embodiments of the stent 10 described in the following incorporate further measures which can be provided additionally to the above-described embodiments of retaining arches, auxiliary arches and radial arches which may more securely anchor of stent 10, endoprosthesis 1 respectively, at the site of implantation and which may prevent a positional displacement of endoprosthesis 1.
In detail, at least one annular collar 40, which forms the lower end 2 of the stent 10, is provided in accordance with the seventh embodiment as an additional anchoring measure for the stent 10 depicted in
Apart from the connection of the annular collar 40 to the stent body, the stent design depicted in
Contrary to the stent design of, for example, the sixth embodiment, however, in the stent design depicted in
Contrary to the stent design depicted in
In general, however, the stent 10 of the seventh embodiment an annular collar 40 wherein the annular collar 40 may also be connected to each or a part of the lower end sections of the respective arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the auxiliary arches 18a, 18b, 18c, as can be seen in particular from the flat roll-out view pursuant to
The annular collar 40 exhibits a plurality of supporting webs 41 which run parallel to the longitudinal axis of the stent 10 in the non-expanded state of said stent 10 and are inter-connected by transversal webs 42 (cf.
The annular collar 40 serves as a supporting body through which the radial forces developing due to the self-expansion are transmitted to the vascular wall. Since a relatively large contact area of the stent 10 interacts with the vascular wall, and because of the rhomboidal or serpentine structure to the annular collar 40, there may be a decreased risk of injury to the artery or the tissue despite the increased radial forces.
Accordingly, not only the rigidity of the stent 10 can be increased after its self-expansion by the providing of the annular collar 40, but also the anchorage of the stent 10 in the implanted state can be improved or strengthened. Additionally, the annular cross-sectional shape to annular collar 40 increases the seal between the vascular wall and the endoprosthesis 1.
Such an annular collar 40 is advantageously configured as a self-expandable supporting structure which advantageously effects an even further improved anchoring of the stent 10 at the site of implantation due to its radially-outward-acting contact pressure and its design such that a displacing of the stent 10 with the valvular prosthesis 100 can be further prevented.
An eighth embodiment of the inventive stent 10 is shown in
Except for the upper end section, the stent 10 according to the eighth embodiment essentially corresponds to the stent according to the fifth embodiment of the present. Invention described above with reference to
Hence, the stent 10 of the eighth embodiment similarly has a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent 10 in the plane of the valve of the pulmonary valve or the aortic valve. As in other embodiments of the stent 10, the positioning arches 15a, 15b, 15c have a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent 10 at the implantation site in the heart (see
A total of three retaining arches 16a, 16b, 16c and three fastening arches 19a, 19b, 19c are also provided.
Furthermore, in the eighth embodiment stent 10, further notches 26a are provided in addition to the fastening holes 12 in the fastening portion 11 which serve as additional anchoring means for the tissue component(s) of the valvular prosthesis 100 and guides for the suture thread or wire. These additional notches 26a also minimize movement of the suture thread or wire thereby reducing wear on the thread or wire by rubbing on the first connecting web 17 when the endoprosthesis 1 is implanted. The additional notches 26a also ensure that the upper region of a valvular prosthesis can be fastened firmly to the cardiac valve stent 10 allowing minimal movement of the prosthesis thereby further minimizing the likelihood of wear induced by friction on the suture thread or wire.
A total of three retaining arches 16a, 16b, 16c and three fastening arches 19a, 19b, 19c are also provided.
In contrast to the seventh embodiment (cf.
To be seen from the illustration of the cutting pattern according to
Since the upper annular collar 40′ utilized in the eighth embodiment is comparable to the lower annular collar 40 utilized in the seventh embodiment in terms of functioning. In particular, the upper annular collar 40′ provides good anchoring to prevent migration of the endoprosthesis in its implanted state and a uniform distribution of these radial forces.
The following will reference
Since an upper annular collar 40′ is likewise formed at the upper end 3 of the stent 10, the stent 10 in accordance with the ninth embodiment is similar to the previously-described stent according to
As also with the eighth embodiment described above with reference to
In contrast, for example, to the eighth embodiment (cf.
To be seen from the illustration of the cutting pattern according to
Since the lower annular collar 40 utilized in the tenth embodiment is comparable to the lower annular collar 40 utilized in the seventh embodiment in terms of functioning, and is not further described for clarification purposes.
Except for the upper and lower end section, the stent 10 according to the eleventh embodiment is similar to the stent according to the fifth embodiment of the present invention described above with reference to
Hence, the stent 10 according to the eleventh embodiment has also a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent 10 in the plane of the valve of the pulmonary valve or the aortic valve. As in other embodiments of the stent 10, the positioning arches 15a, 15b, 15c have a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent 10 at the implantation site in the heart (see
A total of three retaining arches 16a, 16b, 16c and three fastening arches 19a, 19b, 19c are also provided.
The eleventh embodiment of the stent 10 also includes radial arches 32a, 32b, 32c extending from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent 10. As is shown in
The eleventh embodiment of the stent (cf.
As already described with respect to the seventh to tenth embodiment of the present invention, the upper and lower annular collars 40, 40′ exhibits a plurality of supporting webs 41 which run parallel to the longitudinal axis of the stent 10 in the non-expanded state of said stent 10 and are interconnected by transversal webs 42 (cf.
A comparison of
Naturally, the annular collar 40 or 40′ can in principle also be arranged in a plane in which the valvular prosthesis is situated. It is furthermore not imperative for the annular collar 40 to be connected to all the end sections of the retaining arches 16a, 16b, 16c or the auxiliary fastening arches 19a-c respectively. Nor does the upper annular collar 40′ necessarily have to be connected to all the end sections of the radial arches 32.
Elements in
In principle, the stent according to the twelfth embodiment is similar to the stent of the fifth embodiment already described with reference to
Briefly summarized, the stent of the twelfth embodiment similarly has a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent in the plane of the pulmonary valve or the aortic valve. As in other embodiments of the stent, the positioning arches 15a, 15b, 15c have a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent at the implantation site in the heart (see
Also, the stent of the twelfth embodiment is provided with a total of three retaining arches 16a, 16b, 16c. According to the cutting pattern depicted in
In addition, essentially U-shaped or V-shaped radial arches 32a, 32b, 32c are likewise provided to increase the radially acting contact force in the upper region 3 of the stent. The radial arches 32a, 32b, 32c of the stent according to the twelfth embodiment extend from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent. According to the cutting pattern depicted in
The two arms 32′, 32″ of each radial arch 32a, 32b, 32c are connected together at the upper end 3 of the stent by means of a radiused connecting portion or head. This head is not only radiused but also widens at the tip so that the head abuts against the interior wall of the vessel over as large a contact area as possible when the stent of the twelfth embodiment is in its expanded and implanted state.
The heads of each radial arch 32a, 32b, 32c also serve as additional means by which the stent of the twelfth embodiment may be retained in a catheter before and during. Implantation and/or to recapture the stent after implantation.
In addition to retaining arches 16a, 16b, 16c, the stent of the twelfth embodiment further comprises auxiliary arches 18a, 18b, 18c, which likewise exert a radially-acting contact force against the wall of the blood vessel in the implanted state of stent, thereby further improving anchoring of stent at the site of implantation. To recapitulate, providing retaining arches 16a, 16b, 16c on the one hand and auxiliary arches 18a, 18b, 18c on the other hand results in a radial force being exerted on the vascular wall by the respective lower end portions of these arches.
This provides both a secure seal of a valvular prosthesis affixed to the stent relative the vascular wall, as well as a secure anchoring of the stent, at the site of implantation in the heart.
As can be seen from the cutting pattern according to
Although not explicitly illustrated in the cutting pattern according to
It can be seen from the cutting pattern shown in
As in the fifth embodiment, the stent according to the twelfth embodiment may have more than three radial arches 32 in order to increase the radial contact force further.
It is also possible to provide barb elements on all or some of the radial arches 32a, 32b, 32c, for example, to anchor the stent at the implantation site.
As already indicated, the stent according to the twelfth embodiment exhibits a structure integrally cut from a portion of tube, and in particular from a metal tube. As in other stent embodiments of the present invention, in the stent according to the twelfth embodiment, a retaining arch 16a, 16b, 16c is allocated to each positioning arch 15a, 15b, 15c, and each retaining arch 16a, 16b, 16c is connected to a neighboring retaining arch by means of an auxiliary arch 18a, 18b, 18c. Also, at least one fastening portion 11 with a specific number of fastening holes 12 is configured in each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of retaining arch 16a, 16b, 16c.
The stent of the twelfth embodiment differs, in particular, from the stent of the fifth embodiment in that the stent according to the twelfth embodiment is not provided with additional notches denoted, for example, in
In detail, first additional fastening portions 11a are provided for additional fastening of the tissue component(s) of the valvular prosthesis or parts of a valvular prosthesis.
These first additional fastening portions 11a are provided with auxiliary fastening holes 12b and/or other fastening means, for example notches, to anchor a thread or a thin wire which is used to fastened the pericardial material or the tissue component(s) of the valvular prosthesis to the stent allowing minimal, preferably no, movement of the valvular prosthesis. The first additional fastening portions 11a are arranged between the first and second arms 16a″, 16b′; 16b″, 16c′; 16c″, 16a′ of two neighboring retaining arches 16a, 16b, 16c and extend from the respective lower ends 17d of the first connecting webs 17 in the direction of the lower end 3 of the stent, the first connecting webs 17 being provided with the already mentioned second additional fastening portions 11b.
In addition to the first additional fastening portions 11a, the stent according to the twelfth embodiment further comprises second additional fastening portions 11b. In detail, each first connecting web 17 of the stent according to the twelfth embodiment is provided with at least one second additional fastening portion 11b, said at least one second additional fastening portion 11b being a portion which comprises additional auxiliary fastening holes 12c and/or other fastening means. The at least one second additional fastening portion 11b extends essentially in the longitudinal direction L of stent according to the twelfth embodiment.
A comparison of the cutting pattern depicted in
In detail, the first connecting webs 17 with the second additional fastening portions 11b connect with connecting portions 22 via their upper ends 17d and with the upper ends of the first additional fastening portions 11a on the one hand as well as with the upper ends of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c via their lower ends 17p.
The additional auxiliary fastening holes 12c and/or other fastening means of the second additional fastening portions 11b serve for anchoring a thread or a thin wire which is used to fastened the pericardial material or the tissue component(s) of the valvular prosthesis to the stent allowing minimal, preferably no, movement of the valvular prosthesis.
With regard to the first and second additional fastening portions 11a, 11b of the stent according to the twelfth embodiment, it is of course conceivable to provide fastening holes 12b, 12c or fastening eyelets, the diameter of which is adapted to the thickness of the thread or wire used for fastening the tissue component(s) of the valvular prosthesis. Preferably, the fastening holes 12b, 12c or fastening eyelets should be radiused to minimize wear of the thread or the wire induced by friction so far as is possible.
The presence of first and second additional fastening portions 11a, 11b with auxiliary and additional auxiliary fastening holes 12b, 12c is a particular advantage when a valve constructed from a sheet of biological material, such as pericardium, is used as an endoprosthesis, including a valvular prosthesis which is made up of several pieces of material.
When pericardial valves are used, care must be taken to ensure that the pericardial material can be securely attached to the stent. For this reason, the stent according to the twelfth embodiment has a total of three first additional fastening portions 11a each comprising auxiliary fastening holes 12b, as well as a total of three second additional fastening portions 11b each comprising additional auxiliary fastening holes 12c.
Apart from the above described difference, the stent of the twelfth embodiment differs particularly from the stent of the fifth embodiment in that the stent according to the twelfth embodiment is provided with at least one so-called “leaflet guard arch”. In detail, according to the cutting pattern depicted in
Each leaflet guard arch 50a, 50b, 50c has a substantially U-shaped or V-shaped structure which is closed to the lower end 2 of stent. In particular, each leaflet guard arch 50a, 50b, 50c has a shape that is roughly similar to the shape of the positioning arch 15a, 15b, 15c in between the corresponding leaflet guard arch 50a, 50b, 50c is arranged. Furthermore, each leaflet guard arch 50a, 50b, 50c extends in the same direction as the positioning arch 15a, 15b, 15c.
In the stent design of the twelfth embodiment, each arm of a leaflet guard arch 50a, 50b, 50c merges at about the mid-point of the length of an arm of a radial arch 32a, 32b, 32c Into the arm of an opposing radial arch 32a, 32b, 32c. It can be seen from the cutting pattern shown in
In this regard, during the insertion procedure, the stent with a valvular prosthesis affixed thereto can be sequentially released upon reaching the site of implantation at the heart wherein, during a first release step, the proximal side K of the delivery portion of the insertion catheter system is manipulated such that the positioning arches 15a-c of stent are released while the remaining parts of the stent, in particular the leaflet guard arches 50a, 50b, 50c, the retaining arches 16a, 16b, 16c, the auxiliary arches 18a-c and the radial arches 32a-c are still in their collapsed state (cf.
In the second release step which follows, the proximal side K of the delivery portion of the insertion catheter system is manipulated such that the leaflet guard arches 50a, 50b, 50c are released while the remaining parts of the stent, in particular the retaining arches 16a, 16b, 16c, the auxiliary arches 18a-c and the radial arches 32a-c are still in their collapsed state. The leaflet guard arches 50a, 50b, 50c released during the second release step expand and spread radially outward. The expanded leaflet guard arches 50a, 50b, 50c push the diseased leaflets, i.e. the leaflets of the native (diseased) cardiac valve, to the neighboring tissue or blood vessel.
In the third release step which follows, the proximal side K of the delivery portion of the insertion catheter system is manipulated such that the arches forming the lower end 2 of the stent (auxiliary arches 18a-c and retaining arches 16a, 16b, 16c) are released while the upper end 3 of the stent is however still firmly affixed to the proximal side K of the delivery portion by using a sleeve-like portion and is not released (cf.
If a functional test shows that the valvular prosthesis 100 affixed to the stent satisfactorily functions, the sleeve-like portion at the proximal side K of the catheter system can be distally pushed further in the direction to the lower end section of the stent 10 in order to release the radial arches 32a, 32b and 32c.
Then, also the upper end section 3 of the stent 10 with the catheter retaining means 23 is fully released, as shown in
The positioning arches 15a-c disposed on the stent and also the retaining arches 16a, 16b, 16c may be curved in convex and arched fashion in the direction to the lower end section of the stent; i.e. toward the lower end 2 of the stent, whereby such a rounded form may reduce injuries to the artery as well as facilitate the unfolding during the self-expansion. Such a design may enable an easier insertion of the positioning arches 15a-c into the pockets of the native cardiac valve without correspondingly injuring the neighboring tissue or blood vessels.
Although not explicitly illustrated in the cutting pattern according to
When the stent is in its expanded and implanted state, the leaflet guard arches 50a, 50b, 50c actively keep the diseased leaflets, i.e. the leaflets of the native cardiac valve, from impinging the leaflet tissue of the valvular prosthesis attached to the stent, when the positioning arches 15a, 15b, 15c are placed outside the native leaflets. In addition, the leaflet guard arches 50a, 50b, 50c may also provide additional anchoring and securing against migration. This feature is unique compared to the cage known from the prior art stent designs which are not provided with positioning arches to push the diseased leaflets out of the way.
In addition to the above described features, the stent design according to the twelfth embodiment further differs from the stent design of, for example, the fifth embodiment in that the stent according to the twelfth embodiment is provided with additional arches. In the expanded state of the stent, each of these additional arches (hereinafter “extra arches”) has a substantially U-shaped or V-shaped structure which is dosed to the lower end 2 of stent. In particular, each extra arch extends in the same direction as the retaining arch 16a, 16b, 16c and the auxiliary arch 18a, 18b, 18c and positioned therebetween.
In detail, according to the cutting pattern depicted in
Providing retaining arches 16a, 16b, 16c and auxiliary arches 18a, 18b, 18c on the one hand and extra arches 60a-f on the other hand may provide a radial force being exerted on the vascular wall by the respective lower end portions of these arches. This provides both a secure seal of a valvular prosthesis affixed to stent relative the vascular wall, as well as a secure anchoring of the stent, at the site of implantation in the heart.
As can be seen from the cutting pattern according to
This stent design particularly provides a total of twelve arches (retaining arches 16a, 16b, 16c, auxiliary arches 18a, 18b, 18c and extra arches 60a-f) substantially uniformly distributed around the lower end region 2 of stent, each of which press against the vascular wall and effectively hold the stent in position in the expanded and implanted state of stent. Hence, in a top plan view of the lower end region 2 of the expanded stent (not explicitly shown), the lower end region 2 of the stent exhibits a polygonal structure having a plurality of vertices formed from the individual arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c, the individual arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the auxiliary arches 18a, 18b, 18c, as well as from the individual arms of the extra arches 60a, 60b, 60c, 60d, 60e, 60f. In this regard, the stent according to the twelfth embodiment has a lower end section 2 with a continuous design that may provide a substantially uniform radial force to help secure the stent in its implanted stage and resist migration. Such a radial force may also help to minimize the risk of leakage.
On the other hand, the extra arches 60a-f of the stent according to the twelfth embodiment may not increase the overall length of the stent. Hence, although this stent design may provide uniform radial force, the risk of contacting with the nerve bundles and heart block if the lower end portion of the stent is below the annulus at the location where the nerve bundles enter, may be reduced.
A stent 10 according to a thirteenth embodiment of the invention is shown in
As in the embodiments previously described, the stent 10 of the thirteenth embodiment is configured as a one-piece structure cut from a portion of tube, in particular from a metal tube, the cutting pattern being shown as a two-dimensional projection in
The thirteenth embodiment of the stent 10 is similar in structure and function with respect to the previously described twelfth embodiment. To avoid repetition, reference is therefore made to the above description of the twelfth embodiment.
Hence, the stent 10 according to the thirteenth embodiment is provided with corresponding retaining arches 16a, 16b, 16c. One retaining arch 16a, 16b, 16c is allocated to each positioning arch 15a, 15b, 15c, wherein each retaining arch 16a, 16b, 16c is connected to a neighboring retaining arch by means of an auxiliary arch 18a, 18b, 18c. Also, according to the thirteenth embodiment of the stent 10, at least one fastening portion 11 with a number of fastening holes 12 is configured in each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c.
In addition to the at least one fastening portion 11, the stent 10 according to the thirteenth embodiment also comprises first and second additional fastening portions 11a, 11b for additional fastening of a valvular prosthesis or parts of a valvular prosthesis. In this regard, the stent 10 has a configuration with an enhanced number of fastening portions 11, 11a, 11b to attach the material of a valvular prosthesis.
As in the twelfth embodiment, the stent 10 depicted in
As shown in
As previously mentioned, the respective arms of the leaflet guard arches 50a, 50b, 50c merge at about the mid-point of the length of an arm of a radial arch 32a, 32b, 32c into the arm of an opposing radial arch 32a, 32b, 32c. Contrary to the twelfth embodiment, however, in the stent design of the thirteenth embodiment, the arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c do not merge. Into an arm 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c. According to the stent design of the thirteenth embodiment, the respective arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c are not directly connected with the arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c.
Rather, the leaflet guard arms of the stent design according to the thirteenth embodiment are directly connected with one of the second connecting webs 25, i.e. with one of the webs which connect the connecting portions 22 of the stent 10 with the catheter retaining means 23. As already mentioned above, the connecting portions 22 of the stent 10 is used for connecting each two adjoining arms 15b″, 15c′; 15c″, 15a′; 15a″, 15b′ of two neighboring positioning arches 15b, 15c, 15a. In this regard, the deployment of the positioning arches 15a, 15b, 15c is enhanced without releasing the leaflet guard arches 50a, 50b, 50c until the positioning arches 15a, 15b, 15c are placed behind the diseased leaflets in the valve pockets.
As can be seen in particular from the two-dimensional cutting pattern according to
Referring to
As in the stent design according to the twelfth embodiment, the lower end region 2 of the stent 10 of the thirteenth embodiment also exhibits a polygonal structure having eighteen vertices formed from the individual arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of retaining arches 16a, 16b, 16c, the individual arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the auxiliary arches 18a, 18b, 18c, as well as the individual arms of the extra arches 60a-f. In this regard, the stent 10 of the thirteenth embodiment has a lower end section 2 with a continuous design which may provide substantially uniform radial force to help secure the stent 10 in its implanted stage and may help resist migration. Such a uniform radial force may also help minimize the risk of blood leakage in the expanded and implanted stage of the stent 10 and a valvular prosthesis affixed thereto.
The stent 10 according to the thirteenth embodiment also differs from the stent of the twelfth embodiment in that additional fastening portions are provided at the lower end 2 of the stent 10. In detail, according to
As can be seen from
In this regard, the auxiliary arches 18a, 18b, 18c with the fastening holes 12d on the one hand and the connection portions 30 with the fastening holes 12e on the other hand provide for additional fastening holes 12d, 12e at the lower end section 2 of the stent 10, wherein these additional fastening holes 12d, 12e are arranged to be equally distributed around the continuous design of the lower end section 2 of the stent 10. A thread 101 or a thin wire with which a valvular prosthesis 100 is attached to stent 10 may be guided through each of the respective fastening holes 12d, 12e.
Hence, the additional fastening holes 12d, 12e are provided at the lower end section 2 of the stent 10 for additional fastening of a valvular prosthesis or parts of a valvular prosthesis. The presence of additional fastening holes 12d, 12e at the lower end section 2 of the stent 10 may provide additional structure to attach the valve skirt of the valvular prosthesis and minimize leakage. In addition, the additional fastening holes 12d, 12e at the lower end section 2 of the stent 10 may help keep the skirt of the valvular prosthesis from moving when the valve is collapsed into a catheter for implanting the stent with the valvular prosthesis affixed thereto.
Again, elements in
Except for the structure of the lower end section 2, the stent 10 according to the fourteenth embodiment is substantially similar to the stent according to the thirteenth embodiment of the present invention described above with reference to
Hence, the stent 10 according to the fourteenth embodiment has also a total of three positioning arches 15a, 15b, 15c, which again undertake the function of automatic positioning of the stent 10. As in other embodiments of the stent 10, each of the positioning arches 15a, 15b, 15c has a radiused head portion 20, which engages in the pockets of the native heart valve H being treated during positioning of the stent at the implantation site in the heart (see
The fourteenth embodiment of the stent 10 also includes radial arches 32a, 32b, 32c. As is shown most clearly in
As in the thirteenth embodiment, in the stent design of the fourteenth embodiment, the respective arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c are not directly connected with the arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c. Rather, the respective arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c are directly connected to leaflet guard arms which in turn are directly connected with one of the second connecting webs 25, i.e. with one of the webs which connect the connecting portions 22 of the stent 10 with the catheter retaining means 23. In this regard, the deployment of the positioning arches 15a, 15b, 15c is enhanced without releasing the leaflet guard arches 50a, 50b, 50c until the positioning arches 15a, 15b, 15c are placed behind the diseased leaflets in the valve pockets.
A total of three retaining arches 16a, 16b, 16c is also provided. One retaining arch 16a, 16b, 16c is allocated to each positioning arch 15a, 15b, 15c. Also, according to the fourteenth embodiment of the inventive stent 10, at least one fastening portion 11 with a number of fastening holes 12 is configured in each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c.
In addition to the at least one fastening portion 11, the stent 10 according to the fourteenth embodiment also comprises first and second additional fastening portions 11a, 11b for additional fastening of the tissue component(s) of the valvular prosthesis or parts of a valvular prosthesis. In this regard, the stent 10 has a configuration with an enhanced number of fastening portions 11, 11a, 11b to attach the material of a valvular prosthesis.
As in the twelfth or thirteenth embodiment, the stent 10 depicted in
The respective arms of the leaflet guard arches 50a, 50b, 50c merges at about the mid-point of the length to the arm of an opposing radial arch 32a, 32b, 32c. As in the thirteenth embodiment, the arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c do not merge into an arm 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c, because the respective arms 32a′, 32a″, 32b′, 32b″, 32c′, 32c″ of the radial arches 32a, 32b, 32c are not directly connected with the arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c. Rather, the leaflet guard arms of the stent design according to the fourteenth embodiment are directly connected with one of the second connecting webs 25, i.e. with one of the webs which connect the connecting portions 22 of the stent 10 with the catheter retaining means 23. As already mentioned above, the connecting portions 22 of the stent 10 is used for connecting each two adjoining arms 15b″, 15c′; 15c″, 15a′; 15a″, 15b′ of two neighboring positioning arches 15b, 15c, 15a.
The stent 10 depicted in
The at least one annular collar 40 may be connected to each or a part of the lower end sections of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c, as can be seen in particular from the cutting pattern pursuant to
The at least one annular collar 40 exhibits a plurality of supporting webs 41 which run parallel to the longitudinal axis of the stent 10 in the non-expanded state of said stent 10 and are inter-connected by transversal webs 42 (cf.
The annular collar 40 serves as a supporting body through which the radial forces developing due to the self-expansion are transmitted to the vascular wall. Since a relatively large contact area of the stent 10 interacts with the vascular wall, and because of the rhomboidal or serpentine structure to the annular collar 40, there may be a decreased risk of injury to the artery or the tissue despite the increased radial forces.
It is important to note that a certain amount of radial force is needed to prevent migration of the implanted endoprosthesis 1. Hence, a more uniform structure of the lower end section of the stent provides a more uniform distribution of the radial pressure provided by the stent in its fully expanded state. In this regard, the radial pressure provided by the stent in its fully expanded state is distributed and there are reduced high contact pressures for the same overall radial force.
Accordingly, not only the rigidity of the stent 10 can be increased after its self-expansion by the providing of the annular collar 40, but also the anchorage of the stent 10 in the implanted state can be improved or strengthened. Additionally, the annular cross-sectional shape to annular collar 40 increases the seal between the vascular wall and the stent having a vascular prosthesis affixed thereto.
Such an annular collar 40 is advantageously configured as a self-expandable supporting structure which advantageously effects an even further improved anchoring of the stent 10 at the site of implantation due to its radially-outward-acting contact pressure and its design such that a displacing of the stent 10 with a valvular prosthesis affixed thereto can be further prevented.
The stent 10 depicted in
In addition, this structure of the lattice cells 70 formed by a plurality of struts in the area between the adjacent arms of two neighbouring retaining arches 16a, 16b, 16c may provide uniform stent structure which may minimize blood leakage in the implanted stage of the stent 10 having a heart valve prosthesis attached thereto.
Hence, according to the stent design of the fourteenth embodiment, the lower end section of the annular collar 40 is provided at the lower end section of the stent body and connected with the stent body via the retaining arches 16a, 16b, 16c on the one hand and the previously described structure of the lattice cells 70 on the other hand.
Although not shown in
It is important to note, however, that the stent 10 depicted in
Again, elements in
The stent according to the fifteenth embodiment essentially corresponds to the stent of the fourteenth embodiment previously described with reference to
In the two-dimensional projection of a cutting pattern according to
Furthermore, in the stent design of the fifteenth embodiment each of the leaflet guard arches shall preferably have a substantially U-shaped or V-shaped structure which is closed to the lower end 2 of stent. In particular, each leaflet guard arch shall have a shape that is roughly similar to the shape of the positioning arch 15a, 15b, 15c in between the corresponding leaflet guard arch is arranged. Furthermore, each leaflet guard arch shall extend in the same direction as the positioning arch 15a, 15b, 15c in between the corresponding leaflet guard arch is provided.
The stent design according to the fifteenth embodiment of the invention is also provided with an annular collar 40 which is arranged at the lower end section of the stent body. As in the stent design according to the fourteenth embodiment, this at least one collar 40 serves as an additional anchoring measure for a stent cut from a portion of a tube by using the cutting pattern depicted in
According to the cutting pattern depicted in
The technical effects which can be obtained by the at least one collar 40 provided at the lower end section 2 of the stent have already been described in connection with the stent of the fourteenth embodiment of the invention. Hence, in order to avoid repetitions, reference is made to the previously discussed aspects.
The stent design according to the fifteenth embodiment differs from the stent design according to the fourteenth embodiment in that at the lower end section of every second supporting web 41 of the annular collar 40 an eyelet 12f as an additional fastening means is provided. In this regard, the eyelets 12f are more uniformly distributed around the lower end section of the annular collar 40, thereby providing a more uniform fixation of a heart valve prosthesis to the stent. Hence, the risk of an axial displacement of the heart valve prosthesis relative to the stent may be further reduced.
As in the stent design according to the previously described fourteenth embodiment, the stent design of the fifteenth embodiment is further provided with a structure of lattice cells 70 formed by a plurality of struts in the area between the arms of two neighbouring (adjacent) retaining arches 16a, 16b, 16c. As depicted in the cutting pattern of
The stent design of the fifteenth embodiment differs from the previously described stent designs in that the stent according to the fifteenth embodiment is not provided with first additional fastening portions are arranged between the first and second arms 16a″, 16b′; 16b″, 16c′; 16c″, 16a′ of two neighboring retaining arches 16a, 16b, 16c and extend from the respective lower ends 17d of the first connecting webs 17 in the direction of the lower end 3 of the stent.
Rather, according to the stent design of the fifteenth embodiment, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are provided with a number of additional fastening portions 11c, each having a number of additional fastening holes 12a provided for fastening the tissue component(s) of a valvular prosthesis. Specifically, the additional fastening portions 11c are separated from each other and distributed over the length of each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c. The additional fastening holes 12a are directly formed in the additional fastening portions 11c. It is of course conceivable that the additional fastening holes 12a are not formed in the arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c but are configured as eyelets. The additional fastening holes 12a enable the upper region of a valvular prosthesis to be additionally secured to the stent.
The size of the additional fastening holes 12a may be adapted to the thickness of particular thread or wire used to fasten the valvular prosthesis to the stent. The cross-sectional shape of the additional fastening holes 12a may also be adapted to the cross-sectional shape of the thread or wire used for fastening the valvular prosthesis. Due to the presence of a number of additional fastening holes 12a for fixing the valvular prosthesis to the cardiac valve stent, the fastening position of the valvular prosthesis to the cardiac valve stent can be precisely defined.
As an alternative to fastening holes 12a, the same region of the stent 10 may be provided with one or more additional notches. These notches perform a similar function as the fastening holes 12a and assist with additional anchoring of a prosthetic valve within the stent.
A stent 10 according to a sixteenth embodiment of the invention is shown in
On the other hand,
A flat roll-out view of a stent according to the sixteenth embodiment is shown in
As in the embodiments previously described, the stent 10 of the sixteenth embodiment is again configured as a one-piece structure cut from a portion of tube, in particular from a metal tube, the cutting pattern being shown as a two-dimensional projection in
Also, the stent design according to the sixteenth embodiment of the invention is also provided with an annular collar 40 which is arranged at the lower end section of the stent body. As in the stent design according to the fourteenth or fifteenth embodiment, this at least one collar 40 serves as an additional anchoring measure for a stent cut from a portion of a tube by using the cutting pattern depicted in
The sixteenth embodiment of the stent 10 is similar in structure and function with respect to the fifteenth embodiment. To avoid repetition, reference is therefore made to the above description of the fifteenth embodiment. In particular, essentially U-shaped or V-shaped radial arches 32a, 32b, 32c are likewise provided to increase the radially acting contact force in the upper region of the stent 10.
In addition, the stent 10 according to the sixteenth embodiment is provided with corresponding retaining arches 16a, 16b, 16c. One retaining arch 16a, 16b, 16c is allocated to one of the positioning arches 15a, 15b, 15c. Also, according to the sixteenth embodiment of the inventive stent 10, a number of additional fastening portions 11c with a number of additional fastening holes 12a is configured in each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c.
In addition to the additional fastening portions 11c, the stent 10 according to the sixteenth embodiment also comprises second additional fastening portions 11b for additional fastening of the tissue component(s) of a valvular prosthesis or parts of a valvular prosthesis. As already discussed with respect to the twelfth embodiment, each first connecting web 17 of the stent is provided with at least one second additional fastening portion 11b, said at least one second additional fastening portion 11b being a portion which comprises additional auxiliary fastening holes 12c and/or other fastening means. The at least one second additional fastening portion 11b extends essentially in the longitudinal direction L of stent according to the twelfth embodiment.
In this regard, the stent 10 according to the sixteenth embodiment has a configuration with a number of fastening portions 11, 11b to attach the material of a valvular prosthesis.
As in the thirteenth embodiment of the invention, the stent 10 depicted in
As already mentioned, the structure of the sixteenth embodiment is quite similar to the structure of the previously described fifteenth embodiment. However, the sent design depicted in
In detail, according to the stent design of the sixteenth embodiment, in the expanded state of the stent 10, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are formed similar to how a surgical placed tissue valve might be constructed. Furthermore, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are provided with a number of additional fastening portions 11c, each having a number of additional fastening holes 12a or eyelets provided for fastening the tissue component(s) of a valvular prosthesis. These additional fastening holes 12a or eyelets provide for good attachment points of the leaflet and skirt of a heart valve prosthesis attached to the stent 10.
Hence, according to the stent design of the sixteenth embodiment, in the expanded state of the stent 10, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a shape that substantially matches the leaflets of a heart valve prosthesis attached to the stent 10. This specific design of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c is unique for catheter delivered valves and has valve durability advantages. The so formed arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c serve for supporting the skirt and edge of the leaflets of a heart valve prosthesis attached to the stent 10 across the gap behind the positioning arches 15a-c. As depicted, for example, in
In detail and as depicted in the cutting pattern shown in
When manufacturing the stent 10, the stent structure and in particular the structure of the retaining arches 16a, 16b, 16c is programmed such that the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a curved shape in the expanded state of the stent 10. The shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c is such defined that the arms follow the shape of the leaflets 102 of a valvular prosthesis 100 to be affixed to the stent 10 (cf.
Hence, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c of the stent 10, onto which the valvular prosthesis 100 is sewn or sewable, will change their shape when the stent 10 expands, wherein the retaining arches 16a, 16b, 16c are curved in the expanded state of the stent 10, but relatively straight when the stent 10 is collapsed.
As can be seen, for example, in
Reference is made to
The valvular prosthesis 100 comprises at least one leaflet 102 (see
To reduce longitudinal displacement of the valvular prosthesis 100 affixed to stent 10 relative to the stent 10, even during the peristaltic movement of the heart and the blood vessel in which stent 10 is deployed, the stent 10 according to the sixteenth embodiment of the invention comprises a plurality of fastening portions 11 extending in the longitudinal direction L of stent 10. In addition, the stent 100 according to the sixteenth embodiment is provided with additional fastening portions 11b, 11c. By means of both, the fastening portions 11 and the additional fastening portions 11b, 11c the tissue component(s) of the valvular prosthesis 100 is affixed to the stent 10.
In detail, the valvular prosthesis 100 is fastened to the stent 10 by means of a thread 101 or a thin wire which is guided through fastening holes 12, 12a of the fastening portions 11 and the additional fastening portions 11b, 11c, respectively. This allows fixing of the tissue component(s) of the valvular prosthesis 100 to the stent 10 at a predefined position relative to the stent 10.
It can further be seen from the
At the lower end 2 of the stent 10, the valvular prosthesis 100 exhibits a bead 105.
This bead 105, which is annular in the plan view of endoprosthesis 1, is formed by turning the lower end of the valvular prosthesis 100 inside out by rolling it over on itself and defines the inflow edge of the endoprosthesis 1.
The annular bead 105 at the lower end of the valvular prosthesis 100 may provide anchoring of the peripheral area of the valvular prosthesis 100 to the blood vessel in the implanted state of the endoprosthesis 1, even given the peristaltic motion, and thus may provide a seal relative the vascular wall. Due to the annular collar 40 provided at the lower end section 2 of the stent 10, the annular bead 105 at the lower end of the valvular prosthesis 100 has a round shape adapted to the anatomy in the implantation side. In this regard, the contact surface between the lower end section 2 of the endoprosthesis 1 in its expanded and implanted state and the wall of the blood vessel, into which the endoprosthesis 1 is inserted, may be enhanced, thereby improving sealing between the endoprosthesis 1 and the wall of the blood vessel.
The annular bead 105 may achieve a seal of the valvular prosthesis 100 at the vascular wall despite the basic triangular structure to the stent 10 in a plan view of the expanded endoprosthesis 1. When implanting the endoprosthesis 1 in a native blood vessel any leakage between the peripheral area of the annular bead 105 and the vascular wall may be sealed by naturally-occurring accretion, in particular calcification. Accordingly, the bead-shaped area 105 provides a seal, particularly also during the filling phase of the heart cycle (diastole).
The material for the valvular prosthesis 100 and, in particular the material for the leaflets 102 of the valvular prosthesis 100 can be made from synthetics, animal valves or other animal tissues such as pericardium. The animal tissues can be from a number of types of animals. Preferably, the leaflet tissue of the valvular prosthesis 100 is from either bovine or porcine pericardium, but other animals can also be considered, for example equine, kangaroo, etc.
Animal pericardium is the preferred material for optimum valve design and the ability to collapse into a catheter system having a small diameter. Although bovine is preferred, the thickness is generally thicker than porcine and it has been discovered that there may be substantial swelling of the tissue (35%) during fixation. This swelling may make bovine more difficult to collapse for small catheter size deployment.
As depicted in
In addition, an improved sealing between the endoprosthesis 1 and the wall of the blood vessel may be achieved when an uniform radial force is applied from the lower end section 2 of the stent 10 to the wall of the blood vessel.
In order to further improve securing of the position of an implanted and expanded endoprosthesis 1 and preventing antegrade migration, the stent 10 according to the sixteenth embodiment is provided with a flared or tapered section with a radius shape at its lower end section 2. In detail and as depicted in
The stent 10 depicted in
Although not shown in the drawings, it is particularly preferred for the stent 10 according to any embodiments of the invention that the stent 10 has a scalloped inflow edge design at its lower end section 2 when the stent 10 is in its expanded state. Hence, the inflow edge of the stent 10 does not lie entirely in a plane perpendicular to the longitudinal direction L of the stent 10. Rather, the edge of the stent on its inflow side may have a scalloped shape. In addition, the scalloped inflow edge may also be flared or tapered around its entire circumference or only at selected locations. For example, one embodiment may include a flare at the inflow edge only near the locations of the positioning arches that transition to a non-flared straight cylindrical shape in the area between two neighboring positioning arches. In particular, the location of the respective flares and the respective straight cylindrical shape may be determined by the location of the arms of the respective retaining arches to which the tissue component(s) of the valvular prosthesis is attached.
A stent 10 having such a scalloped inflow edge design reduces the length of the stent 10 having an inflow edge which lies in a plane perpendicular to the longitudinal direction L of the stent 10 in areas that have critical structures such as those containing nerve bundles. However, the scallop shape generally follows the native valve annulus and does not compromise the ability of the valve to seal against leakage
The invention is not limited to a stent which is provided with a scalloped inflow edge design. Rather, it is conceivable that the stent 10 according to the invention is provided with an inflow edge having a non-continuous flare design or a tapered flare design with an inflow edge that lies in a plane perpendicular to the longitudinal direction L of the stent 10 or a design which is provided with flares non-continuously distributed around the inflow edge or with flares having a tapered configuration for inflow edge of a stent 10 that does not lie entirely in a plane perpendicular to the longitudinal direction L of the stent 10.
A stent 10 according to a seventeenth embodiment of the invention is shown in
On the other hand,
A flat roll-out view of a stent 10 according to the seventeenth embodiment is shown in
The seventeenth embodiment of the stent 10 is similar in structure and function with respect to the sixteenth embodiment. However, the sent design depicted in
The above described embodiments of the inventive stent have a specific structure that can provide some flexing during diastole to relieve and better distribute leaflet stresses in order to avoid high stress concentrations at the attachment points at which the valvular prosthesis 100 is connected to the stent 10. For offering flexibility to the leaflets 102 of a heart valve prosthesis 100 attached to the stent 10 and for enhancing the durability of the prosthesis 100 affixed to the stent 10, the stent 10 preferably has not a continuous cage around the circumference at the top of the new valve commissures, i.e. the commissures of a valvular prosthesis 100 affixed to the stent 10. In this regard, there is some inherent flexibility of the stent commissures. In particular, the stents 10 described herein, which are not provided with an upper collar 40′ at the upper end section 3 of the stent 10, offer valve commissure flexibility advantages over other cage valve designs. Surgical biological prosthetic valves are designed with stents that provide some flexibility at the upper end section of the valve commissures to reduce stress concentrations in the valve leaflets that enhances the longevity (i.e. valve durability) of the prosthesis and to improve leaflet coaptation.
It is preferred that the stent diameter at the base, i.e. the diameter at the lower end section 2 of the stent 10, should be able to accommodate a range of annulus diameters around the target diameter. Within this range the forces applied due to the stiffness should be adequate to prevent migration, but not too great to cause annular rupture. At the top of the commissures, it is desirable that the stent not vary in diameter significantly to minimize the impact to the valve coaptation or opening performance even when the annulus diameter is not exactly at the target diameter.
In addition, the overall stent height should be minimized to shorten the delivery section of the catheter. This is important because the portion of the delivery catheter system containing the endoprosthesis 1 is generally stiff relative to the rest of the catheter system. In case of a transfemoral approach, it is an advantage to have greater flexibility in the catheter system to follow the curves of the patient anatomy (e.g. the ascending aorta).
As already discussed in connection with the sixteenth embodiment, a more continuous base design may provide uniform radial force to secure the valve against migration. Uniform radial force may also minimize leakage in the implanted stage. Preferably, the base of the stent 10 is flared with a radius shape or a slight taper to a larger diameter as shown, for example, in
As depicted in
If the implanted and expanded stent together with a valvular prosthesis affixed thereto cannot extend too far below the annulus of the heart there may be the risk that the implanted endoprosthesis consisting of the stent one the one hand and the valvular prosthesis on the other hand contacts the nerve bundles and heart block. The nerve bundles may enter at a location approximately 6 to 10 mm below the annulus of the heart.
In this regard, it may be preferred to reduce the total height of the stent and thus the total height of the endoprosthesis to be implanted into the body of the patient. As in the seventeenth embodiment depicted in
On the other hand, also a scalloped inflow edge design is conceivable. Hence, the stent 10 may have a scalloped inflow edge design at its lower end section 2 when the stent 10 is in its expanded state. With such a design, the inflow edge of the stent 10 does not lie in a plane perpendicular to the longitudinal direction L of the stent 10. Rather, the edge of the stent on its inflow side may have a scalloped shape with flares near the locations of the positioning arches and indentations in the area between two neighboring positioning arches. In particular, the shape and location of the respective flares and the respective indentations may be determined by the arms of the respective retaining arches to which the tissue component(s) of the valvular prosthesis is attached.
The stent 10 is preferably made from a shape memory material. The state of stent 10 shown in
Said external stimulus is preferably a specifiable switching temperature whereby, to activate the shape memory effect and thus regenerate the saved permanent shape of the stent 10, the stent material is warmed to a higher temperature than the switching temperature. By selecting a suitable chemical composition of the material used for stent 10, a specific switching temperature can be predefined. In the preferred embodiment of the solution described herein, the switching temperature ranges from between about 20° C. and the body temperature of the patient.
The surface of the stent 10 should be smooth and edges should be rounded to maximize fatigue, biocompatibility and minimize damage to attached tissue and sutures or damage to native tissue. Hence, it is preferred that the surface of the stent is polished, for example electropolished. Polishing of the stent surface can be performed before or after the programming process during which the shape of the desired (expanded) stent structure is fixed.
When implanting the stent 10, it is conceivable for the stent 10 to be cooled during the insertion procedure. Once the stent 10 has been guided to its desired site of implantation, i.e. to the native cardiac valve H (cf.
The stent 10 described herein, as well as the insertion catheter system used to implant the stent, are preferably configured so that the stent 10 with the valvular prosthesis 100 affixed thereto can be introduced transarterially into the body of the patient. In one example, the stent 10 is accommodated in the tip of the catheter of the insertion catheter system, the catheter tip being introduced into the body via, for example, puncture of the A. femoris communis (inguinal artery). A suitable catheter system is described in WO2006/076890 and PCT/EP2008/003803, the details of which are incorporated herein by reference.
Alternatively, the stent 10 according to certain embodiments of the invention is also suited for transapical implantation, in which—coming from the apex of the heart—the catheter tip of the insertion catheter system is advanced to the aortic valve through, for example, the left ventricle. With a catheter tip modified accordingly, an analogous implantation of the stent 10 with the valvular prosthesis 100 is thus possible. A suitable catheter system is described in PCT/EP2008/003803, the details of which are incorporated herein by reference
Regardless of whether the stent 10 is delivered to the site of implantation via a transarterial or transapical approach, the tip of the catheter of the insertion catheter system is preferably advanced to the implantation site using angiographic (angiography) and echocardiographic (ultrasound) control. The actual implantation of stent 10 with the attached valvular prosthesis 100 then follows.
The catheter system used to implant the stent 10 described herein is ideally configured such that a liquid cooling agent can be fed through a hollow interior of the catheter system to the delivery portion of the catheter system. The liquid cooling agent, for example in the form of a saline solution, maintains the stent 10 accommodated in the delivery portion of the catheter system at a temperature below the switching temperature while the proximal side K of the delivery portion of the catheter system is being advanced to the site of implantation. This is of particular advantage when a shape memory material is provided as the material of the stent 10. This is because the stent 10 transforms from a temporary shape into a permanent shape upon the influence of an external stimulus. The temporary shape is the first shape of stent 10 (in collapsed state, when the stent 10 is accommodated in the delivery portion of the catheter system) and the “permanent shape” is the second shape of stent 10 (the expanded state of the stent 10).
It is to be noted that the “permanent shape” of the expanded stent 10 conforms to the native shape of its environment. This allows for variations in the shape of the environment at the site of implantation which will vary from patient to patient. This property of stent 10, related to the “permanent shape” of the expanded stent 10 automatically adapting completely to the native shape of its environment, will thus always ensure that the valvular prosthesis 100 is optimally implanted.
The difference between the fully expanded permanent shape of the stent 10 and the constrained shape of the stent 10 in its implanted stage depends from the environment at the side of implantation and determines the radial pressures applied by the stent 10 to the vessel wall for preventing migration and for assuring good sealing. The fully expanded shape of the stent 10 is designed to provide the appropriate radial pressures for the target patient anatomy size.
Because a shape memory material such as Nitinol, i.e. an equiatomic alloy of nickel and titanium, can be used for the stent 10 described herein, a particularly gentle implantation procedure is achievable when implanting the stent 10 with the valvular prosthesis 100 affixed thereto. Nitinol as material for the stent 10 is preferred because of its good biocompatibility.
The stent 10 accommodated in the delivery portion of the catheter system can be cooled by flushing the insertion catheter system with a suitable cooling agent while the delivery portion of the catheter system is being advanced to keep the temperature of the stent material below the critical transition temperature. Once the delivery portion of the catheter system with the cooled stent 10 has been advanced to the site of implantation, cooling of the stent 10 should be stopped, as a consequence of which the stent 10 warms up to the body temperature (37° C.) of the patient and the shape memory effect of the stent material is thus activated.
Once the self-expanding property of the individual components of stent 10 have been activated, radial forces are generated which act on the individual components of stent 10, in particular on the positioning arches 15a, 15b, 15c, the retaining arches 16a, 16b, 16c, the leaflet guard arches 50a, 50b, 50c and the auxiliary arches 18a, 18b, 18c of stent 10. Since the respective components of stent 10 are still situated in the delivery portion of the catheter system, the radial forces developing upon the critical switching temperature being exceeded and acting on the individual components of the stent 10 are still compensated by the wall of the delivery portion of the catheter system, so that—despite the activation of the shape memory effect—the stent 10 is forcibly kept in its first (collapsed) shape.
Upon the subsequent manipulation of the delivery portion of the catheter system—by the appropriate incremental release of the stent 10—the individual components of stent 10, are then discharged from the delivery portion of the catheter system.
For example, as
Thereafter—as depicted in
The radial forces acting on both the retaining arches 16a, 16b, 16c and the auxiliary, arches 18a, 18b, 18c of the stent 10 as well as the radial forces acting on the upper end region 3 of stent 10, result in the stent 10 being pressed radially against the vascular wall (cf.
The delivery portion of the insertion catheter system is then manipulated further to release the eyelets 24 of the stent 10, thereby allowing the upper end region 3 of the stent 10 to expand. In so doing, the leaflets of the native cardiac valve H are clamped between respective positioning and retaining arches and the valvular prosthesis 100 disposed on the lower end 2 of stent 10 can spread open.
After the successful implantation of the stent 10 and valvular prosthesis 100, the catheter is then removed from the body of the patient.
The stent 10 is not limited to being made from shape memory material which self-expands from its first (collapsed) shape into its second (expanded) shape in response to an external stimulus. Rather, it is also categorically conceivable for the stent 10 to be expanded using a conventional balloon system.
It will be appreciated that the solution described herein is also not limited to the specific embodiments as described with reference to the attached drawings. Rather, the invention encompasses combinations of the individual features exemplified in the embodiments described.
In particular, the stent 10 may not be provided with radial arches 32a-c. Rather, the base configuration of the stent 10 may only comprise a plurality of positioning arches 15a-c and a plurality of retaining arches 16a, 16b, 16c.
A eighteenth embodiment of the stent 10 according to the present invention is described in the following with reference to
Hence, the stent 10 according to the eighteenth embodiment comprises a plurality of positioning arches 15a, 15b, 15c configured to be positioned within a plurality of pockets T of the patient's native heart valve H and positioned on a first side of a plurality of native heart valve leaflets, and a plurality of retaining arches 16a, 16b, 16c configured to be positioned on a second side of the plurality of native heart valve leaflets opposite the first side, wherein furthermore a plurality of leaflet guard arches 50a, 50b, 50c are provided, each interspaced between the two arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of one of the plurality of positioning arches 15a, 15b, 15c. In addition, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are preferably provided with a plurality of bending edges 33 in order to divide each arm 16a, 16a″, 16b′, 16b″, 16c′, 16c″ into a plurality of arm segments, wherein the structure of the stent 10 is programmed such that the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a curved shape at least in the expanded state of the stent 10. In particular, the shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c shall be such defined that the arms follow the shape of the leaflets 102 of a valvular prosthesis 100 to be affixed to the stent 10 (cf.
In addition, the stent 10 according to the eighteenth embodiment may further include at least one auxiliary arch 18a, 18b, 18c interspaced between two adjacent retaining arches 16a, 16b, 16c, wherein the at least one auxiliary arch 18a, 18b, 18c includes a first arm 18a′, 18b′, 18c′ connected at a first end thereof to a first retaining arch 16a, 16b, 16c and a second arm 18a″, 18b″, 18c″ connected at a first end thereof to a second retaining arch 16a, 16b, 16c, and wherein the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c each include respective second ends connected to one another at a joint that includes at least one fastening hole configured to receive a suture.
In addition or instead of the at least one auxiliary arch 18a, 18b, 18c, the stent according to the eighteenth embodiment of the invention may further comprise at least one radial arch 32a, 32b, 32c substantially circumferentially aligned with at least one of the plurality of positioning arches 15a, 15b, 15c.
Furthermore, the stent 10 according to the eighteenth embodiment of the invention may also be provided with a plurality of extra arches 60a, 60b, 60c, each of said plurality of extra arches 60a, 60b, 60c being interspaced between a first retaining arch 16a, 16b, 16c and an adjacent second retaining arch 16a, 16b, 16c.
Also, at least one annular collar 40, 40′ may be provided at the lower end section 2 and/or at the upper end section 3 of the stent 10 according to the eighteenth embodiment of the invention.
Moreover, with respect to fixing the upper area 3 of stent 10 to the wall of the blood vessel into which the stent 10 is deployed, it would be conceivable for the stent 10 to comprise barb members arranged, for example, on the eyelets 24, the tips of the barbs pointing toward the lower end 2 of stent 10.
In addition, a liner or sheath, typically a fabric, polymeric or pericardial sheet, membrane, or the like, may be provided over at least a portion of the exterior of the stent 10 to cover all or most of the surface of the outside of the stent 10, extending from a location near the lower end section of the stent to a location near the upper end section of the stent. The liner may be attached to the stent 10 at at least one end, as well as at a plurality of locations between said ends thereby forming an exterior coverage. Such exterior coverage provides a circumferential seal against the inner wall of the blood vessel lumen in order to inhibit leakage of blood flow between the stent 10 and the luminal wall thereby and to prevent a blood flow bypassing the endoprosthesis 1.
For example, the liner may be stitched or otherwise secured to the stent 10 along a plurality of circumferentially spaced-apart axial lines. Such attachment permits the liner to fold along a plurality of axial fold lines when the stent 10 is radially compressed. The liner will further be able to open and conform to the luminal wall of the tubular frame as the frame expands. Alternatively, the liner may heat welded, or ultrasonically welded to the stent 10. In an exemplary embodiment where the stent is provided with a plurality of independent fastening portions 11, 11a, the liner may be secured at these fastening portions 11, 11a. In a second exemplary embodiment where a plurality of independent arches (positioning arches 15a, 15b, 15c, retaining arches 16a, 16b, 16c, auxiliary arches 18a, 18b, 18c and/or fastening arches 19, 19a, 19b, 19c) are provided, the liner is secured to these arches preferably along axial lines. The liner will preferably be circumferentially sealed against the stent 10 at at least one end.
By covering at least a part of the outside surface of the stent 10 with the liner or sheath, thrombogenicity of the endoprosthesis 1 resulting from exposed stent elements is greatly reduced or eliminated. Such reduction of thrombogenicity is achieved while maintaining the benefits of having a stent structure which is used for spreading up a valvular prosthesis 100 and for anchoring the valvular prosthesis 100 in place.
As already mentioned, the stent 10 can be compressed from a relaxed, large diameter configuration to a small diameter configuration to facilitate introduction. It is necessary, of course, that the outer liner remain attached to the stent 10 both in its radially compressed configuration and in its expanded, relaxed configuration.
The liner is composed of pericardial material or conventional biological graft materials, such as polyesters, polytetrafluoroethylenes (PTFE's), polyurethanes, and the like, usually being in the form of woven fabrics, non-woven fabrics, polymeric sheets, membranes, and the like. A presently preferred fabric liner material is a plain woven polyester, such as Dacron® yarn (Dupont, Wilmington, Del.).
A nineteenth embodiment of the stent 10 according to the present invention is described in the following with reference to
In detail,
Thus, it appears that the stent 10 according to the nineteenth embodiment comprises a plurality of positioning arches 15a, 15b, 15c and a plurality of retaining arches 16a, 16b, 16c. Each of the plurality of positioning arches 15a, 15b, 15c is configured to be positioned within a plurality of pockets T of the patient's native heart valve H and positioned on a first side of a plurality of native heart valve leaflets (see
Furthermore, a plurality of leaflet guard arches 50a, 50b, 50c are provided, each interspaced between the two arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of one of the plurality of positioning arches 15a, 15b, 15c. In addition, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are preferably provided with a plurality of bending edges 33 in order to divide each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ into a plurality of arm segments, wherein the structure of the stent 10 is programmed such that the respective arms 16a′, 16a″, 16b, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a curved shape at least in the expanded state of the stent 10. In particular, the shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c shall be such defined that the arms follow the shape of the leaflets 102 of a valvular prosthesis 100 to be affixed to the stent 10.
In detail and as depicted in the flat roll-out view shown in
When manufacturing the stent 10, the stent structure and in particular the structure of the retaining arches 16a, 16b, 16c is programmed such that the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ have a curved shape in the expanded state of the stent 10. The shape of the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ is such defined that the arms follow the shape of the leaflets of a valvular prosthesis 100 to be affixed to the stent 10 (cf.
Hence, the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″, onto which the valvular prosthesis 100 is sewn or sewable, will change their shape when the stent 10 expands, wherein the retaining arches 16a, 16b, 16c are curved in the expanded state of the stent 10, but relatively straight when the stent 10 is collapsed.
As can be seen, for example, in
According to the stent design of the nineteenth embodiment, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are not provided with fastening holes 12a, as it is the case, for example, in the eighteenth or seventeenth embodiment. Rather, in the nineteenth embodiment, the bending edges 33 provided in the retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ are not only used for defining a bending point of two neighboring arm segments, but also as fastening notches which can be used for fixing a heart valve prosthesis to the stent 10.
A comparison with, for example, the flat roll-out view pursuant to
Moreover, by using the bending edges 33 provided in the retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ as fastening notches for fixing a heart valve prosthesis to the stent 10, a greater number of attachment points compared with the number of fastening holes 12a can be generated. In this regard, high stress concentrations at each single attachment point can be effectively avoided.
In addition, in the nineteenth embodiment, the attachment points (bending edges 33) to be used for fixing a heart valve prosthesis to the retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the stent 10 are more uniformly distributed along the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″, thereby providing a more uniform fixation of a heart valve prosthesis to the stent. Hence, the risk of an axial displacement of the heart valve prosthesis relative to the stent may be further reduced. Each individual bending edge 30 provided in the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ thereby serves to guide a thread or thin wire with which the tissue component(s) of the valvular prosthesis is affixed or sewn to the corresponding retaining arch arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the stent 10. In detail, the means (thread or thin wire) provided for fastening the tissue component(s) of the valvular prosthesis to the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ is guided by way of the bending edge 33 acting as fastening notch so that a longitudinal displacement of the valvular prosthesis relative to the stent 10 is substantially minimized. This also allows exact positioning of the valvular prosthesis relative the stent 10.
In addition, the stent 10 according to the nineteenth embodiment may further include at least one auxiliary arch 18a, 18b, 18c interspaced between two adjacent retaining arches 16a, 16b, 16c, wherein the at least one auxiliary arch 18a, 18b, 18c Includes a first arm 18a′, 18b′, 18c′ connected at a first end thereof to a first retaining arch 16a, 16b, 16c and a second arm 18a″, 18b″, 18c″ connected at a first end thereof to a second retaining arch 16a, 16b, 16c, and wherein the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c each include respective second ends connected to an annular collar 40 which is arranged at the lower end section of the stent body. As in the previously described stent design (14th to 18th embodiment), this at least one collar 40 serves as an additional anchoring measure for a stent cut from a portion of a tube by using the cutting pattern depicted in
In detail, the respective first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c are part of a strut or web structure which is provided between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c in order to support a valvular prosthesis 100 to be affixed to the stent 10 (see, for example,
The terms “strength” or “resistance to deformation” as used herein may be used to denote any of a number of different properties associated with the reinforcement members. For example, the terms may be used to refer to properties of the material from which the reinforcement members are made, such as the yield strength, the modulus of elasticity, the modulus of rigidity, or the elongation percentage. Similarly, the terms may be used to refer to the hardness of the reinforcement members. Hardness may be characterized as the “durometer” of the material, in reference to the apparatus used to measure the hardness of the material. The terms may also be used to denote geometric characteristics of the reinforcement members, such as the thickness of the reinforcement members. The terms “strength” or “resistance to deformation” may also be used to characterize any combination of the above properties as well as additional properties and/or characteristics.
The strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c can be increased in any number of ways. As can be seen from
It is also conceivable that a reinforcement web is provided in order to increase the strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c. This reinforcement web may also be composed by a plurality of reinforcement elements (e.g. struts or strut-like members) which are interconnected to each other thereby forming a rhomboidal pattern.
The strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c can be increased, for example, by increasing the thickness of the reinforcement members, by eliminating stress concentration risers in the design of the stent 10, or by changing other aspects of the geometry of the reinforcement members. The strength can also be increased by changing the material properties of the stent 10 and/or the reinforcement members. For example, the reinforcement members can be made from a number of different materials, preferably shape memory materials, each having a different level of hardness. In this regard, it is conceivable to vary the stoichiometric composition of the material used for forming the stent and the reinforcement members such as to adapt the material properties of the stent 10 and/or the reinforcement members to the specific needs of each stent application. It is also conceivable to use different materials, for example nitinol and a shape-memory polymer, for forming the stent and the reinforcement members. In this manner, the selection of the reinforcement members can be tailored to the specific needs of each stent application. For example, in regions where a high external force is expected, reinforcement members having a high hardness may be preferred. The strength may also be increased by combining material properties with geometric changes.
As can be seen from
In addition, this structure of the lattice cells 70 formed by a plurality of struts in the area between the adjacent arms of two neighbouring retaining arches 16a, 16b, 16c may provide uniform stent structure which may minimize blood leakage in the implanted stage of the stent 10 having a heart valve prosthesis attached thereto.
The upper end sections of the respective struts which are forming the structure of the lattice cells 70 are connected to the respective arms of the retaining arches 16a, 16b, 16c. Preferably, the upper end sections of the struts comprise a widened diameter in order to strengthen the connection between the upper end sections of the struts and the arms of the retaining arches 16a, 16b, 16c.
The already mentioned annular collar 40, which is provided at the lower end section of the stent body, is connected with the stent body via the retaining arches 16a, 16b, 16c on the one hand and the second ends of the respective arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c on the other hand, wherein these arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c are part of the structure of the lattice cells 70. In particular, the stent 10 according to the nineteenth embodiment of the invention is provided with an annular collar 40 which is shortened in its length by having only a single row of cells.
As can be seen from the flat roll-out view pursuant to
In order to further improve securing of the position of an implanted and expanded endoprosthesis 1 and preventing antegrade migration, the stent 10 according to the nineteenth embodiment is provided with a flared or tapered section with a radius shape at its lower end section 2. In detail and as depicted in
The stent 10 depicted in
As depicted in
If the implanted and expanded stent together with a valvular prosthesis affixed thereto extend too far below the annulus of the heart there may be the risk that the implanted endoprosthesis consisting of the stent one the one hand and the valvular prosthesis on the other hand contacts the nerve bundles and heart block. The nerve bundles may enter at a location approximately 6 to 10 mm below the annulus of the heart.
In order to avoid that the lower end section 2 of the implanted stent 10 may touch the atrioventricular node, the stent 10 pursuant to the nineteenth embodiment is provided with an annular collar 40 which is shortened in its length by having only a single row of cells. In this regard, the total height of the stent 10 and thus the total height of the endoprosthesis 1 to be implanted into the body of the patient are reduced.
Moreover, in the programming process during which the shape of the desired (expanded) stent structure is fixed, the supporting webs 41 of the annular collar 40 may be programmed so that—when the stent 10 of the nineteenth embodiment is in its expanded state—only the upper section of the annular collar 40 extends in a radial direction outside the circumference of the stent 10, whereas the lower end section of the annular collar 40 bended relative to the upper section of the annular collar 40 in the radial direction inside the circumference of the stent 10. The lower end section of the annular collar 40 may be bended such that it extends, for example, approximately parallel to the longitudinal direction L of the stent 10. In this way, an increased contact force (radial force) is applied by the upper section of the annular collar 40 to the wall of the blood vessel into which the stent 10 is deployed, whereas the risk is reduced that the lower end section of the annular collar 40 can tough the atrioventricular node.
It is important to note, that the stent 10 according to the nineteenth embodiment comprises a several number of notches 12e uniformly distributed around the lower end section of the annular collar 40. These notches 12e can be used for fixing a heart valve prosthesis (not shown in
A comparison with, for example, the flat roll-out view pursuant to
Hence, by providing notches 12e instead of eyelets 12f as additional fastening means at the lower end section of the annular collar 40, a greater number of notches 12e compared with the number of eyelets 12f can be generated. In detail, according to the nineteenth embodiment, the lower end sections of every supporting web 41 of the annular collar 40 is provided with a corresponding notch 12e acting as additional fastening means. In contrast, in the seventeenth and eighteenth embodiments only the lower end sections of every second supporting web 41 of the annular collar 40 can be provided with a corresponding eyelet 12f acting as additional fastening means.
In this regard, the stent design according to the nineteenth embodiment differs from the stent design, for example, according to the eighteenth embodiment in that at the lower end section of every supporting web 41 of the annular collar 40 an additional fastening means is provided. This is due to the fact that, in the nineteenth embodiment of the stent 10, notches 12e are used as additional fastening means.
Hence, in the nineteenth embodiment, the additional fastening means to be used for fixing a heart valve prosthesis to the stent 10 are more uniformly distributed around the lower end section of the annular collar 40, thereby providing a more uniform fixation of a heart valve prosthesis to the stent. Hence, the risk of an axial displacement of the heart valve prosthesis relative to the stent may be further reduced. Each individual notch 12e provided at the lower end section of the annular collar 40 thereby serves to guide a thread or thin wire with which the tissue component(s) of the valvular prosthesis is affixed or sewn to the lower end section of the annular collar 40 of the stent 10. In detail, the means (thread or thin wire) provided for fastening the tissue component(s) of the valvular prosthesis to the lower end section of the annular collar 40 is guided by way of the notches 12e so that a longitudinal displacement of the valvular prosthesis relative to the stent 10 is substantially minimized. This also allows exact positioning of the valvular prosthesis relative the stent 10.
Moreover, by using corresponding notches 12e for the secure and defined fixing of the tissue component(s) of the valvular prosthesis to the lower end section of the annular collar 40 of the stent 10, the means (threads or thin wires) used to fasten the tissue component(s) to the stent 10 are effectively prevented from being squeezed and thus degraded when the stent 10 with the valvular prosthesis affixed thereto, i.e. the endoprosthesis 1, is compressed and brought into its collapsed shape such as to be ready for being inserted into a catheter system which is used for implanting the endoprosthesis 1. In this regard, the risk of structural deterioration in the threads or thin wires used to fasten the tissue component(s) of the valvular prosthesis 100 to the stent 10 is reduced.
The cross-sectional shape to the notches 12e may be adapted to the cross-sectional shape of the thread or thin wire used to fasten the tissue component(s) of the valvular prosthesis 100. This allows fixing of the tissue component(s) of the valvular prosthesis 100 to the stent 10 at a precise predefined position relative to the stent 10. Because the fastening holes 12 are adapted to the thickness and/or the cross-sectional shape of the thread or thin wire used to affix the valvular prosthesis 100 to the stent 10, relative movement between the stent 10 and the tissue component(s) of the valvular prosthesis 100 due to the peristaltic motion of the heart can be effectively prevented when the endoprosthesis 1 is implanted. In the fully expanded and implanted state of the endoprosthesis 1, the tissue component(s) of the valvular prosthesis 100 is/are thus fastened to the stent 10 with minimal play, based on which friction-induced wear of the thread or thin wire used to affix the valvular prosthesis is minimized. As shown in, for example, in
As can be seen, in particular from
Referring to the flat roll-out view shown in
On the other hand, each leaflet guard arch 50a, 50b, 50c has a substantially U-shaped or V-shaped structure which is closed to the lower end 2 of stent. Again, each leaflet guard arch 50a, 50b, 50c has a shape that is roughly similar to the shape of the positioning arch 15a, 15b, 15c in between the corresponding leaflet guard arch 50a, 50b, 50c is arranged. Furthermore, each leaflet guard arch 50a, 50b, 50c extends in the same direction as the positioning arch 15a, 15b, 15c.
In the stent design of the nineteenth embodiment, each arm of a leaflet guard arch 50a, 50b, 50c merges at about the mid-point of the length of an arm of a radial arch 32a, 32b, 32c into the arm of an opposing radial arch 32a, 32b, 32c. According to the stent design of the nineteenth embodiment, the leaflet guard arches 50a, 50b, 50c project in the longitudinal direction L of the stent and have a reduced length such that the positioning arches 15a, 15b, 15c can deploy during the expansion of the stent 10 and the leaflet guard arches 50a, 50b, 50c do not interfere during deployment.
The positioning arches 15a, 15b, 15c disposed on the stent 10 and also the retaining arches 16a, 16b, 16c may be curved in convex and arched fashion in the direction to the lower end section of the stent; i.e. toward the lower end 2 of the stent, whereby such a rounded form may reduce injuries to the artery as well as facilitate the unfolding during the self-expansion. Such a design may enable an easier insertion of the positioning arches 15a, 15b, 15c into the pockets T of the native cardiac valve without correspondingly injuring the neighboring tissue or blood vessels (cf.
Although not explicitly illustrated in the flat roll-out view according to
When the stent is in its expanded and implanted state, the leaflet guard arches 50a, 50b, 50c actively keep the diseased leaflets H, i.e. the leaflets of the native cardiac valve, from impinging the leaflet tissue of the valvular prosthesis 100 attached to the stent 10, when the positioning arches 15a, 15b, 15c are placed outside the native leaflets. In addition, the leaflet guard arches 50a, 50b, 50c may also provide additional anchoring and securing against migration. This feature may be unique compared to the cage known from the prior art stent designs which are not provided with positioning arches to push the diseased leaflets out of the way.
As can be seen from the roll-out view depicted in
In the programming process during which the shape of the desired (expanded) stent structure is fixed, the radial arches 32a, 32b, 32c are programmed so that they extend in a radial direction outside the circumference of the stent 10 when the stent is in its expanded state. In this way an increased contact force can be applied to the vessel wall by the upper end region of the stent 10. This, in turn, allows an increased security in the fixing of the stent 10 in situ, thereby reducing the likelihood of migration of the stent 10. Therefore, in its expanded state, in addition to the clamping effect of the positioning arches 15a, 15b, 15c and in addition to the additional anchoring obtainable by the leaflet guard arches 50a, 50b, 50c, the stent of the nineteenth embodiment is secured in place on implantation via radial forces exerted by the retaining arches 16a, 16b, 16c, the auxiliary arches 18a, 18b, 18c, the radial arches 32a, 32b, 32c, and the annular collar 40, all of which project outwards in a radial direction from the circumference of the stent 10.
It can be seen from the flat roll-out view shown in
In principle, the stent 10 may have more than three radial arches 32 in order to increase the radial contact force further. It is also possible to provide barb elements on all or some of the radial arches 32a, 32b, 32c, for example, to allow a still better anchoring of the stent 10 at the implantation site.
Moreover, with respect to fixing the upper area 3 of stent 10 to the wall of the blood vessel into which the stent 10 is deployed, it would be conceivable for the stent 10 to comprise barb members arranged, for example, on the eyelets 24, the tips of the barbs pointing toward the lower end 2 of stent 10.
In addition, a liner or sheath, typically a fabric, polymeric or pericardial sheet, membrane, or the like, may be provided over at least a portion of the exterior of the stent 10 to cover all or most of the surface of the outside of the stent 10, extending from a location near the lower end section of the stent to a location near the upper end section of the stent. The liner may be attached to the stent 10 at at least one end, as well as at a plurality of locations between said ends thereby forming an exterior coverage. Such exterior coverage provides a circumferential seal against the inner wall of the blood vessel lumen in order to inhibit leakage of blood flow between the stent 10 and the luminal wall thereby and to prevent a blood flow bypassing the endoprosthesis 1.
For example, the liner may be stitched or otherwise secured to the stent 10 along a plurality of circumferentially spaced-apart axial lines. Such attachment permits the liner to fold along a plurality of axial fold lines when the stent 10 is radially compressed. The liner will further be able to open and conform to the luminal wall of the tubular frame as the frame expands. Alternatively, the liner may heat welded, or ultrasonically welded to the stent 10. The liner may be secured to the plurality of independent arches (positioning arches 15a, 15b, 15c, retaining arches 16a, 16b, 16c, auxiliary arches 18a, 18b, 18c, leaflet guard arches 50a, 50b, 50c) preferably along axial lines. In addition, the liner may be secured to the annular collar 40 provided at the lower end section 2 of the stent 10. The liner will preferably be circumferentially sealed against the stent 10 at at least one end.
By covering at least a part of the outside surface of the stent 10 with the liner or sheath, thrombogenicity of the endoprosthesis 1 resulting from exposed stent elements is greatly reduced or eliminated. Such reduction of thrombogenicity is achieved while maintaining the benefits of having a stent structure which is used for spreading up a valvular prosthesis 100 and for anchoring the valvular prosthesis 100 in place.
As already mentioned, the stent 10 can be compressed from a relaxed, large diameter configuration to a small diameter configuration to facilitate introduction. It is necessary, of course, that the outer liner remain attached to the stent 10 both in its radially compressed configuration and in its expanded, relaxed configuration.
The liner is composed of pericardial material or conventional biological graft materials, such as polyesters, polytetrafluoroethylenes (PTFE's), polyurethanes, and the like, usually being in the form of woven fabrics, non-woven fabrics, polymeric sheets, membranes, and the like. A presently preferred fabric liner material is a plain woven polyester, such as Dacron® yarn (Dupont, Wilmington, Del.).
A twentieth embodiment of the stent 10 according to the present invention is described in the following with reference to
The twentieth embodiment of the stent 10 is similar in structure and function with respect to the nineteenth embodiment. To avoid repetition, reference is therefore made to the above description of the nineteenth embodiment. In particular, the lower end section of the stent 10 is constituted by an annular collar 40 which is likewise provided with notches 12e acting as additional fastening means.
In addition, the stent 10 according to the twentieth embodiment is provided with retaining arches 16a, 16b, 16c whose arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ are segmented by a plurality of bending edges 33 which are not only used for defining a bending point of two neighboring arm segments, but also as fastening notches which can be used for fixing a heart valve prosthesis to the stent 10.
The twentieth embodiment of the stent 10 also includes radial arches 32a, 32b, 32c extending from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent 10. As is shown in the
Contrary to the stent design of the nineteenth embodiment, however, the stent design of the twentieth embodiment is not provided with leaflet guard arches 50a, 50b, 50c. Furthermore, each arm of a radial arch 32a, 32b, 32c merges at about the mid-point of the length of the stent 10 into an arm 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c.
A twenty-first embodiment of the stent 10 according to the present invention is described in the following with reference to
From a comparison of
The twenty-first embodiment of the stent 10 only differs from the nineteenth embodiment in that the respective lower end sections of the leaflet guard arches 50a, 50b, 50c are removed. In particular, the lower end sections of the leaflet guard arches 50a, 50b, 50c between the points where each arm of a radial arch 32a, 32b, 32c merges is removed.
The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims.
Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
This application is a continuation of U.S. patent application Ser. No. 16/919,014, filed Jul. 1, 2020 (now U.S. Pat. No. 10,993,805), which is a continuation of U.S. patent application Ser. No. 16/199,763, filed Nov. 26, 2018 (now U.S. Pat. No. 10,702,382), which is a continuation of U.S. patent application Ser. No. 15/266,295, filed Sep. 15, 2016 (now U.S. Pat. No. 10,154,901), which is a continuation of U.S. patent application Ser. No. 15/221,860, filed Jul. 28, 2016 (now U.S. Pat. No. 9,987,133), which is a continuation of U.S. patent application Ser. No. 14/312,180, filed Jun. 23, 2014 (now U.S. Pat. No. 9,439,759), which is a continuation of U.S. patent application Ser. No. 13/896,905, filed May 17, 2013 (now U.S. Pat. No. 8,790,395), which is a continuation of U.S. patent application Ser. No. 13/033,023, filed Feb. 23, 2011 (now U.S. Pat. No. 8,465,540), which is a continuation-in-part of U.S. patent application Ser. No. 12/713,058, filed Feb. 25, 2010 (now U.S. Pat. No. 8,398,704), which is a continuation-in-part of U.S. patent application Ser. No. 12/392,467, filed Feb. 25, 2009 (now U.S. Pat. No. 8,317,858), which is a continuation-in-part of U.S. patent application Ser. No. 12/285,544, filed Oct. 8, 2008 (now U.S. Pat. No. 9,168,130), which is a continuation-in-part of U.S. patent application Ser. No. 12/071,814, filed Feb. 26, 2008 (now U.S. Pat. No. 9,044,318), each of which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 15192 | Peale | Jun 1856 | A |
| 388776 | Hall | Aug 1888 | A |
| 944214 | Rydquist | Dec 1909 | A |
| 2121182 | Benjamin | Jun 1938 | A |
| 2669896 | Clough | Feb 1954 | A |
| 2682057 | Lord | Jun 1954 | A |
| 2701559 | Cooper | Feb 1955 | A |
| 2832078 | Williams | Apr 1958 | A |
| 3029819 | Edward et al. | Apr 1962 | A |
| 3099016 | Lowell et al. | Jul 1963 | A |
| 3113586 | Edmark, Jr. et al. | Dec 1963 | A |
| 3130418 | Head et al. | Apr 1964 | A |
| 3143742 | Cromie | Aug 1964 | A |
| 3210836 | Johanson et al. | Oct 1965 | A |
| 3221006 | Moore et al. | Nov 1965 | A |
| 3334629 | Cohn | Aug 1967 | A |
| 3365728 | Lowell et al. | Jan 1968 | A |
| 3367364 | Cruz, Jr. et al. | Feb 1968 | A |
| 3409013 | Henry et al. | Nov 1968 | A |
| 3445916 | Schulte et al. | May 1969 | A |
| 3540431 | Mobin-Uddin et al. | Nov 1970 | A |
| 3548417 | Kischer et al. | Dec 1970 | A |
| 3570014 | Hancock et al. | Mar 1971 | A |
| 3574865 | Hamaker | Apr 1971 | A |
| 3587115 | Shiley et al. | Jun 1971 | A |
| 3592184 | Watkins et al. | Jul 1971 | A |
| 3628535 | Ostrowsky et al. | Dec 1971 | A |
| 3642004 | Osthagen et al. | Feb 1972 | A |
| 3657744 | Ersek | Apr 1972 | A |
| 3671979 | Moulopoulos | Jun 1972 | A |
| 3714671 | Edwards et al. | Feb 1973 | A |
| 3725961 | Magovern et al. | Apr 1973 | A |
| 3755823 | Hancock | Sep 1973 | A |
| 3795246 | Sturgeon | Mar 1974 | A |
| 3839741 | Haller | Oct 1974 | A |
| 3868956 | Alfidi et al. | Mar 1975 | A |
| 3874388 | King et al. | Apr 1975 | A |
| 3983581 | Angell et al. | Oct 1976 | A |
| 3997923 | Possis | Dec 1976 | A |
| 4035849 | Angell et al. | Jul 1977 | A |
| 4056854 | Boretos et al. | Nov 1977 | A |
| 4078268 | Possis | Mar 1978 | A |
| 4084268 | Ionescu et al. | Apr 1978 | A |
| 4106126 | Traenkle | Aug 1978 | A |
| 4106129 | Carpentier et al. | Aug 1978 | A |
| 4118806 | Porier et al. | Oct 1978 | A |
| 4164046 | Cooley | Aug 1979 | A |
| 4182446 | Penny | Jan 1980 | A |
| 4191218 | Clark et al. | Mar 1980 | A |
| 4214587 | Sakura, Jr. | Jul 1980 | A |
| 4215871 | Hirsch et al. | Aug 1980 | A |
| 4222126 | Boretos et al. | Sep 1980 | A |
| 4233690 | Akins | Nov 1980 | A |
| 4261342 | Aranguren Duo | Apr 1981 | A |
| 4263680 | Reul et al. | Apr 1981 | A |
| 4265694 | Boretos et al. | May 1981 | A |
| 4291420 | Reul | Sep 1981 | A |
| 4297749 | Davis et al. | Nov 1981 | A |
| 4319831 | Matsui et al. | Mar 1982 | A |
| RE30912 | Hancock | Apr 1982 | E |
| 4323358 | Lentz et al. | Apr 1982 | A |
| 4326306 | Poler | Apr 1982 | A |
| 4339831 | Johnson | Jul 1982 | A |
| 4343048 | Ross et al. | Aug 1982 | A |
| 4345340 | Rosen | Aug 1982 | A |
| 4350492 | Wright et al. | Sep 1982 | A |
| 4373216 | Klawitter | Feb 1983 | A |
| 4388735 | Ionescu et al. | Jun 1983 | A |
| 4406022 | Roy | Sep 1983 | A |
| 4423809 | Mazzocco | Jan 1984 | A |
| 4425908 | Simon | Jan 1984 | A |
| 4441215 | Kaster | Apr 1984 | A |
| 4441216 | Ionescu et al. | Apr 1984 | A |
| 4470157 | Love | Sep 1984 | A |
| 4484579 | Meno et al. | Nov 1984 | A |
| 4485816 | Krumme | Dec 1984 | A |
| 4491986 | Gabbay | Jan 1985 | A |
| 4501030 | Lane | Feb 1985 | A |
| 4502488 | Degironimo et al. | Mar 1985 | A |
| 4531943 | Van Tassel et al. | Jul 1985 | A |
| 4535483 | Klawitter et al. | Aug 1985 | A |
| 4546499 | Possis et al. | Oct 1985 | A |
| 4562597 | Possis et al. | Jan 1986 | A |
| 4574803 | Storz | Mar 1986 | A |
| 4580568 | Gianturco | Apr 1986 | A |
| 4592340 | Boyles | Jun 1986 | A |
| 4602911 | Ahmadi et al. | Jul 1986 | A |
| 4605407 | Black et al. | Aug 1986 | A |
| 4610688 | Silvestrini et al. | Sep 1986 | A |
| 4612011 | Kautzky | Sep 1986 | A |
| 4617932 | Kornberg | Oct 1986 | A |
| 4619246 | Molgaard-Nielsen et al. | Oct 1986 | A |
| 4643732 | Pietsch et al. | Feb 1987 | A |
| 4647283 | Carpentier et al. | Mar 1987 | A |
| 4648881 | Carpentier et al. | Mar 1987 | A |
| 4655218 | Kulik et al. | Apr 1987 | A |
| 4655771 | Wallsten | Apr 1987 | A |
| 4662885 | DiPisa, Jr. | May 1987 | A |
| 4665906 | Jervis | May 1987 | A |
| 4665918 | Garza et al. | May 1987 | A |
| 4680031 | Alonso | Jul 1987 | A |
| 4681908 | Broderick et al. | Jul 1987 | A |
| 4687483 | Fisher et al. | Aug 1987 | A |
| 4692164 | Dzemeshkevich et al. | Sep 1987 | A |
| 4705516 | Barone et al. | Nov 1987 | A |
| 4710192 | Liotta et al. | Dec 1987 | A |
| 4733665 | Palmaz | Mar 1988 | A |
| 4755181 | Igoe | Jul 1988 | A |
| 4759758 | Gabbay | Jul 1988 | A |
| 4769029 | Patel | Sep 1988 | A |
| 4777951 | Cribier et al. | Oct 1988 | A |
| 4787899 | Lazarus | Nov 1988 | A |
| 4787901 | Baykut | Nov 1988 | A |
| 4796629 | Grayzel | Jan 1989 | A |
| 4797901 | Goerne et al. | Jan 1989 | A |
| 4806595 | Noishiki et al. | Feb 1989 | A |
| 4819751 | Shimada et al. | Apr 1989 | A |
| 4829990 | Thuroff et al. | May 1989 | A |
| 4834755 | Silvestrini et al. | May 1989 | A |
| 4846830 | Knoch et al. | Jul 1989 | A |
| 4851001 | Taheri | Jul 1989 | A |
| 4856516 | Hillstead | Aug 1989 | A |
| 4865600 | Carpentier et al. | Sep 1989 | A |
| 4872874 | Taheri | Oct 1989 | A |
| 4873978 | Ginsburg | Oct 1989 | A |
| 4878495 | Grayzel | Nov 1989 | A |
| 4878906 | Lindemann et al. | Nov 1989 | A |
| 4883458 | Shiber | Nov 1989 | A |
| 4885005 | Nashef et al. | Dec 1989 | A |
| 4909252 | Goldberger | Mar 1990 | A |
| 4917102 | Miller et al. | Apr 1990 | A |
| 4922905 | Strecker | May 1990 | A |
| 4927426 | Dretler | May 1990 | A |
| 4950227 | Savin et al. | Aug 1990 | A |
| 4953553 | Tremulis | Sep 1990 | A |
| 4954126 | Wallsten | Sep 1990 | A |
| 4966604 | Reiss | Oct 1990 | A |
| 4969890 | Sugita et al. | Nov 1990 | A |
| 4979939 | Shiber | Dec 1990 | A |
| 4986830 | Owens et al. | Jan 1991 | A |
| 4994077 | Dobben | Feb 1991 | A |
| 5002556 | Ishida et al. | Mar 1991 | A |
| 5002559 | Tower | Mar 1991 | A |
| 5002566 | Carpentier et al. | Mar 1991 | A |
| 5007896 | Shiber | Apr 1991 | A |
| 5026366 | Leckrone | Jun 1991 | A |
| 5026377 | Burton et al. | Jun 1991 | A |
| 5032128 | Alonso | Jul 1991 | A |
| 5035706 | Giantureo et al. | Jul 1991 | A |
| 5037434 | Lane | Aug 1991 | A |
| 5047041 | Samuels | Sep 1991 | A |
| 5053008 | Bajaj | Oct 1991 | A |
| 5059177 | Towne et al. | Oct 1991 | A |
| 5061273 | Yock | Oct 1991 | A |
| 5061277 | Carpentier et al. | Oct 1991 | A |
| 5061277 | Carpentier et al. | Oct 1991 | B1 |
| 5064435 | Porter | Nov 1991 | A |
| 5078720 | Burton et al. | Jan 1992 | A |
| 5080668 | Bolz et al. | Jan 1992 | A |
| 5085635 | Cragg | Feb 1992 | A |
| 5089015 | Ross | Feb 1992 | A |
| 5094661 | Levy et al. | Mar 1992 | A |
| 5104399 | Lazarus | Apr 1992 | A |
| 5104407 | Lam et al. | Apr 1992 | A |
| 5104407 | Lam et al. | Apr 1992 | B1 |
| 5108425 | Hwang | Apr 1992 | A |
| 5122154 | Rhodes | Jun 1992 | A |
| 5132473 | Furutaka et al. | Jul 1992 | A |
| 5141494 | Danforth et al. | Aug 1992 | A |
| 5143987 | Hansel et al. | Sep 1992 | A |
| 5147388 | Yamazaki | Sep 1992 | A |
| 5152771 | Sabbaghian et al. | Oct 1992 | A |
| 5159937 | Tremulis | Nov 1992 | A |
| 5161547 | Tower | Nov 1992 | A |
| 5163953 | Vince | Nov 1992 | A |
| 5163955 | Love et al. | Nov 1992 | A |
| 5167628 | Boyles | Dec 1992 | A |
| 5178632 | Hanson | Jan 1993 | A |
| 5192301 | Kamiya et al. | Mar 1993 | A |
| 5193546 | Shaknovich | Mar 1993 | A |
| 5197979 | Quintero et al. | Mar 1993 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5207695 | Trout, III | May 1993 | A |
| 5209741 | Spaeth | May 1993 | A |
| 5211183 | Wilson | May 1993 | A |
| 5215541 | Nashef et al. | Jun 1993 | A |
| 5217481 | Barbara | Jun 1993 | A |
| 5217483 | Tower | Jun 1993 | A |
| 5232445 | Bonzel | Aug 1993 | A |
| 5234447 | Kaster et al. | Aug 1993 | A |
| 5234456 | Silvestrini | Aug 1993 | A |
| 5238004 | Sahatjian et al. | Aug 1993 | A |
| 5258008 | Wilk | Nov 1993 | A |
| 5258023 | Reger | Nov 1993 | A |
| 5258042 | Mehta | Nov 1993 | A |
| 5272909 | Nguyen et al. | Dec 1993 | A |
| 5275580 | Yamazaki | Jan 1994 | A |
| 5279612 | Eberhardt | Jan 1994 | A |
| 5282847 | Trescony et al. | Feb 1994 | A |
| 5287861 | Wilk | Feb 1994 | A |
| 5295958 | Shturman | Mar 1994 | A |
| 5327774 | Nguyen et al. | Jul 1994 | A |
| 5330486 | Wilk | Jul 1994 | A |
| 5330500 | Song | Jul 1994 | A |
| 5332402 | Teitelbaum | Jul 1994 | A |
| 5336258 | Quintero et al. | Aug 1994 | A |
| 5342348 | Kaplan | Aug 1994 | A |
| 5344426 | Lau et al. | Sep 1994 | A |
| 5344427 | Cottenceau et al. | Sep 1994 | A |
| 5344442 | Deac | Sep 1994 | A |
| 5350398 | Pavcnik et al. | Sep 1994 | A |
| 5350399 | Erlebacher et al. | Sep 1994 | A |
| 5352240 | Ross | Oct 1994 | A |
| 5354330 | Hanson et al. | Oct 1994 | A |
| 5360444 | Kusuhara | Nov 1994 | A |
| 5368608 | Levy et al. | Nov 1994 | A |
| 5370685 | Stevens | Dec 1994 | A |
| 5380054 | Galvis | Jan 1995 | A |
| 5387235 | Chuter | Feb 1995 | A |
| 5389096 | Aita et al. | Feb 1995 | A |
| 5389106 | Tower | Feb 1995 | A |
| 5397351 | Pavcnik et al. | Mar 1995 | A |
| 5397355 | Marin et al. | Mar 1995 | A |
| 5409019 | Wilk | Apr 1995 | A |
| 5411552 | Andersen et al. | May 1995 | A |
| 5415633 | Lazarus et al. | May 1995 | A |
| 5425739 | Jessen | Jun 1995 | A |
| 5425762 | Muller | Jun 1995 | A |
| 5429144 | Wilk | Jul 1995 | A |
| 5431676 | Dubrul et al. | Jul 1995 | A |
| 5433723 | Lindenberg et al. | Jul 1995 | A |
| 5443446 | Shturman | Aug 1995 | A |
| 5443449 | Buelna | Aug 1995 | A |
| 5443477 | Marin et al. | Aug 1995 | A |
| 5443495 | Buscemi et al. | Aug 1995 | A |
| 5443499 | Schmitt | Aug 1995 | A |
| 5449384 | Johnson | Sep 1995 | A |
| 5456712 | Maginot | Oct 1995 | A |
| 5456713 | Chuter | Oct 1995 | A |
| 5464449 | Ryan et al. | Nov 1995 | A |
| 5469868 | Reger | Nov 1995 | A |
| 5470320 | Tiefenbrun et al. | Nov 1995 | A |
| 5476506 | Lunn | Dec 1995 | A |
| 5476508 | Amstrup | Dec 1995 | A |
| 5476510 | Eberhardt et al. | Dec 1995 | A |
| 5480423 | Ravenscroft et al. | Jan 1996 | A |
| 5480424 | Cox | Jan 1996 | A |
| 5486193 | Bourne et al. | Jan 1996 | A |
| 5487760 | Villafana | Jan 1996 | A |
| 5489294 | McVenes et al. | Feb 1996 | A |
| 5489297 | Duran | Feb 1996 | A |
| 5489298 | Love et al. | Feb 1996 | A |
| 5496346 | Horzewski et al. | Mar 1996 | A |
| 5499995 | Teirstein | Mar 1996 | A |
| 5500014 | Quijano et al. | Mar 1996 | A |
| 5500015 | Deac | Mar 1996 | A |
| 5507767 | Maeda et al. | Apr 1996 | A |
| 5509930 | Love | Apr 1996 | A |
| 5522881 | Lentz | Jun 1996 | A |
| 5527337 | Stack et al. | Jun 1996 | A |
| 5530949 | Koda et al. | Jun 1996 | A |
| 5534007 | St. Germain et al. | Jul 1996 | A |
| 5540712 | Kleshinski et al. | Jul 1996 | A |
| 5545133 | Burns et al. | Aug 1996 | A |
| 5545209 | Roberts et al. | Aug 1996 | A |
| 5545211 | An et al. | Aug 1996 | A |
| 5545214 | Stevens | Aug 1996 | A |
| 5549665 | Vesely et al. | Aug 1996 | A |
| 5549666 | Hata et al. | Aug 1996 | A |
| 5554119 | Harrison et al. | Sep 1996 | A |
| 5554185 | Block et al. | Sep 1996 | A |
| 5569274 | Rapacki et al. | Oct 1996 | A |
| 5571167 | Maginot | Nov 1996 | A |
| 5571174 | Love et al. | Nov 1996 | A |
| 5571175 | Vanney et al. | Nov 1996 | A |
| 5571215 | Sterman et al. | Nov 1996 | A |
| 5573520 | Schwartz et al. | Nov 1996 | A |
| 5575818 | Pinchuk | Nov 1996 | A |
| 5580922 | Park et al. | Dec 1996 | A |
| 5591185 | Kilmer et al. | Jan 1997 | A |
| 5591195 | Taheri et al. | Jan 1997 | A |
| 5593434 | Williams | Jan 1997 | A |
| 5595571 | Jaffe et al. | Jan 1997 | A |
| 5596471 | Hanlin | Jan 1997 | A |
| 5607464 | Trescony et al. | Mar 1997 | A |
| 5607465 | Camilli | Mar 1997 | A |
| 5609626 | Quijano et al. | Mar 1997 | A |
| 5613982 | Goldstein | Mar 1997 | A |
| 5618299 | Khosravi et al. | Apr 1997 | A |
| 5626553 | Frassica et al. | May 1997 | A |
| 5628784 | Strecker | May 1997 | A |
| 5632778 | Goldstein | May 1997 | A |
| 5634942 | Chevillon et al. | Jun 1997 | A |
| 5643278 | Wijay | Jul 1997 | A |
| 5645559 | Hachtman et al. | Jul 1997 | A |
| 5653684 | Laptewicz et al. | Aug 1997 | A |
| 5653745 | Trescony et al. | Aug 1997 | A |
| 5653749 | Love et al. | Aug 1997 | A |
| 5655548 | Nelson et al. | Aug 1997 | A |
| 5662124 | Wilk | Sep 1997 | A |
| 5662671 | Barbut et al. | Sep 1997 | A |
| 5662703 | Yurek et al. | Sep 1997 | A |
| 5665115 | Cragg | Sep 1997 | A |
| 5667523 | Bynon et al. | Sep 1997 | A |
| 5674277 | Freitag | Oct 1997 | A |
| 5674298 | Levy et al. | Oct 1997 | A |
| 5679112 | Levy et al. | Oct 1997 | A |
| 5681345 | Euteneuer | Oct 1997 | A |
| 5682906 | Sterman et al. | Nov 1997 | A |
| 5683451 | Lenker et al. | Nov 1997 | A |
| 5690644 | Yurek et al. | Nov 1997 | A |
| 5693083 | Baker et al. | Dec 1997 | A |
| 5693088 | Lazarus | Dec 1997 | A |
| 5693310 | Gries et al. | Dec 1997 | A |
| 5695498 | Tower | Dec 1997 | A |
| 5697972 | Kim et al. | Dec 1997 | A |
| 5700269 | Pinchuk et al. | Dec 1997 | A |
| 5702368 | Stevens et al. | Dec 1997 | A |
| 5709713 | Evans et al. | Jan 1998 | A |
| 5713917 | Leonhardt et al. | Feb 1998 | A |
| 5713950 | Cox | Feb 1998 | A |
| 5713951 | Garrison et al. | Feb 1998 | A |
| 5713953 | Vallana et al. | Feb 1998 | A |
| 5716370 | Williamson, IV et al. | Feb 1998 | A |
| 5716417 | Girard et al. | Feb 1998 | A |
| 5718725 | Sterman et al. | Feb 1998 | A |
| 5720391 | Dohm et al. | Feb 1998 | A |
| 5720776 | Chuter et al. | Feb 1998 | A |
| 5725549 | Lam | Mar 1998 | A |
| 5725550 | Nadal | Mar 1998 | A |
| 5728068 | Leone et al. | Mar 1998 | A |
| 5728151 | Garrison et al. | Mar 1998 | A |
| 5733267 | Del Toro | Mar 1998 | A |
| 5733325 | Robinson et al. | Mar 1998 | A |
| 5735842 | Krueger et al. | Apr 1998 | A |
| 5746476 | Novak et al. | May 1998 | A |
| 5746709 | Rom et al. | May 1998 | A |
| 5746765 | Kleshinski et al. | May 1998 | A |
| 5746775 | Levy et al. | May 1998 | A |
| 5749890 | Shaknovich | May 1998 | A |
| 5749921 | Lenker et al. | May 1998 | A |
| 5755682 | Knudson et al. | May 1998 | A |
| 5755777 | Chuter | May 1998 | A |
| 5755783 | Stobie et al. | May 1998 | A |
| 5756476 | Epstein et al. | May 1998 | A |
| 5758663 | Wilk et al. | Jun 1998 | A |
| 5766151 | Valley et al. | Jun 1998 | A |
| 5769780 | Hata et al. | Jun 1998 | A |
| 5769812 | Stevens et al. | Jun 1998 | A |
| 5769882 | Fogarty et al. | Jun 1998 | A |
| 5769887 | Brown et al. | Jun 1998 | A |
| 5772609 | Nguyen et al. | Jun 1998 | A |
| 5776188 | Shepherd et al. | Jul 1998 | A |
| 5782809 | Umeno et al. | Jul 1998 | A |
| 5782904 | White et al. | Jul 1998 | A |
| 5795331 | Cragg et al. | Aug 1998 | A |
| 5797946 | Chin | Aug 1998 | A |
| 5797960 | Stevens et al. | Aug 1998 | A |
| 5799661 | Boyd et al. | Sep 1998 | A |
| 5800456 | Maeda et al. | Sep 1998 | A |
| 5800508 | Goicoechea et al. | Sep 1998 | A |
| 5800531 | Cosgrove et al. | Sep 1998 | A |
| 5807327 | Green et al. | Sep 1998 | A |
| 5807384 | Mueller | Sep 1998 | A |
| 5807405 | Vanney et al. | Sep 1998 | A |
| 5810836 | Hussein et al. | Sep 1998 | A |
| 5814016 | Valley et al. | Sep 1998 | A |
| 5817113 | Gifford, III et al. | Oct 1998 | A |
| 5817126 | Imran | Oct 1998 | A |
| 5823956 | Roth et al. | Oct 1998 | A |
| 5824037 | Fogarty et al. | Oct 1998 | A |
| 5824038 | Wall | Oct 1998 | A |
| 5824041 | Lenker et al. | Oct 1998 | A |
| 5824043 | Cottone, Jr. | Oct 1998 | A |
| 5824053 | Khosravi et al. | Oct 1998 | A |
| 5824055 | Spiridigliozzi et al. | Oct 1998 | A |
| 5824056 | Rosenberg | Oct 1998 | A |
| 5824061 | Quijano et al. | Oct 1998 | A |
| 5824063 | Cox | Oct 1998 | A |
| 5824064 | Taheri | Oct 1998 | A |
| 5824071 | Nelson et al. | Oct 1998 | A |
| 5824080 | Lamuraglia | Oct 1998 | A |
| 5829447 | Stevens et al. | Nov 1998 | A |
| 5830222 | Makower | Nov 1998 | A |
| 5840081 | Andersen et al. | Nov 1998 | A |
| 5841382 | Walden et al. | Nov 1998 | A |
| 5843158 | Lenker et al. | Dec 1998 | A |
| 5843161 | Solovay | Dec 1998 | A |
| 5843181 | Jaffe et al. | Dec 1998 | A |
| 5851232 | Lois | Dec 1998 | A |
| 5853419 | Imran | Dec 1998 | A |
| 5853420 | Chevillon et al. | Dec 1998 | A |
| 5855210 | Sterman et al. | Jan 1999 | A |
| 5855597 | Jayaraman | Jan 1999 | A |
| 5855600 | Alt | Jan 1999 | A |
| 5855601 | Bessler et al. | Jan 1999 | A |
| 5855602 | Angell | Jan 1999 | A |
| 5860966 | Tower | Jan 1999 | A |
| 5860996 | Urban et al. | Jan 1999 | A |
| 5861024 | Rashidi | Jan 1999 | A |
| 5861028 | Angell | Jan 1999 | A |
| 5865723 | Love | Feb 1999 | A |
| 5868783 | Tower | Feb 1999 | A |
| 5873812 | Ciana et al. | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5876373 | Giba et al. | Mar 1999 | A |
| 5876419 | Carpenter et al. | Mar 1999 | A |
| 5876434 | Flomenblit et al. | Mar 1999 | A |
| 5876448 | Thompson et al. | Mar 1999 | A |
| 5878751 | Hussein et al. | Mar 1999 | A |
| 5880242 | Hu et al. | Mar 1999 | A |
| 5885228 | Rosenman et al. | Mar 1999 | A |
| 5885238 | Stevens et al. | Mar 1999 | A |
| 5885259 | Berg | Mar 1999 | A |
| 5888201 | Stinson et al. | Mar 1999 | A |
| 5891160 | Williamson, IV et al. | Apr 1999 | A |
| 5891191 | Stinson | Apr 1999 | A |
| 5895399 | Barbut et al. | Apr 1999 | A |
| 5895420 | Mirsch, II et al. | Apr 1999 | A |
| 5899936 | Goldstein | May 1999 | A |
| 5906619 | Olson et al. | May 1999 | A |
| 5907893 | Zadno-Azizi et al. | Jun 1999 | A |
| 5908028 | Wilk | Jun 1999 | A |
| 5908029 | Knudson et al. | Jun 1999 | A |
| 5908451 | Yeo | Jun 1999 | A |
| 5908452 | Bokros et al. | Jun 1999 | A |
| 5910144 | Hayashi | Jun 1999 | A |
| 5910154 | Tsugita et al. | Jun 1999 | A |
| 5911734 | Tsugita et al. | Jun 1999 | A |
| 5911752 | Dustrude et al. | Jun 1999 | A |
| 5913842 | Boyd et al. | Jun 1999 | A |
| 5916193 | Stevens et al. | Jun 1999 | A |
| 5922022 | Nash et al. | Jul 1999 | A |
| 5924424 | Stevens et al. | Jul 1999 | A |
| 5925012 | Murphy-Chutorian et al. | Jul 1999 | A |
| 5925063 | Khosravi | Jul 1999 | A |
| 5928281 | Huynh et al. | Jul 1999 | A |
| 5931848 | Saadat | Aug 1999 | A |
| 5935119 | Guy et al. | Aug 1999 | A |
| 5935161 | Robinson et al. | Aug 1999 | A |
| 5935163 | Gabbay | Aug 1999 | A |
| 5938632 | Ellis | Aug 1999 | A |
| 5938697 | Killion et al. | Aug 1999 | A |
| 5941908 | Goldsteen et al. | Aug 1999 | A |
| 5944019 | Knudson et al. | Aug 1999 | A |
| 5944738 | Amplatz et al. | Aug 1999 | A |
| 5948017 | Taheri | Sep 1999 | A |
| 5954764 | Parodi | Sep 1999 | A |
| 5954766 | Zadno-Azizi et al. | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5961549 | Nguyen et al. | Oct 1999 | A |
| 5964405 | Benary et al. | Oct 1999 | A |
| 5964798 | Imran | Oct 1999 | A |
| 5968064 | Selmon et al. | Oct 1999 | A |
| 5968068 | Dehdashtian et al. | Oct 1999 | A |
| 5968070 | Bley et al. | Oct 1999 | A |
| 5971993 | Hussein et al. | Oct 1999 | A |
| 5975949 | Holliday et al. | Nov 1999 | A |
| 5976153 | Fischell et al. | Nov 1999 | A |
| 5976155 | Foreman et al. | Nov 1999 | A |
| 5976174 | Ruiz | Nov 1999 | A |
| 5976178 | Goldsteen et al. | Nov 1999 | A |
| 5976192 | McIntyre et al. | Nov 1999 | A |
| 5976650 | Campbell et al. | Nov 1999 | A |
| 5979455 | Maginot | Nov 1999 | A |
| 5980455 | Daniel et al. | Nov 1999 | A |
| 5980533 | Holman | Nov 1999 | A |
| 5980548 | Evans et al. | Nov 1999 | A |
| 5984956 | Tweden et al. | Nov 1999 | A |
| 5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
| 5984959 | Robertson et al. | Nov 1999 | A |
| 5984964 | Roberts et al. | Nov 1999 | A |
| 5987344 | West | Nov 1999 | A |
| 5989276 | Houser et al. | Nov 1999 | A |
| 5989287 | Yang et al. | Nov 1999 | A |
| 5993469 | McKenzie et al. | Nov 1999 | A |
| 5993481 | Marcade et al. | Nov 1999 | A |
| 5997525 | March et al. | Dec 1999 | A |
| 5997557 | Barbut et al. | Dec 1999 | A |
| 5997563 | Kretzers | Dec 1999 | A |
| 5997573 | Quijano et al. | Dec 1999 | A |
| 5999678 | Murphy-Chutorian et al. | Dec 1999 | A |
| 6001123 | Lau | Dec 1999 | A |
| 6001126 | Nguyen-Thien-Nhon | Dec 1999 | A |
| 6004261 | Sinofsky et al. | Dec 1999 | A |
| 6004347 | McNamara et al. | Dec 1999 | A |
| 6004348 | Banas et al. | Dec 1999 | A |
| 6007543 | Ellis et al. | Dec 1999 | A |
| 6010449 | Selmon et al. | Jan 2000 | A |
| 6010522 | Barbut et al. | Jan 2000 | A |
| 6010530 | Goicoechea | Jan 2000 | A |
| 6010531 | Donlon et al. | Jan 2000 | A |
| 6012457 | Lesh | Jan 2000 | A |
| 6013854 | Moriuchi | Jan 2000 | A |
| 6015431 | Thornton et al. | Jan 2000 | A |
| 6019777 | MacKenzie | Feb 2000 | A |
| 6019778 | Wilson et al. | Feb 2000 | A |
| 6022370 | Tower | Feb 2000 | A |
| 6026814 | LaFontaine et al. | Feb 2000 | A |
| 6027476 | Sterman et al. | Feb 2000 | A |
| 6027520 | Tsugita et al. | Feb 2000 | A |
| 6027525 | Suh et al. | Feb 2000 | A |
| 6029671 | Stevens et al. | Feb 2000 | A |
| 6029672 | Vanney et al. | Feb 2000 | A |
| 6033582 | Lee et al. | Mar 2000 | A |
| 6035856 | LaFontaine et al. | Mar 2000 | A |
| 6036677 | Javier, Jr. et al. | Mar 2000 | A |
| 6036697 | DiCaprio | Mar 2000 | A |
| 6042554 | Rosenman et al. | Mar 2000 | A |
| 6042581 | Ryan et al. | Mar 2000 | A |
| 6042589 | Marianne | Mar 2000 | A |
| 6042598 | Tsugita et al. | Mar 2000 | A |
| 6042607 | Williamson, IV et al. | Mar 2000 | A |
| 6045565 | Ellis et al. | Apr 2000 | A |
| 6051014 | Jang | Apr 2000 | A |
| 6051104 | Oriaran et al. | Apr 2000 | A |
| 6053924 | Hussein | Apr 2000 | A |
| 6053942 | Eno et al. | Apr 2000 | A |
| 6056743 | Ellis et al. | May 2000 | A |
| 6059809 | Amor et al. | May 2000 | A |
| 6059827 | Fenton, Jr. | May 2000 | A |
| 6066160 | Colvin et al. | May 2000 | A |
| 6067988 | Mueller | May 2000 | A |
| 6068638 | Makower | May 2000 | A |
| 6071292 | Makower et al. | Jun 2000 | A |
| 6074416 | Berg et al. | Jun 2000 | A |
| 6074417 | Peredo | Jun 2000 | A |
| 6074418 | Buchanan et al. | Jun 2000 | A |
| 6076529 | Vanney et al. | Jun 2000 | A |
| 6076742 | Benary | Jun 2000 | A |
| 6077297 | Robinson et al. | Jun 2000 | A |
| 6079414 | Roth | Jun 2000 | A |
| 6080163 | Hussein et al. | Jun 2000 | A |
| 6080170 | Nash et al. | Jun 2000 | A |
| 6083257 | Taylor et al. | Jul 2000 | A |
| 6091042 | Benary | Jul 2000 | A |
| 6092526 | LaFontaine et al. | Jul 2000 | A |
| 6092529 | Cox | Jul 2000 | A |
| 6093166 | Knudson et al. | Jul 2000 | A |
| 6093177 | Javier, Jr. et al. | Jul 2000 | A |
| 6093185 | Ellis et al. | Jul 2000 | A |
| 6093203 | Uflacker | Jul 2000 | A |
| 6093530 | McIlroy et al. | Jul 2000 | A |
| 6096074 | Pedros | Aug 2000 | A |
| 6102941 | Tweden et al. | Aug 2000 | A |
| 6102944 | Huynh et al. | Aug 2000 | A |
| 6106550 | Magovern et al. | Aug 2000 | A |
| 6110191 | Dehdashtian et al. | Aug 2000 | A |
| 6110198 | Fogarty et al. | Aug 2000 | A |
| 6110201 | Quijano et al. | Aug 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6113630 | Vanney et al. | Sep 2000 | A |
| 6113823 | Eno | Sep 2000 | A |
| 6117169 | Moe | Sep 2000 | A |
| 6120520 | Saadat et al. | Sep 2000 | A |
| 6120534 | Ruiz | Sep 2000 | A |
| 6123682 | Knudson et al. | Sep 2000 | A |
| 6123723 | Konya et al. | Sep 2000 | A |
| 6125852 | Stevens et al. | Oct 2000 | A |
| 6126649 | Vantassel et al. | Oct 2000 | A |
| 6126654 | Giba et al. | Oct 2000 | A |
| 6126685 | Lenker et al. | Oct 2000 | A |
| 6126686 | Badylak et al. | Oct 2000 | A |
| 6132451 | Payne et al. | Oct 2000 | A |
| 6132473 | Williams et al. | Oct 2000 | A |
| 6132986 | Pathak et al. | Oct 2000 | A |
| 6139510 | Palermo | Oct 2000 | A |
| 6139541 | Vanney et al. | Oct 2000 | A |
| 6142987 | Tsugita | Nov 2000 | A |
| 6143021 | Staehle | Nov 2000 | A |
| 6143987 | Makita | Nov 2000 | A |
| 6146366 | Schachar | Nov 2000 | A |
| 6146415 | Fitz | Nov 2000 | A |
| 6146417 | Ischinger | Nov 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6152956 | Pierce | Nov 2000 | A |
| 6155264 | Ressemann et al. | Dec 2000 | A |
| 6156031 | Aita et al. | Dec 2000 | A |
| 6156055 | Ravenscroft | Dec 2000 | A |
| 6156531 | Pathak et al. | Dec 2000 | A |
| 6157852 | Selmon et al. | Dec 2000 | A |
| 6159225 | Makower | Dec 2000 | A |
| 6159239 | Greenhalgh | Dec 2000 | A |
| 6162208 | Hipps | Dec 2000 | A |
| 6162245 | Jayaraman | Dec 2000 | A |
| 6165185 | Shennib et al. | Dec 2000 | A |
| 6165188 | Saadat et al. | Dec 2000 | A |
| 6165200 | Tsugita et al. | Dec 2000 | A |
| 6165209 | Patterson et al. | Dec 2000 | A |
| 6167605 | Morales | Jan 2001 | B1 |
| 6168579 | Tsugita | Jan 2001 | B1 |
| 6168614 | Andersen et al. | Jan 2001 | B1 |
| 6168616 | Brown, III | Jan 2001 | B1 |
| 6171251 | Mueller et al. | Jan 2001 | B1 |
| 6171327 | Daniel et al. | Jan 2001 | B1 |
| 6171335 | Wheatley et al. | Jan 2001 | B1 |
| 6177514 | Pathak et al. | Jan 2001 | B1 |
| 6179859 | Bates et al. | Jan 2001 | B1 |
| 6182664 | Cosgrove | Feb 2001 | B1 |
| 6182668 | Tweden et al. | Feb 2001 | B1 |
| 6183481 | Lee et al. | Feb 2001 | B1 |
| 6186972 | Nelson et al. | Feb 2001 | B1 |
| 6187016 | Hedges et al. | Feb 2001 | B1 |
| 6190353 | Makower et al. | Feb 2001 | B1 |
| 6190393 | Bevier et al. | Feb 2001 | B1 |
| 6190405 | Culombo et al. | Feb 2001 | B1 |
| 6193726 | Vanney | Feb 2001 | B1 |
| 6193734 | Bolduc et al. | Feb 2001 | B1 |
| 6196230 | Hall et al. | Mar 2001 | B1 |
| 6197050 | Eno et al. | Mar 2001 | B1 |
| 6197053 | Cosgrove et al. | Mar 2001 | B1 |
| 6197296 | Davies et al. | Mar 2001 | B1 |
| 6197324 | Crittenden | Mar 2001 | B1 |
| 6200311 | Danek et al. | Mar 2001 | B1 |
| 6200336 | Pavcnik et al. | Mar 2001 | B1 |
| 6203550 | Olson | Mar 2001 | B1 |
| 6203556 | Evans et al. | Mar 2001 | B1 |
| 6206888 | Bicek et al. | Mar 2001 | B1 |
| 6206911 | Milo | Mar 2001 | B1 |
| 6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
| 6210957 | Carpentier et al. | Apr 2001 | B1 |
| 6213126 | LaFontaine et al. | Apr 2001 | B1 |
| 6214036 | Letendre et al. | Apr 2001 | B1 |
| 6214041 | Tweden et al. | Apr 2001 | B1 |
| 6214054 | Cunanan et al. | Apr 2001 | B1 |
| 6214055 | Simionescu et al. | Apr 2001 | B1 |
| 6217527 | Selmon et al. | Apr 2001 | B1 |
| 6217549 | Selmon et al. | Apr 2001 | B1 |
| 6217575 | DeVore et al. | Apr 2001 | B1 |
| 6217609 | Haverkost | Apr 2001 | B1 |
| 6218662 | Tchakarov et al. | Apr 2001 | B1 |
| 6221006 | Dubrul et al. | Apr 2001 | B1 |
| 6221049 | Selmon et al. | Apr 2001 | B1 |
| 6221091 | Khosravi | Apr 2001 | B1 |
| 6221096 | Aiba et al. | Apr 2001 | B1 |
| 6221100 | Strecker | Apr 2001 | B1 |
| 6223752 | Vanney et al. | May 2001 | B1 |
| 6224584 | March et al. | May 2001 | B1 |
| 6231544 | Tsugita et al. | May 2001 | B1 |
| 6231546 | Milo et al. | May 2001 | B1 |
| 6231551 | Barbut | May 2001 | B1 |
| 6231587 | Makower | May 2001 | B1 |
| 6231602 | Carpentier et al. | May 2001 | B1 |
| 6235000 | Milo et al. | May 2001 | B1 |
| 6237607 | Vanney et al. | May 2001 | B1 |
| 6238406 | Ellis et al. | May 2001 | B1 |
| 6241667 | Vetter et al. | Jun 2001 | B1 |
| 6241738 | Dereume | Jun 2001 | B1 |
| 6241741 | Duhaylongsod et al. | Jun 2001 | B1 |
| 6241757 | An et al. | Jun 2001 | B1 |
| 6245102 | Jayaraman | Jun 2001 | B1 |
| 6245103 | Stinson | Jun 2001 | B1 |
| 6245105 | Nguyen et al. | Jun 2001 | B1 |
| 6248112 | Gambale et al. | Jun 2001 | B1 |
| 6248116 | Chevillon et al. | Jun 2001 | B1 |
| 6250305 | Tweden | Jun 2001 | B1 |
| 6251079 | Gambale et al. | Jun 2001 | B1 |
| 6251104 | Kesten et al. | Jun 2001 | B1 |
| 6251116 | Shennib et al. | Jun 2001 | B1 |
| 6251135 | Stinson et al. | Jun 2001 | B1 |
| 6251418 | Ahern et al. | Jun 2001 | B1 |
| 6253768 | Wilk | Jul 2001 | B1 |
| 6253769 | LaFontaine et al. | Jul 2001 | B1 |
| 6254564 | Wilk et al. | Jul 2001 | B1 |
| 6254635 | Schroeder et al. | Jul 2001 | B1 |
| 6254636 | Peredo | Jul 2001 | B1 |
| 6257634 | Wei | Jul 2001 | B1 |
| 6258052 | Milo | Jul 2001 | B1 |
| 6258087 | Edwards et al. | Jul 2001 | B1 |
| 6258114 | Konya et al. | Jul 2001 | B1 |
| 6258115 | Dubrul | Jul 2001 | B1 |
| 6258119 | Hussein et al. | Jul 2001 | B1 |
| 6258120 | McKenzie et al. | Jul 2001 | B1 |
| 6258129 | Dybdal et al. | Jul 2001 | B1 |
| 6258150 | MacKellar | Jul 2001 | B1 |
| 6261304 | Hall et al. | Jul 2001 | B1 |
| 6267783 | Letendre et al. | Jul 2001 | B1 |
| 6269819 | Oz et al. | Aug 2001 | B1 |
| 6270513 | Tsugita et al. | Aug 2001 | B1 |
| 6270521 | Fischell et al. | Aug 2001 | B1 |
| 6270526 | Cox | Aug 2001 | B1 |
| 6273876 | Klima et al. | Aug 2001 | B1 |
| 6273895 | Pinchuk et al. | Aug 2001 | B1 |
| 6276661 | Laird | Aug 2001 | B1 |
| 6277555 | Duran et al. | Aug 2001 | B1 |
| 6283127 | Sterman et al. | Sep 2001 | B1 |
| 6283951 | Flaherty et al. | Sep 2001 | B1 |
| 6283983 | Makower et al. | Sep 2001 | B1 |
| 6283995 | Moe et al. | Sep 2001 | B1 |
| 6285903 | Rosenthal et al. | Sep 2001 | B1 |
| 6287317 | Makower et al. | Sep 2001 | B1 |
| 6287334 | Moll et al. | Sep 2001 | B1 |
| 6287338 | Sarnowski et al. | Sep 2001 | B1 |
| 6287339 | Vazquez et al. | Sep 2001 | B1 |
| 6290709 | Ellis et al. | Sep 2001 | B1 |
| 6290728 | Phelps et al. | Sep 2001 | B1 |
| 6296662 | Caffey | Oct 2001 | B1 |
| 6299637 | Shaolian et al. | Oct 2001 | B1 |
| 6302875 | Makower et al. | Oct 2001 | B1 |
| 6302892 | Wilk | Oct 2001 | B1 |
| 6302906 | Goicoechea et al. | Oct 2001 | B1 |
| 6306164 | Kujawski | Oct 2001 | B1 |
| 6309382 | Garrison et al. | Oct 2001 | B1 |
| 6309417 | Spence et al. | Oct 2001 | B1 |
| 6311693 | Sterman et al. | Nov 2001 | B1 |
| 6312465 | Griffin et al. | Nov 2001 | B1 |
| 6319281 | Patel | Nov 2001 | B1 |
| 6322548 | Payne et al. | Nov 2001 | B1 |
| 6322593 | Pathak et al. | Nov 2001 | B1 |
| 6325067 | Sterman et al. | Dec 2001 | B1 |
| 6327772 | Zadno-Azizi et al. | Dec 2001 | B1 |
| 6330884 | Kim | Dec 2001 | B1 |
| 6331189 | Wolinsky et al. | Dec 2001 | B1 |
| 6334873 | Lane et al. | Jan 2002 | B1 |
| 6336934 | Gilson et al. | Jan 2002 | B1 |
| 6336937 | Vonesh et al. | Jan 2002 | B1 |
| 6338735 | Stevens | Jan 2002 | B1 |
| 6338740 | Carpentier | Jan 2002 | B1 |
| 6342070 | Nguyen-Thien-Nhon | Jan 2002 | B1 |
| 6344044 | Fulkerson et al. | Feb 2002 | B1 |
| 6346074 | Roth | Feb 2002 | B1 |
| 6346116 | Brooks et al. | Feb 2002 | B1 |
| 6348063 | Yassour et al. | Feb 2002 | B1 |
| 6350248 | Knudson et al. | Feb 2002 | B1 |
| 6350277 | Kocur | Feb 2002 | B1 |
| 6350278 | Lenker et al. | Feb 2002 | B1 |
| 6352547 | Brown et al. | Mar 2002 | B1 |
| 6352554 | De Paulis | Mar 2002 | B2 |
| 6352708 | Duran et al. | Mar 2002 | B1 |
| 6357104 | Myers | Mar 2002 | B1 |
| 6358277 | Duran | Mar 2002 | B1 |
| 6361519 | Knudson et al. | Mar 2002 | B1 |
| 6361545 | Macoviak et al. | Mar 2002 | B1 |
| 6363938 | Saadat et al. | Apr 2002 | B2 |
| 6363939 | Wilk | Apr 2002 | B1 |
| 6364895 | Greenhalgh | Apr 2002 | B1 |
| 6368338 | Konya et al. | Apr 2002 | B1 |
| 6371970 | Khosravi et al. | Apr 2002 | B1 |
| 6371983 | Lane | Apr 2002 | B1 |
| 6375615 | Flaherty et al. | Apr 2002 | B1 |
| 6378221 | Ekholm, Jr. et al. | Apr 2002 | B1 |
| 6379319 | Garibotto et al. | Apr 2002 | B1 |
| 6379365 | Diaz | Apr 2002 | B1 |
| 6379372 | Dehdashtian et al. | Apr 2002 | B1 |
| 6379383 | Palmaz et al. | Apr 2002 | B1 |
| 6379740 | Rinaldi et al. | Apr 2002 | B1 |
| 6380457 | Yurek et al. | Apr 2002 | B1 |
| 6383193 | Cathcart et al. | May 2002 | B1 |
| 6387119 | Wolf et al. | May 2002 | B2 |
| 6387122 | Cragg | May 2002 | B1 |
| 6390098 | LaFontaine et al. | May 2002 | B1 |
| 6391051 | Sullivan, III et al. | May 2002 | B2 |
| 6391538 | Vyavahare et al. | May 2002 | B1 |
| 6395208 | Herweck et al. | May 2002 | B1 |
| 6398807 | Chouinard et al. | Jun 2002 | B1 |
| 6401720 | Stevens et al. | Jun 2002 | B1 |
| 6402736 | Brown et al. | Jun 2002 | B1 |
| 6402740 | Ellis et al. | Jun 2002 | B1 |
| 6406488 | Tweden et al. | Jun 2002 | B1 |
| 6406491 | Vanney | Jun 2002 | B1 |
| 6406493 | Tu et al. | Jun 2002 | B1 |
| 6409697 | Eno et al. | Jun 2002 | B2 |
| 6409750 | Hyodoh et al. | Jun 2002 | B1 |
| 6409751 | Hall et al. | Jun 2002 | B1 |
| 6409755 | Vrba | Jun 2002 | B1 |
| 6409759 | Peredo | Jun 2002 | B1 |
| 6413275 | Nguyen et al. | Jul 2002 | B1 |
| 6416490 | Ellis et al. | Jul 2002 | B1 |
| 6416510 | Altman et al. | Jul 2002 | B1 |
| 6423089 | Gingras et al. | Jul 2002 | B1 |
| 6425916 | Garrison et al. | Jul 2002 | B1 |
| 6432119 | Saadat | Aug 2002 | B1 |
| 6432126 | Gambale et al. | Aug 2002 | B1 |
| 6432127 | Kim et al. | Aug 2002 | B1 |
| 6432132 | Cottone et al. | Aug 2002 | B1 |
| 6440164 | DiMatteo et al. | Aug 2002 | B1 |
| 6443158 | LaFontaine et al. | Sep 2002 | B1 |
| 6447522 | Gambale et al. | Sep 2002 | B2 |
| 6447539 | Nelson et al. | Sep 2002 | B1 |
| 6451025 | Jervis | Sep 2002 | B1 |
| 6451054 | Stevens | Sep 2002 | B1 |
| 6454760 | Vanney | Sep 2002 | B2 |
| 6454794 | Knudson et al. | Sep 2002 | B1 |
| 6454799 | Schreck | Sep 2002 | B1 |
| 6458092 | Gambale et al. | Oct 2002 | B1 |
| 6458140 | Akin et al. | Oct 2002 | B2 |
| 6458153 | Bailey et al. | Oct 2002 | B1 |
| 6458323 | Boekstegers | Oct 2002 | B1 |
| 6461382 | Cao | Oct 2002 | B1 |
| 6464709 | Shennib et al. | Oct 2002 | B1 |
| 6468303 | Amplatz et al. | Oct 2002 | B1 |
| 6468660 | Ogle et al. | Oct 2002 | B2 |
| 6471723 | Ashworth et al. | Oct 2002 | B1 |
| 6475169 | Ferrera | Nov 2002 | B2 |
| 6475226 | Belef et al. | Nov 2002 | B1 |
| 6475239 | Campbell et al. | Nov 2002 | B1 |
| 6475244 | Herweck et al. | Nov 2002 | B2 |
| 6478819 | Moe | Nov 2002 | B2 |
| 6479079 | Pathak et al. | Nov 2002 | B1 |
| 6482220 | Mueller | Nov 2002 | B1 |
| 6482228 | Norred | Nov 2002 | B1 |
| 6485501 | Green | Nov 2002 | B1 |
| 6485502 | Don Michael et al. | Nov 2002 | B2 |
| 6485513 | Fan | Nov 2002 | B1 |
| 6485524 | Strecker | Nov 2002 | B2 |
| 6487581 | Spence et al. | Nov 2002 | B1 |
| 6488704 | Connelly et al. | Dec 2002 | B1 |
| 6491689 | Ellis et al. | Dec 2002 | B1 |
| 6491707 | Makower et al. | Dec 2002 | B2 |
| 6494211 | Boyd et al. | Dec 2002 | B1 |
| 6494897 | Sterman et al. | Dec 2002 | B2 |
| 6494909 | Greenhalgh | Dec 2002 | B2 |
| 6503272 | Duerig et al. | Jan 2003 | B2 |
| 6508496 | Huang | Jan 2003 | B1 |
| 6508803 | Horikawa et al. | Jan 2003 | B1 |
| 6508825 | Selmon et al. | Jan 2003 | B1 |
| 6508833 | Pavcnik et al. | Jan 2003 | B2 |
| 6509145 | Torrianni | Jan 2003 | B1 |
| 6511458 | Milo et al. | Jan 2003 | B2 |
| 6511491 | Grudem et al. | Jan 2003 | B2 |
| 6514217 | Selmon et al. | Feb 2003 | B1 |
| 6514271 | Evans et al. | Feb 2003 | B2 |
| 6517527 | Gambale et al. | Feb 2003 | B2 |
| 6517558 | Gittings et al. | Feb 2003 | B2 |
| 6517573 | Pollock et al. | Feb 2003 | B1 |
| 6521179 | Girardot et al. | Feb 2003 | B1 |
| 6524323 | Nash et al. | Feb 2003 | B1 |
| 6524335 | Hartley et al. | Feb 2003 | B1 |
| 6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
| 6530949 | Konya et al. | Mar 2003 | B2 |
| 6530952 | Vesely | Mar 2003 | B2 |
| 6533807 | Wolinsky et al. | Mar 2003 | B2 |
| 6537297 | Tsugita et al. | Mar 2003 | B2 |
| 6537310 | Palmaz et al. | Mar 2003 | B1 |
| 6540768 | Diaz et al. | Apr 2003 | B1 |
| 6540782 | Snyders | Apr 2003 | B1 |
| 6544230 | Flaherty et al. | Apr 2003 | B1 |
| 6547827 | Carpentier et al. | Apr 2003 | B2 |
| 6551303 | Van Tassel et al. | Apr 2003 | B1 |
| 6558318 | Daniel et al. | May 2003 | B1 |
| 6558417 | Peredo | May 2003 | B2 |
| 6558418 | Carpentier et al. | May 2003 | B2 |
| 6558429 | Taylor | May 2003 | B2 |
| 6559132 | Holmer | May 2003 | B1 |
| 6561998 | Roth et al. | May 2003 | B1 |
| 6562031 | Chandrasekaran et al. | May 2003 | B2 |
| 6562058 | Seguin et al. | May 2003 | B2 |
| 6562063 | Euteneuer et al. | May 2003 | B1 |
| 6562069 | Cai et al. | May 2003 | B2 |
| 6564805 | Garrison et al. | May 2003 | B2 |
| 6565528 | Mueller | May 2003 | B1 |
| 6565594 | Herweck et al. | May 2003 | B1 |
| 6569145 | Shmulewitz et al. | May 2003 | B1 |
| 6569147 | Evans et al. | May 2003 | B1 |
| 6569196 | Vesely | May 2003 | B1 |
| 6572642 | Rinaldi et al. | Jun 2003 | B2 |
| 6572643 | Gharibadeh | Jun 2003 | B1 |
| 6572652 | Shaknovich | Jun 2003 | B2 |
| 6575168 | LaFontaine et al. | Jun 2003 | B2 |
| 6579311 | Makower | Jun 2003 | B1 |
| 6582444 | Wilk | Jun 2003 | B2 |
| 6582460 | Cryer | Jun 2003 | B1 |
| 6582462 | Andersen et al. | Jun 2003 | B1 |
| 6585756 | Strecker | Jul 2003 | B1 |
| 6585758 | Chouinard et al. | Jul 2003 | B1 |
| 6585766 | Huynh et al. | Jul 2003 | B1 |
| 6589279 | Anderson et al. | Jul 2003 | B1 |
| 6592546 | Barbut et al. | Jul 2003 | B1 |
| 6592614 | Lenker et al. | Jul 2003 | B2 |
| 6599304 | Selmon et al. | Jul 2003 | B1 |
| 6600803 | Bruder et al. | Jul 2003 | B2 |
| 6605053 | Kamm et al. | Aug 2003 | B1 |
| 6605112 | Moll et al. | Aug 2003 | B1 |
| 6605113 | Wilk | Aug 2003 | B2 |
| 6608040 | Lin et al. | Aug 2003 | B1 |
| 6610077 | Hancock et al. | Aug 2003 | B1 |
| 6610085 | Lazarus | Aug 2003 | B1 |
| 6610100 | Phelps et al. | Aug 2003 | B2 |
| 6613069 | Boyd et al. | Sep 2003 | B2 |
| 6613077 | Gilligan et al. | Sep 2003 | B2 |
| 6613079 | Wolinsky et al. | Sep 2003 | B1 |
| 6613081 | Kim et al. | Sep 2003 | B2 |
| 6613086 | Moe et al. | Sep 2003 | B1 |
| 6616675 | Evard et al. | Sep 2003 | B1 |
| 6616682 | Joergensen et al. | Sep 2003 | B2 |
| 6622604 | Chouinard et al. | Sep 2003 | B1 |
| 6623491 | Thompson | Sep 2003 | B2 |
| 6623518 | Thompson et al. | Sep 2003 | B2 |
| 6623521 | Steinke et al. | Sep 2003 | B2 |
| 6626938 | Butaric et al. | Sep 2003 | B1 |
| 6626939 | Burnside et al. | Sep 2003 | B1 |
| 6632241 | Hancock et al. | Oct 2003 | B1 |
| 6632243 | Zadno-Azizi et al. | Oct 2003 | B1 |
| 6632470 | Morra et al. | Oct 2003 | B2 |
| 6635068 | Dubrul et al. | Oct 2003 | B1 |
| 6635079 | Unsworth et al. | Oct 2003 | B2 |
| 6635080 | Lauterjung et al. | Oct 2003 | B1 |
| 6635085 | Caffey et al. | Oct 2003 | B1 |
| 6638237 | Guiles et al. | Oct 2003 | B1 |
| 6638247 | Selmon et al. | Oct 2003 | B1 |
| 6638293 | Makower et al. | Oct 2003 | B1 |
| 6641610 | Wolf et al. | Nov 2003 | B2 |
| 6651670 | Rapacki et al. | Nov 2003 | B2 |
| 6651672 | Roth | Nov 2003 | B2 |
| 6652540 | Cole et al. | Nov 2003 | B1 |
| 6652546 | Nash et al. | Nov 2003 | B1 |
| 6652555 | Vantassel et al. | Nov 2003 | B1 |
| 6652571 | White et al. | Nov 2003 | B1 |
| 6652578 | Bailey et al. | Nov 2003 | B2 |
| 6655386 | Makower et al. | Dec 2003 | B1 |
| 6656213 | Solem | Dec 2003 | B2 |
| 6660003 | DeVore et al. | Dec 2003 | B1 |
| 6660024 | Flaherty et al. | Dec 2003 | B1 |
| 6663588 | DuBois et al. | Dec 2003 | B2 |
| 6663663 | Kim et al. | Dec 2003 | B2 |
| 6663667 | Dehdashtian et al. | Dec 2003 | B2 |
| 6666863 | Wentzel et al. | Dec 2003 | B2 |
| 6669709 | Cohn et al. | Dec 2003 | B1 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6673089 | Yassour et al. | Jan 2004 | B1 |
| 6673101 | Fitzgerald et al. | Jan 2004 | B1 |
| 6673106 | Mitelberg et al. | Jan 2004 | B2 |
| 6673109 | Cox | Jan 2004 | B2 |
| 6676668 | Mercereau et al. | Jan 2004 | B2 |
| 6676692 | Rabkin et al. | Jan 2004 | B2 |
| 6676693 | Belding et al. | Jan 2004 | B1 |
| 6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
| 6679268 | Stevens et al. | Jan 2004 | B2 |
| 6682543 | Barbut et al. | Jan 2004 | B2 |
| 6682558 | Tu et al. | Jan 2004 | B2 |
| 6682559 | Myers et al. | Jan 2004 | B2 |
| 6685648 | Flaherty et al. | Feb 2004 | B2 |
| 6685739 | DiMatteo et al. | Feb 2004 | B2 |
| 6689144 | Gerberding | Feb 2004 | B2 |
| 6689164 | Seguin | Feb 2004 | B1 |
| 6692512 | Jang | Feb 2004 | B2 |
| 6692513 | Streeter et al. | Feb 2004 | B2 |
| 6694983 | Wolf et al. | Feb 2004 | B2 |
| 6695864 | Macoviak et al. | Feb 2004 | B2 |
| 6695865 | Boyle et al. | Feb 2004 | B2 |
| 6695875 | Stelter et al. | Feb 2004 | B2 |
| 6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
| 6699274 | Stinson | Mar 2004 | B2 |
| 6701932 | Knudson et al. | Mar 2004 | B2 |
| 6702851 | Chinn et al. | Mar 2004 | B1 |
| 6709425 | Gambale et al. | Mar 2004 | B2 |
| 6709444 | Makower | Mar 2004 | B1 |
| 6712842 | Gifford, III et al. | Mar 2004 | B1 |
| 6712843 | Elliott | Mar 2004 | B2 |
| 6714842 | Ito | Mar 2004 | B1 |
| 6719770 | Laufer et al. | Apr 2004 | B2 |
| 6719787 | Cox | Apr 2004 | B2 |
| 6719788 | Cox | Apr 2004 | B2 |
| 6719789 | Cox | Apr 2004 | B2 |
| 6723116 | Taheri | Apr 2004 | B2 |
| 6723122 | Yang et al. | Apr 2004 | B2 |
| 6726677 | Flaherty et al. | Apr 2004 | B1 |
| 6729356 | Baker et al. | May 2004 | B1 |
| 6730118 | Spenser et al. | May 2004 | B2 |
| 6730121 | Ortiz et al. | May 2004 | B2 |
| 6730377 | Wang | May 2004 | B2 |
| 6733513 | Boyle et al. | May 2004 | B2 |
| 6733525 | Yang et al. | May 2004 | B2 |
| 6736827 | McAndrew et al. | May 2004 | B1 |
| 6736839 | Cummings | May 2004 | B2 |
| 6736845 | Marquez et al. | May 2004 | B2 |
| 6736846 | Cox | May 2004 | B2 |
| 6743252 | Bates et al. | Jun 2004 | B1 |
| 6746464 | Makower | Jun 2004 | B1 |
| 6752828 | Thornton | Jun 2004 | B2 |
| 6755854 | Gillick et al. | Jun 2004 | B2 |
| 6755855 | Yurek et al. | Jun 2004 | B2 |
| 6758855 | Fulton, III et al. | Jul 2004 | B2 |
| 6764503 | Ishimaru | Jul 2004 | B1 |
| 6764509 | Chinn et al. | Jul 2004 | B2 |
| 6767345 | St. Germain et al. | Jul 2004 | B2 |
| 6767362 | Schreck | Jul 2004 | B2 |
| 6769434 | Liddicoat et al. | Aug 2004 | B2 |
| 6773454 | Wholey et al. | Aug 2004 | B2 |
| 6773455 | Allen et al. | Aug 2004 | B2 |
| 6773456 | Gordon et al. | Aug 2004 | B1 |
| 6774278 | Ragheb et al. | Aug 2004 | B1 |
| 6776791 | Stallings et al. | Aug 2004 | B1 |
| 6786925 | Schoon et al. | Sep 2004 | B1 |
| 6786929 | Gambale et al. | Sep 2004 | B2 |
| 6790229 | Berreklouw | Sep 2004 | B1 |
| 6790230 | Beyersdorf et al. | Sep 2004 | B2 |
| 6790237 | Stinson | Sep 2004 | B2 |
| 6792979 | Konya et al. | Sep 2004 | B2 |
| 6797000 | Simpson et al. | Sep 2004 | B2 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6802319 | Stevens et al. | Oct 2004 | B2 |
| 6802858 | Gambale et al. | Oct 2004 | B2 |
| 6805711 | Quijano et al. | Oct 2004 | B2 |
| 6808498 | Laroya et al. | Oct 2004 | B2 |
| 6808504 | Schorgl et al. | Oct 2004 | B2 |
| 6808529 | Fulkerson | Oct 2004 | B2 |
| 6814746 | Thompson et al. | Nov 2004 | B2 |
| 6814754 | Greenhalgh | Nov 2004 | B2 |
| 6820676 | Palmaz et al. | Nov 2004 | B2 |
| 6821211 | Otten et al. | Nov 2004 | B2 |
| 6821297 | Snyders | Nov 2004 | B2 |
| 6824041 | Grieder et al. | Nov 2004 | B2 |
| 6824970 | Vyavahare et al. | Nov 2004 | B2 |
| 6830568 | Kesten et al. | Dec 2004 | B1 |
| 6830575 | Stenzel et al. | Dec 2004 | B2 |
| 6830584 | Seguin | Dec 2004 | B1 |
| 6830585 | Artof et al. | Dec 2004 | B1 |
| 6830586 | Quijano et al. | Dec 2004 | B2 |
| 6837901 | Rabkin et al. | Jan 2005 | B2 |
| 6837902 | Nguyen et al. | Jan 2005 | B2 |
| 6840957 | DiMatteo et al. | Jan 2005 | B2 |
| 6843802 | Villalobos et al. | Jan 2005 | B1 |
| 6846325 | Liddicoat | Jan 2005 | B2 |
| 6849084 | Rabkin et al. | Feb 2005 | B2 |
| 6849085 | Marton | Feb 2005 | B2 |
| 6854467 | Boekstegers | Feb 2005 | B2 |
| 6860898 | Stack et al. | Mar 2005 | B2 |
| 6861211 | Levy et al. | Mar 2005 | B2 |
| 6863668 | Gillespie et al. | Mar 2005 | B2 |
| 6863684 | Kim et al. | Mar 2005 | B2 |
| 6863688 | Ralph et al. | Mar 2005 | B2 |
| 6866650 | Stevens et al. | Mar 2005 | B2 |
| 6866669 | Buzzard et al. | Mar 2005 | B2 |
| 6872223 | Roberts et al. | Mar 2005 | B2 |
| 6872226 | Cali et al. | Mar 2005 | B2 |
| 6875231 | Anduiza et al. | Apr 2005 | B2 |
| 6881199 | Wilk et al. | Apr 2005 | B2 |
| 6881220 | Edwin et al. | Apr 2005 | B2 |
| 6883522 | Spence et al. | Apr 2005 | B2 |
| 6887266 | Williams et al. | May 2005 | B2 |
| 6890330 | Streeter et al. | May 2005 | B2 |
| 6890340 | Duane | May 2005 | B2 |
| 6893459 | Macoviak | May 2005 | B1 |
| 6893460 | Spenser et al. | May 2005 | B2 |
| 6896690 | Lambrecht et al. | May 2005 | B1 |
| 6899704 | Sterman et al. | May 2005 | B2 |
| 6905743 | Chen et al. | Jun 2005 | B1 |
| 6908481 | Cribier | Jun 2005 | B2 |
| 6911036 | Douk et al. | Jun 2005 | B2 |
| 6911040 | Johnson et al. | Jun 2005 | B2 |
| 6911043 | Myers et al. | Jun 2005 | B2 |
| 6913021 | Knudson et al. | Jul 2005 | B2 |
| 6913600 | Valley et al. | Jul 2005 | B2 |
| 6916304 | Eno et al. | Jul 2005 | B2 |
| 6920674 | Thornton | Jul 2005 | B2 |
| 6920732 | Mårtensson | Jul 2005 | B2 |
| 6926690 | Renati | Aug 2005 | B2 |
| 6926732 | Derus et al. | Aug 2005 | B2 |
| 6929009 | Makower et al. | Aug 2005 | B2 |
| 6929011 | Knudson et al. | Aug 2005 | B2 |
| 6929653 | Strecter | Aug 2005 | B2 |
| 6936058 | Forde et al. | Aug 2005 | B2 |
| 6936066 | Palmaz et al. | Aug 2005 | B2 |
| 6936067 | Buchanan | Aug 2005 | B2 |
| 6939352 | Buzzard et al. | Sep 2005 | B2 |
| 6939359 | Tu et al. | Sep 2005 | B2 |
| 6939365 | Fogarty et al. | Sep 2005 | B1 |
| 6939370 | Hartley et al. | Sep 2005 | B2 |
| 6942682 | Vrba et al. | Sep 2005 | B2 |
| 6945949 | Wilk | Sep 2005 | B2 |
| 6945997 | Huynh et al. | Sep 2005 | B2 |
| 6949080 | Wolf et al. | Sep 2005 | B2 |
| 6949118 | Kohler et al. | Sep 2005 | B2 |
| 6951571 | Srivastava | Oct 2005 | B1 |
| 6953332 | Kurk et al. | Oct 2005 | B1 |
| 6953481 | Phelps et al. | Oct 2005 | B2 |
| 6955175 | Stevens et al. | Oct 2005 | B2 |
| 6955681 | Evans et al. | Oct 2005 | B2 |
| 6964652 | Guiles et al. | Nov 2005 | B2 |
| 6964673 | Tsugita et al. | Nov 2005 | B2 |
| 6964676 | Gerberding et al. | Nov 2005 | B1 |
| 6969395 | Eskuri | Nov 2005 | B2 |
| 6972025 | Wasdyke | Dec 2005 | B2 |
| 6972029 | Mayrhofer et al. | Dec 2005 | B2 |
| 6974464 | Quijano et al. | Dec 2005 | B2 |
| 6974474 | Pavcnik et al. | Dec 2005 | B2 |
| 6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
| 6976990 | Mowry | Dec 2005 | B2 |
| 6979350 | Moll et al. | Dec 2005 | B2 |
| 6984242 | Campbell et al. | Jan 2006 | B2 |
| 6984244 | Perez et al. | Jan 2006 | B2 |
| 6986742 | Hart et al. | Jan 2006 | B2 |
| 6986784 | Weiser et al. | Jan 2006 | B1 |
| 6988949 | Wang | Jan 2006 | B2 |
| 6989027 | Allen et al. | Jan 2006 | B2 |
| 6989028 | Lashinski et al. | Jan 2006 | B2 |
| 6991649 | Sievers | Jan 2006 | B2 |
| 7001425 | McCullagh et al. | Feb 2006 | B2 |
| 7004176 | Lau | Feb 2006 | B2 |
| 7008397 | Tweden et al. | Mar 2006 | B2 |
| 7011095 | Wolf et al. | Mar 2006 | B2 |
| 7011681 | Vesely | Mar 2006 | B2 |
| 7014655 | Barbarash et al. | Mar 2006 | B2 |
| 7018401 | Hyodoh et al. | Mar 2006 | B1 |
| 7018406 | Seguin et al. | Mar 2006 | B2 |
| 7018408 | Bailey et al. | Mar 2006 | B2 |
| 7022134 | Quijano et al. | Apr 2006 | B1 |
| 7025773 | Gittings et al. | Apr 2006 | B2 |
| 7025780 | Gabbay | Apr 2006 | B2 |
| 7025791 | Levine et al. | Apr 2006 | B2 |
| 7028692 | Sterman et al. | Apr 2006 | B2 |
| 7037331 | Mitelberg et al. | May 2006 | B2 |
| 7037333 | Myers et al. | May 2006 | B2 |
| 7041128 | McGuckin, Jr. et al. | May 2006 | B2 |
| 7041132 | Quijano et al. | May 2006 | B2 |
| 7044966 | Svanidze et al. | May 2006 | B2 |
| 7048014 | Hyodoh et al. | May 2006 | B2 |
| 7048757 | Shaknovich | May 2006 | B2 |
| 7050276 | Nishiyama | May 2006 | B2 |
| 7074236 | Rabkin et al. | Jul 2006 | B2 |
| 7078163 | Torrianni | Jul 2006 | B2 |
| 7081132 | Cook et al. | Jul 2006 | B2 |
| 7097658 | Oktay | Aug 2006 | B2 |
| 7097659 | Woolfson et al. | Aug 2006 | B2 |
| 7101396 | Artof et al. | Sep 2006 | B2 |
| 7105016 | Shiu et al. | Sep 2006 | B2 |
| 7108715 | Lawrence-Brown et al. | Sep 2006 | B2 |
| 7115141 | Menz et al. | Oct 2006 | B2 |
| 7118585 | Addis | Oct 2006 | B2 |
| 7122020 | Mogul | Oct 2006 | B2 |
| 7125418 | Duran et al. | Oct 2006 | B2 |
| 7128759 | Osborne et al. | Oct 2006 | B2 |
| 7137184 | Schreck | Nov 2006 | B2 |
| 7141063 | White et al. | Nov 2006 | B2 |
| 7141064 | Scott et al. | Nov 2006 | B2 |
| 7143312 | Wang et al. | Nov 2006 | B1 |
| 7147662 | Pollock et al. | Dec 2006 | B1 |
| 7147663 | Berg et al. | Dec 2006 | B1 |
| 7153324 | Case et al. | Dec 2006 | B2 |
| 7160319 | Chouinard et al. | Jan 2007 | B2 |
| 7163556 | Xie et al. | Jan 2007 | B2 |
| 7166097 | Barbut | Jan 2007 | B2 |
| 7175652 | Cook et al. | Feb 2007 | B2 |
| 7175653 | Gaber | Feb 2007 | B2 |
| 7175654 | Bonsignore et al. | Feb 2007 | B2 |
| 7175656 | Khairkhahan | Feb 2007 | B2 |
| 7179290 | Cao | Feb 2007 | B2 |
| 7186265 | Sharkawy et al. | Mar 2007 | B2 |
| 7189258 | Johnson et al. | Mar 2007 | B2 |
| 7189259 | Simionescu et al. | Mar 2007 | B2 |
| 7191018 | Gielen et al. | Mar 2007 | B2 |
| 7191406 | Barber et al. | Mar 2007 | B1 |
| 7195641 | Palmaz et al. | Mar 2007 | B2 |
| 7198646 | Figulla et al. | Apr 2007 | B2 |
| 7201761 | Woolfson et al. | Apr 2007 | B2 |
| 7201772 | Schwammenthal et al. | Apr 2007 | B2 |
| 7214344 | Carpentier et al. | May 2007 | B2 |
| 7217287 | Wilson et al. | May 2007 | B2 |
| 7235092 | Banas et al. | Jun 2007 | B2 |
| 7235093 | Gregorich | Jun 2007 | B2 |
| 7238200 | Lee et al. | Jul 2007 | B2 |
| 7241257 | Ainsworth et al. | Jul 2007 | B1 |
| 7252682 | Seguin | Aug 2007 | B2 |
| 7258696 | Rabkin et al. | Aug 2007 | B2 |
| 7258891 | Pacetti et al. | Aug 2007 | B2 |
| 7261732 | Justino | Aug 2007 | B2 |
| 7264632 | Wright et al. | Sep 2007 | B2 |
| 7267686 | DiMatteo et al. | Sep 2007 | B2 |
| 7276078 | Spenser et al. | Oct 2007 | B2 |
| 7276084 | Yang et al. | Oct 2007 | B2 |
| 7285130 | Austin | Oct 2007 | B2 |
| 7297150 | Cartledge et al. | Nov 2007 | B2 |
| 7300457 | Palmaz | Nov 2007 | B2 |
| 7300463 | Liddicoat | Nov 2007 | B2 |
| 7311730 | Gabbay | Dec 2007 | B2 |
| 7314449 | Pfeiffer et al. | Jan 2008 | B2 |
| 7314485 | Mathis | Jan 2008 | B2 |
| 7314880 | Chang et al. | Jan 2008 | B2 |
| 7316706 | Bloom et al. | Jan 2008 | B2 |
| 7316712 | Peredo | Jan 2008 | B2 |
| 7317005 | Hoekstra et al. | Jan 2008 | B2 |
| 7317942 | Brown | Jan 2008 | B2 |
| 7317950 | Lee | Jan 2008 | B2 |
| 7318278 | Zhang et al. | Jan 2008 | B2 |
| 7318998 | Goldstein et al. | Jan 2008 | B2 |
| 7319096 | Malm et al. | Jan 2008 | B2 |
| 7320692 | Bender et al. | Jan 2008 | B1 |
| 7320704 | Lashinski et al. | Jan 2008 | B2 |
| 7320705 | Quintessenza | Jan 2008 | B2 |
| 7320706 | Al-Najjar | Jan 2008 | B2 |
| 7322932 | Xie et al. | Jan 2008 | B2 |
| 7323006 | Andreas et al. | Jan 2008 | B2 |
| 7323066 | Budron | Jan 2008 | B1 |
| 7326174 | Cox et al. | Feb 2008 | B2 |
| 7326219 | Mowry et al. | Feb 2008 | B2 |
| 7326236 | Andreas et al. | Feb 2008 | B2 |
| 7327862 | Murphy et al. | Feb 2008 | B2 |
| 7329278 | Seguin et al. | Feb 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7329280 | Bolling et al. | Feb 2008 | B2 |
| 7329777 | Harter et al. | Feb 2008 | B2 |
| 7331991 | Kheradvar et al. | Feb 2008 | B2 |
| 7331993 | White | Feb 2008 | B2 |
| 7333643 | Murphy et al. | Feb 2008 | B2 |
| 7335158 | Taylor | Feb 2008 | B2 |
| 7335213 | Hyde et al. | Feb 2008 | B1 |
| 7335218 | Wilson et al. | Feb 2008 | B2 |
| 7335490 | Van Gilst et al. | Feb 2008 | B2 |
| 7338484 | Schoon et al. | Mar 2008 | B2 |
| 7338520 | Bailey et al. | Mar 2008 | B2 |
| 7361189 | Case et al. | Apr 2008 | B2 |
| 7361190 | Shaoulian et al. | Apr 2008 | B2 |
| 7364588 | Mathis et al. | Apr 2008 | B2 |
| 7371258 | Woo et al. | May 2008 | B2 |
| 7374560 | Ressemann et al. | May 2008 | B2 |
| 7374571 | Pease et al. | May 2008 | B2 |
| 7377895 | Spence et al. | May 2008 | B2 |
| 7377938 | Sarac et al. | May 2008 | B2 |
| 7377940 | Ryan et al. | May 2008 | B2 |
| 7381210 | Zarbatany et al. | Jun 2008 | B2 |
| 7381216 | Buzzard et al. | Jun 2008 | B2 |
| 7381218 | Schreck | Jun 2008 | B2 |
| 7381219 | Salahieh et al. | Jun 2008 | B2 |
| 7381220 | Macoviak et al. | Jun 2008 | B2 |
| 7384411 | Condado | Jun 2008 | B1 |
| 7387640 | Cummings | Jun 2008 | B2 |
| 7389874 | Quest et al. | Jun 2008 | B2 |
| 7390325 | Wang et al. | Jun 2008 | B2 |
| 7393358 | Malewicz | Jul 2008 | B2 |
| 7393360 | Spenser et al. | Jul 2008 | B2 |
| 7396364 | Moaddeb et al. | Jul 2008 | B2 |
| 7399315 | Lobbi | Jul 2008 | B2 |
| 7402171 | Osborne et al. | Jul 2008 | B2 |
| 7404792 | Spence et al. | Jul 2008 | B2 |
| 7404793 | Lau et al. | Jul 2008 | B2 |
| 7405259 | Frye et al. | Jul 2008 | B2 |
| 7410499 | Bicer | Aug 2008 | B2 |
| 7412274 | Mejia | Aug 2008 | B2 |
| 7412290 | Janke et al. | Aug 2008 | B2 |
| 7415861 | Sokel | Aug 2008 | B2 |
| 7416530 | Turner et al. | Aug 2008 | B2 |
| 7422603 | Lane | Sep 2008 | B2 |
| 7422606 | Ung-Chhun et al. | Sep 2008 | B2 |
| 7423032 | Ozaki et al. | Sep 2008 | B2 |
| 7426413 | Balczewski et al. | Sep 2008 | B2 |
| 7427279 | Frazier et al. | Sep 2008 | B2 |
| 7427287 | Turovskiy et al. | Sep 2008 | B2 |
| 7427291 | Liddicoat et al. | Sep 2008 | B2 |
| 7429269 | Schwammenthal et al. | Sep 2008 | B2 |
| 7430448 | Zimmer et al. | Sep 2008 | B1 |
| 7430484 | Ohara | Sep 2008 | B2 |
| 7431691 | Wilk | Oct 2008 | B1 |
| 7431733 | Knight | Oct 2008 | B2 |
| 7435059 | Smith et al. | Oct 2008 | B2 |
| 7435257 | Lashinski et al. | Oct 2008 | B2 |
| 7442204 | Schwammenthal et al. | Oct 2008 | B2 |
| RE40570 | Carpentier et al. | Nov 2008 | E |
| 7445630 | Lashinski et al. | Nov 2008 | B2 |
| 7445631 | Salahieh et al. | Nov 2008 | B2 |
| 7445632 | McGuckin, Jr. et al. | Nov 2008 | B2 |
| 7452371 | Pavcnik et al. | Nov 2008 | B2 |
| 7455689 | Johnson | Nov 2008 | B2 |
| 7462156 | Mitrev | Dec 2008 | B2 |
| 7462184 | Worley et al. | Dec 2008 | B2 |
| 7462191 | Spenser et al. | Dec 2008 | B2 |
| 7468050 | Kantrowitz | Dec 2008 | B1 |
| 7470284 | Lambrecht et al. | Dec 2008 | B2 |
| 7470285 | Nugent et al. | Dec 2008 | B2 |
| 7473271 | Gunderson | Jan 2009 | B2 |
| 7473275 | Marquez | Jan 2009 | B2 |
| 7473417 | Zeltinger et al. | Jan 2009 | B2 |
| 7476196 | Spence et al. | Jan 2009 | B2 |
| 7476199 | Spence et al. | Jan 2009 | B2 |
| 7476200 | Tal | Jan 2009 | B2 |
| 7476244 | Buzzard et al. | Jan 2009 | B2 |
| 7481838 | Carpentier et al. | Jan 2009 | B2 |
| 7485088 | Murphy et al. | Feb 2009 | B2 |
| 7485143 | Webler et al. | Feb 2009 | B2 |
| 7488346 | Navia | Feb 2009 | B2 |
| 7491232 | Bolduc et al. | Feb 2009 | B2 |
| 7493869 | Foster et al. | Feb 2009 | B1 |
| 7497824 | Taylor | Mar 2009 | B2 |
| 7500949 | Gottlieb et al. | Mar 2009 | B2 |
| 7500989 | Solem et al. | Mar 2009 | B2 |
| 7503929 | Johnson et al. | Mar 2009 | B2 |
| 7503930 | Sharkawy et al. | Mar 2009 | B2 |
| 7507199 | Wang et al. | Mar 2009 | B2 |
| 7510572 | Gabbay | Mar 2009 | B2 |
| 7510574 | L et al. | Mar 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7510577 | Moaddeb et al. | Mar 2009 | B2 |
| 7513863 | Bolling et al. | Apr 2009 | B2 |
| 7513909 | Lane et al. | Apr 2009 | B2 |
| 7522950 | Fuimaono et al. | Apr 2009 | B2 |
| 7524330 | Berreklouw | Apr 2009 | B2 |
| 7530253 | Spenser et al. | May 2009 | B2 |
| 7530995 | Quijano et al. | May 2009 | B2 |
| 7534261 | Friedman | May 2009 | B2 |
| 7544206 | Cohn | Jun 2009 | B2 |
| 7547322 | Sarac et al. | Jun 2009 | B2 |
| 7553324 | Andreas et al. | Jun 2009 | B2 |
| 7556386 | Smith | Jul 2009 | B2 |
| 7556646 | Yang et al. | Jul 2009 | B2 |
| 7569071 | Haverkost et al. | Aug 2009 | B2 |
| 7578828 | Gittings et al. | Aug 2009 | B2 |
| 7585321 | Cribier | Sep 2009 | B2 |
| 7591848 | Allen | Sep 2009 | B2 |
| 7594974 | Cali et al. | Sep 2009 | B2 |
| 7601159 | Ewers et al. | Oct 2009 | B2 |
| 7601195 | Ichikawa | Oct 2009 | B2 |
| 7608099 | Johnson et al. | Oct 2009 | B2 |
| 7611534 | Kapadia et al. | Nov 2009 | B2 |
| 7618446 | Andersen et al. | Nov 2009 | B2 |
| 7622276 | Cunanan et al. | Nov 2009 | B2 |
| 7625403 | Krivoruchko | Dec 2009 | B2 |
| 7628802 | White et al. | Dec 2009 | B2 |
| 7628803 | Pavcnik et al. | Dec 2009 | B2 |
| 7632296 | Malewicz | Dec 2009 | B2 |
| 7632298 | Hijlkema et al. | Dec 2009 | B2 |
| 7635386 | Gammie | Dec 2009 | B1 |
| 7641687 | Chinn et al. | Jan 2010 | B2 |
| 7651519 | Dittman | Jan 2010 | B2 |
| 7655034 | Mitchell et al. | Feb 2010 | B2 |
| 7674282 | Wu et al. | Mar 2010 | B2 |
| 7682390 | Seguin | Mar 2010 | B2 |
| 7704222 | Wilk et al. | Apr 2010 | B2 |
| 7704277 | Zakay et al. | Apr 2010 | B2 |
| 7712606 | Salahieh et al. | May 2010 | B2 |
| 7717955 | Lane et al. | May 2010 | B2 |
| 7722638 | Deyette, Jr. et al. | May 2010 | B2 |
| 7722662 | Steinke et al. | May 2010 | B2 |
| 7722666 | Lafontaine | May 2010 | B2 |
| 7722671 | Carlyle et al. | May 2010 | B1 |
| 7731742 | Schlick et al. | Jun 2010 | B2 |
| 7735493 | Van Der Burg et al. | Jun 2010 | B2 |
| 7736327 | Wilk et al. | Jun 2010 | B2 |
| 7736388 | Goldfarb et al. | Jun 2010 | B2 |
| 7743481 | Lafont et al. | Jun 2010 | B2 |
| 7748389 | Salahieh et al. | Jul 2010 | B2 |
| 7758625 | Wu et al. | Jul 2010 | B2 |
| 7763065 | Schmid et al. | Jul 2010 | B2 |
| 7771463 | Ton et al. | Aug 2010 | B2 |
| 7771467 | Svensson | Aug 2010 | B2 |
| 7776083 | Vesely | Aug 2010 | B2 |
| 7780725 | Haug et al. | Aug 2010 | B2 |
| 7780726 | Seguin | Aug 2010 | B2 |
| 7785360 | Freitag | Aug 2010 | B2 |
| 7794487 | Majercak et al. | Sep 2010 | B2 |
| 7799046 | White et al. | Sep 2010 | B2 |
| 7799065 | Pappas | Sep 2010 | B2 |
| 7803185 | Gabbay | Sep 2010 | B2 |
| 7806919 | Bloom et al. | Oct 2010 | B2 |
| 7823267 | Bolduc | Nov 2010 | B2 |
| 7824442 | Salahieh et al. | Nov 2010 | B2 |
| 7824443 | Salahieh et al. | Nov 2010 | B2 |
| 7833262 | McGuckin, Jr. et al. | Nov 2010 | B2 |
| 7837727 | Goetz et al. | Nov 2010 | B2 |
| 7846203 | Cribier | Dec 2010 | B2 |
| 7846204 | Letac et al. | Dec 2010 | B2 |
| 7854758 | Taheri | Dec 2010 | B2 |
| 7857845 | Stacchino et al. | Dec 2010 | B2 |
| 7862602 | Licata et al. | Jan 2011 | B2 |
| 7867274 | Hill et al. | Jan 2011 | B2 |
| 7887583 | Macoviak | Feb 2011 | B2 |
| 7892276 | Stocker et al. | Feb 2011 | B2 |
| 7892292 | Stack et al. | Feb 2011 | B2 |
| 7896913 | Damm et al. | Mar 2011 | B2 |
| 7896915 | Guyenot et al. | Mar 2011 | B2 |
| 7914569 | Nguyen et al. | Mar 2011 | B2 |
| 7914574 | Schmid et al. | Mar 2011 | B2 |
| 7914575 | Guyenot et al. | Mar 2011 | B2 |
| 7918880 | Austin | Apr 2011 | B2 |
| 7927363 | Perouse | Apr 2011 | B2 |
| 7938851 | Olson et al. | May 2011 | B2 |
| 7947071 | Schmid et al. | May 2011 | B2 |
| 7947075 | Goetz et al. | May 2011 | B2 |
| 7951189 | Haverkost et al. | May 2011 | B2 |
| 7959666 | Salahieh et al. | Jun 2011 | B2 |
| 7959672 | Salahieh et al. | Jun 2011 | B2 |
| 7967853 | Eidenschink et al. | Jun 2011 | B2 |
| 7972359 | Kreidler | Jul 2011 | B2 |
| 7972376 | Dove et al. | Jul 2011 | B1 |
| 7972378 | Tabor et al. | Jul 2011 | B2 |
| 7988724 | Salahieh et al. | Aug 2011 | B2 |
| 7993386 | Elliott | Aug 2011 | B2 |
| 8002824 | Jenson et al. | Aug 2011 | B2 |
| 8002825 | Letac et al. | Aug 2011 | B2 |
| 8012198 | Hill et al. | Sep 2011 | B2 |
| 8021421 | Fogarty et al. | Sep 2011 | B2 |
| RE42818 | Cali et al. | Oct 2011 | E |
| RE42857 | Cali et al. | Oct 2011 | E |
| 8038704 | Sherburne | Oct 2011 | B2 |
| 8038709 | Palasis et al. | Oct 2011 | B2 |
| 8043450 | Cali et al. | Oct 2011 | B2 |
| 8048153 | Salahieh et al. | Nov 2011 | B2 |
| 8052715 | Quinn et al. | Nov 2011 | B2 |
| 8052749 | Salahieh et al. | Nov 2011 | B2 |
| 8052750 | Tuval et al. | Nov 2011 | B2 |
| 8057540 | Letac et al. | Nov 2011 | B2 |
| 8062355 | Figulla et al. | Nov 2011 | B2 |
| 8062536 | Liu et al. | Nov 2011 | B2 |
| 8062537 | Tuominen et al. | Nov 2011 | B2 |
| 8062749 | Shelestak et al. | Nov 2011 | B2 |
| 8070799 | Righini et al. | Dec 2011 | B2 |
| 8075641 | Aravanis et al. | Dec 2011 | B2 |
| 8083788 | Acosta et al. | Dec 2011 | B2 |
| 8092518 | Schreck | Jan 2012 | B2 |
| 8092520 | Quadri | Jan 2012 | B2 |
| 8092521 | Figulla et al. | Jan 2012 | B2 |
| 8128676 | Cummings | Mar 2012 | B2 |
| 8128681 | Shoemaker et al. | Mar 2012 | B2 |
| 8133217 | Stokes et al. | Mar 2012 | B2 |
| 8133270 | Kheradvar et al. | Mar 2012 | B2 |
| 8136659 | Salahieh et al. | Mar 2012 | B2 |
| 8137394 | Stocker et al. | Mar 2012 | B2 |
| 8137398 | Tuval et al. | Mar 2012 | B2 |
| 8147534 | Berez et al. | Apr 2012 | B2 |
| 8157853 | Laske et al. | Apr 2012 | B2 |
| 8167894 | Miles et al. | May 2012 | B2 |
| 8172896 | McNamara et al. | May 2012 | B2 |
| 8182528 | Salahieh et al. | May 2012 | B2 |
| 8192351 | Fishler et al. | Jun 2012 | B2 |
| 8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
| 8211107 | Parks et al. | Jul 2012 | B2 |
| 8216174 | Wilk et al. | Jul 2012 | B2 |
| 8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
| 8221493 | Boyle et al. | Jul 2012 | B2 |
| 8226707 | White | Jul 2012 | B2 |
| 8226710 | Nguyen et al. | Jul 2012 | B2 |
| 8231670 | Salahieh et al. | Jul 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8236241 | Carpentier et al. | Aug 2012 | B2 |
| 8246675 | Zegdi | Aug 2012 | B2 |
| 8246678 | Salahieh et al. | Aug 2012 | B2 |
| 8252051 | Chau et al. | Aug 2012 | B2 |
| 8252052 | Salahieh et al. | Aug 2012 | B2 |
| 8277500 | Schmid et al. | Oct 2012 | B2 |
| 8287584 | Salahieh et al. | Oct 2012 | B2 |
| 8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
| 8308798 | Pintor et al. | Nov 2012 | B2 |
| 8317858 | Straubinger et al. | Nov 2012 | B2 |
| 8323335 | Rowe et al. | Dec 2012 | B2 |
| 8328868 | Paul et al. | Dec 2012 | B2 |
| 8343136 | Howat et al. | Jan 2013 | B2 |
| 8343213 | Salahieh et al. | Jan 2013 | B2 |
| 8348995 | Tuval et al. | Jan 2013 | B2 |
| 8348996 | Tuval et al. | Jan 2013 | B2 |
| 8348999 | Kheradvar et al. | Jan 2013 | B2 |
| 8357387 | Dove et al. | Jan 2013 | B2 |
| 8366767 | Zhang | Feb 2013 | B2 |
| 8372134 | Schlick et al. | Feb 2013 | B2 |
| 8376865 | Forster et al. | Feb 2013 | B2 |
| 8377117 | Keidar et al. | Feb 2013 | B2 |
| 8382822 | Pavcnik et al. | Feb 2013 | B2 |
| 8398704 | Straubinger et al. | Mar 2013 | B2 |
| 8398708 | Meiri et al. | Mar 2013 | B2 |
| 8403983 | Quadri et al. | Mar 2013 | B2 |
| 8414641 | Stocker et al. | Apr 2013 | B2 |
| 8414643 | Tuval et al. | Apr 2013 | B2 |
| 8414644 | Quadri et al. | Apr 2013 | B2 |
| 8414645 | Dwork et al. | Apr 2013 | B2 |
| 8439961 | Jagger et al. | May 2013 | B2 |
| 8445278 | Everaerts et al. | May 2013 | B2 |
| 8460365 | Haverkost et al. | Jun 2013 | B2 |
| 8465540 | Straubinger et al. | Jun 2013 | B2 |
| 8468667 | Straubinger et al. | Jun 2013 | B2 |
| 8470023 | Eidenschink et al. | Jun 2013 | B2 |
| 8491650 | Wiemeyer et al. | Jul 2013 | B2 |
| 8512394 | Schmid et al. | Aug 2013 | B2 |
| 8512399 | Lafontaine | Aug 2013 | B2 |
| 8512400 | Tran et al. | Aug 2013 | B2 |
| 8512401 | Murray, III et al. | Aug 2013 | B2 |
| 8523936 | Schmid et al. | Sep 2013 | B2 |
| 8535368 | Headley, Jr. et al. | Sep 2013 | B2 |
| 8540762 | Schmid et al. | Sep 2013 | B2 |
| 8545547 | Schmid et al. | Oct 2013 | B2 |
| 8551160 | Figulla et al. | Oct 2013 | B2 |
| 8556880 | Freyman et al. | Oct 2013 | B2 |
| 8556966 | Jenson | Oct 2013 | B2 |
| 8568475 | Nguyen et al. | Oct 2013 | B2 |
| 8579962 | Salahieh et al. | Nov 2013 | B2 |
| 8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585759 | Bumbalough | Nov 2013 | B2 |
| 8591570 | Revuelta et al. | Nov 2013 | B2 |
| 8597226 | Wilk et al. | Dec 2013 | B2 |
| 8603159 | Seguin et al. | Dec 2013 | B2 |
| 8603160 | Salahieh et al. | Dec 2013 | B2 |
| 8617235 | Schmid et al. | Dec 2013 | B2 |
| 8617236 | Paul et al. | Dec 2013 | B2 |
| 8623074 | Ryan | Jan 2014 | B2 |
| 8623075 | Murray, III et al. | Jan 2014 | B2 |
| 8623076 | Salahieh et al. | Jan 2014 | B2 |
| 8623078 | Salahieh et al. | Jan 2014 | B2 |
| 8628562 | Cummings | Jan 2014 | B2 |
| 8628571 | Hacohen et al. | Jan 2014 | B1 |
| 8647381 | Essinger et al. | Feb 2014 | B2 |
| 8668733 | Haug et al. | Mar 2014 | B2 |
| 8672997 | Drasler et al. | Mar 2014 | B2 |
| 8679174 | Ottma et al. | Mar 2014 | B2 |
| 8685077 | Laske et al. | Apr 2014 | B2 |
| 8696743 | Holecek et al. | Apr 2014 | B2 |
| 8721713 | Tower et al. | May 2014 | B2 |
| 8721717 | Shoemaker et al. | May 2014 | B2 |
| 8734508 | Hastings et al. | May 2014 | B2 |
| 8758430 | Ferrari et al. | Jun 2014 | B2 |
| 8764818 | Gregg | Jul 2014 | B2 |
| 8778020 | Gregg et al. | Jul 2014 | B2 |
| 8790395 | Straubinger et al. | Jul 2014 | B2 |
| 8795305 | Martin et al. | Aug 2014 | B2 |
| 8795356 | Quadri et al. | Aug 2014 | B2 |
| 8808356 | Braido et al. | Aug 2014 | B2 |
| 8808364 | Palasis et al. | Aug 2014 | B2 |
| 8828078 | Salahieh et al. | Sep 2014 | B2 |
| 8828079 | Thielen et al. | Sep 2014 | B2 |
| 8840662 | Salahieh et al. | Sep 2014 | B2 |
| 8840663 | Salahieh et al. | Sep 2014 | B2 |
| 8845721 | Braido et al. | Sep 2014 | B2 |
| 8851286 | Chang et al. | Oct 2014 | B2 |
| 8852272 | Gross et al. | Oct 2014 | B2 |
| 8858620 | Salahieh et al. | Oct 2014 | B2 |
| 8894703 | Salahieh et al. | Nov 2014 | B2 |
| 8932349 | Jenson et al. | Jan 2015 | B2 |
| 8940014 | Gamarra et al. | Jan 2015 | B2 |
| 8951243 | Crisostomo et al. | Feb 2015 | B2 |
| 8951299 | Paul et al. | Feb 2015 | B2 |
| 8956383 | Aklog et al. | Feb 2015 | B2 |
| 8992608 | Haug et al. | Mar 2015 | B2 |
| 8998976 | Gregg et al. | Apr 2015 | B2 |
| 9005273 | Salahieh et al. | Apr 2015 | B2 |
| 9011521 | Haug et al. | Apr 2015 | B2 |
| 9028542 | Hill et al. | May 2015 | B2 |
| 9039756 | White | May 2015 | B2 |
| 9044318 | Straubinger et al. | Jun 2015 | B2 |
| 9131926 | Crisostomo et al. | Sep 2015 | B2 |
| 9149358 | Tabor et al. | Oct 2015 | B2 |
| 9168130 | Straubinger et al. | Oct 2015 | B2 |
| 9168131 | Yohanan et al. | Oct 2015 | B2 |
| 9168136 | Yang et al. | Oct 2015 | B2 |
| 9180005 | Lashinski et al. | Nov 2015 | B1 |
| 9186482 | Dorn | Nov 2015 | B2 |
| 9211266 | Iwazawa et al. | Dec 2015 | B2 |
| 9216082 | Von Segesser et al. | Dec 2015 | B2 |
| 9248037 | Roeder et al. | Feb 2016 | B2 |
| 9265608 | Miller et al. | Feb 2016 | B2 |
| 9277991 | Salahieh et al. | Mar 2016 | B2 |
| 9277993 | Gamarra et al. | Mar 2016 | B2 |
| 9301840 | Nguyen et al. | Apr 2016 | B2 |
| 9301843 | Richardson et al. | Apr 2016 | B2 |
| 9308085 | Salahieh et al. | Apr 2016 | B2 |
| 9320599 | Salahieh et al. | Apr 2016 | B2 |
| 9326853 | Olson et al. | May 2016 | B2 |
| 9358106 | Salahieh et al. | Jun 2016 | B2 |
| 9358110 | Paul et al. | Jun 2016 | B2 |
| 9370419 | Hill et al. | Jun 2016 | B2 |
| 9370421 | Crisostomo et al. | Jun 2016 | B2 |
| 9387076 | Paul et al. | Jul 2016 | B2 |
| 9393094 | Salahieh et al. | Jul 2016 | B2 |
| 9393113 | Salahieh et al. | Jul 2016 | B2 |
| 9393114 | Sutton et al. | Jul 2016 | B2 |
| 9393115 | Tabor et al. | Jul 2016 | B2 |
| 9415567 | Sogard et al. | Aug 2016 | B2 |
| 9421083 | Eidenschink et al. | Aug 2016 | B2 |
| 9439759 | Straubinger et al. | Sep 2016 | B2 |
| 9463084 | Stinson | Oct 2016 | B2 |
| 9474598 | Gregg et al. | Oct 2016 | B2 |
| 9474609 | Haverkost et al. | Oct 2016 | B2 |
| 9492276 | Lee et al. | Nov 2016 | B2 |
| 9510945 | Sutton et al. | Dec 2016 | B2 |
| 9526609 | Salahieh et al. | Dec 2016 | B2 |
| 9532872 | Salahieh et al. | Jan 2017 | B2 |
| 9539091 | Yang et al. | Jan 2017 | B2 |
| 9554924 | Schlick et al. | Jan 2017 | B2 |
| 9597432 | Nakamura | Mar 2017 | B2 |
| 9649212 | Fargahi | May 2017 | B2 |
| 9717593 | Alkhatib et al. | Aug 2017 | B2 |
| D800908 | Hariton et al. | Oct 2017 | S |
| 9775709 | Miller et al. | Oct 2017 | B2 |
| 9788945 | Ottma et al. | Oct 2017 | B2 |
| 9861476 | Salahieh et al. | Jan 2018 | B2 |
| 9867694 | Girard et al. | Jan 2018 | B2 |
| 9867699 | Straubinger et al. | Jan 2018 | B2 |
| 9872768 | Paul et al. | Jan 2018 | B2 |
| 9889002 | Bonhoeffer et al. | Feb 2018 | B2 |
| 9901445 | Backus et al. | Feb 2018 | B2 |
| 9949824 | Bonhoeffer et al. | Apr 2018 | B2 |
| 9956075 | Salahieh et al. | May 2018 | B2 |
| 9987133 | Straubinger et al. | Jun 2018 | B2 |
| 10092324 | Gillespie et al. | Oct 2018 | B2 |
| 10143552 | Wallace et al. | Dec 2018 | B2 |
| 10154901 | Straubinger et al. | Dec 2018 | B2 |
| 10321987 | Wang et al. | Jun 2019 | B2 |
| 10363134 | Figulla et al. | Jul 2019 | B2 |
| 10543084 | Guyenot et al. | Jan 2020 | B2 |
| 10702382 | Straubinger et al. | Jul 2020 | B2 |
| 10709555 | Schreck et al. | Jul 2020 | B2 |
| 20010000041 | Selmon et al. | Mar 2001 | A1 |
| 20010001314 | Davison et al. | May 2001 | A1 |
| 20010002445 | Vesely | May 2001 | A1 |
| 20010004683 | Gambale et al. | Jun 2001 | A1 |
| 20010004690 | Gambale et al. | Jun 2001 | A1 |
| 20010004699 | Gittings et al. | Jun 2001 | A1 |
| 20010007956 | Letac et al. | Jul 2001 | A1 |
| 20010008969 | Evans et al. | Jul 2001 | A1 |
| 20010010017 | Letac et al. | Jul 2001 | A1 |
| 20010011187 | Pavcnik et al. | Aug 2001 | A1 |
| 20010011189 | Drasler et al. | Aug 2001 | A1 |
| 20010012948 | Vanney | Aug 2001 | A1 |
| 20010014813 | Saadat et al. | Aug 2001 | A1 |
| 20010016700 | Eno et al. | Aug 2001 | A1 |
| 20010018596 | Selmon et al. | Aug 2001 | A1 |
| 20010020172 | Selmon et al. | Sep 2001 | A1 |
| 20010021872 | Bailey et al. | Sep 2001 | A1 |
| 20010025196 | Chinn et al. | Sep 2001 | A1 |
| 20010025643 | Foley | Oct 2001 | A1 |
| 20010027287 | Shmulewitz et al. | Oct 2001 | A1 |
| 20010027338 | Greenberg | Oct 2001 | A1 |
| 20010027339 | Boatman et al. | Oct 2001 | A1 |
| 20010029385 | Shennib et al. | Oct 2001 | A1 |
| 20010032013 | Marton | Oct 2001 | A1 |
| 20010034547 | Hall et al. | Oct 2001 | A1 |
| 20010037117 | Gambale et al. | Nov 2001 | A1 |
| 20010037141 | Yee et al. | Nov 2001 | A1 |
| 20010037149 | Wilk | Nov 2001 | A1 |
| 20010039426 | Makower et al. | Nov 2001 | A1 |
| 20010039445 | Hall et al. | Nov 2001 | A1 |
| 20010039450 | Pavcnik et al. | Nov 2001 | A1 |
| 20010041902 | Lepulu et al. | Nov 2001 | A1 |
| 20010041928 | Pavcnik et al. | Nov 2001 | A1 |
| 20010041930 | Globerman et al. | Nov 2001 | A1 |
| 20010044631 | Akin et al. | Nov 2001 | A1 |
| 20010044634 | Don Michael et al. | Nov 2001 | A1 |
| 20010044647 | Pinchuk et al. | Nov 2001 | A1 |
| 20010044652 | Moore | Nov 2001 | A1 |
| 20010044656 | Williamson, IV et al. | Nov 2001 | A1 |
| 20010047165 | Makower et al. | Nov 2001 | A1 |
| 20010049523 | DeVore et al. | Dec 2001 | A1 |
| 20010051822 | Stack et al. | Dec 2001 | A1 |
| 20010053932 | Phelps et al. | Dec 2001 | A1 |
| 20020002349 | Flaherty et al. | Jan 2002 | A1 |
| 20020002396 | Fulkerson | Jan 2002 | A1 |
| 20020002401 | McGuckin, Jr. et al. | Jan 2002 | A1 |
| 20020004662 | Wilk | Jan 2002 | A1 |
| 20020004663 | Gittings et al. | Jan 2002 | A1 |
| 20020007138 | Wilk et al. | Jan 2002 | A1 |
| 20020010489 | Grayzel et al. | Jan 2002 | A1 |
| 20020010508 | Chobotov | Jan 2002 | A1 |
| 20020026233 | Shaknovich | Feb 2002 | A1 |
| 20020029014 | Jayaraman | Mar 2002 | A1 |
| 20020029079 | Kim et al. | Mar 2002 | A1 |
| 20020029981 | Nigam | Mar 2002 | A1 |
| 20020032476 | Gambale et al. | Mar 2002 | A1 |
| 20020032478 | Boekstegers et al. | Mar 2002 | A1 |
| 20020032480 | Spence et al. | Mar 2002 | A1 |
| 20020032481 | Gabbay | Mar 2002 | A1 |
| 20020035390 | Schaldach et al. | Mar 2002 | A1 |
| 20020035396 | Heath | Mar 2002 | A1 |
| 20020042650 | Vardi et al. | Apr 2002 | A1 |
| 20020042651 | Liddicoat et al. | Apr 2002 | A1 |
| 20020045846 | Kaplon et al. | Apr 2002 | A1 |
| 20020045928 | Boekstegers | Apr 2002 | A1 |
| 20020045929 | Diaz | Apr 2002 | A1 |
| 20020049486 | Knudson et al. | Apr 2002 | A1 |
| 20020052651 | Myers et al. | May 2002 | A1 |
| 20020055767 | Forde et al. | May 2002 | A1 |
| 20020055769 | Wang | May 2002 | A1 |
| 20020055772 | McGuckin, Jr. et al. | May 2002 | A1 |
| 20020055774 | Liddicoat | May 2002 | A1 |
| 20020055775 | Carpentier et al. | May 2002 | A1 |
| 20020058897 | Renati | May 2002 | A1 |
| 20020058987 | Butaric et al. | May 2002 | A1 |
| 20020058993 | Landau et al. | May 2002 | A1 |
| 20020058995 | Stevens | May 2002 | A1 |
| 20020062146 | Makower et al. | May 2002 | A1 |
| 20020065478 | Knudson et al. | May 2002 | A1 |
| 20020065485 | DuBois et al. | May 2002 | A1 |
| 20020072699 | Knudson et al. | Jun 2002 | A1 |
| 20020072789 | Hackett et al. | Jun 2002 | A1 |
| 20020077566 | Laroya et al. | Jun 2002 | A1 |
| 20020077654 | Javier, Jr. et al. | Jun 2002 | A1 |
| 20020077696 | Zadno-Azizi et al. | Jun 2002 | A1 |
| 20020082584 | Rosenman et al. | Jun 2002 | A1 |
| 20020082609 | Green | Jun 2002 | A1 |
| 20020092535 | Wilk | Jul 2002 | A1 |
| 20020092536 | LaFontaine et al. | Jul 2002 | A1 |
| 20020095111 | Tweden et al. | Jul 2002 | A1 |
| 20020095173 | Mazzocchi et al. | Jul 2002 | A1 |
| 20020095206 | Addonizio et al. | Jul 2002 | A1 |
| 20020095209 | Zadno-Azizi et al. | Jul 2002 | A1 |
| 20020099439 | Schwartz et al. | Jul 2002 | A1 |
| 20020100484 | Hall et al. | Aug 2002 | A1 |
| 20020103533 | Langberg et al. | Aug 2002 | A1 |
| 20020107565 | Greenhalgh | Aug 2002 | A1 |
| 20020111627 | Vincent-Prestigiacomo | Aug 2002 | A1 |
| 20020111665 | Lauterjung | Aug 2002 | A1 |
| 20020111668 | Smith | Aug 2002 | A1 |
| 20020111672 | Kim et al. | Aug 2002 | A1 |
| 20020111674 | Chouinard et al. | Aug 2002 | A1 |
| 20020117789 | Childers et al. | Aug 2002 | A1 |
| 20020120322 | Thompson et al. | Aug 2002 | A1 |
| 20020120323 | Thompson et al. | Aug 2002 | A1 |
| 20020120328 | Pathak et al. | Aug 2002 | A1 |
| 20020123698 | Garibotto et al. | Sep 2002 | A1 |
| 20020123786 | Gittings et al. | Sep 2002 | A1 |
| 20020123790 | White et al. | Sep 2002 | A1 |
| 20020123802 | Snyders | Sep 2002 | A1 |
| 20020133183 | Lentz et al. | Sep 2002 | A1 |
| 20020133226 | Marquez et al. | Sep 2002 | A1 |
| 20020138087 | Shennib et al. | Sep 2002 | A1 |
| 20020138138 | Yang | Sep 2002 | A1 |
| 20020143285 | Eno et al. | Oct 2002 | A1 |
| 20020143289 | Ellis et al. | Oct 2002 | A1 |
| 20020143387 | Soetikno et al. | Oct 2002 | A1 |
| 20020144696 | Sharkawy et al. | Oct 2002 | A1 |
| 20020151913 | Berg et al. | Oct 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020156522 | Ivancev et al. | Oct 2002 | A1 |
| 20020161377 | Rabkin | Oct 2002 | A1 |
| 20020161383 | Akin et al. | Oct 2002 | A1 |
| 20020161390 | Mouw | Oct 2002 | A1 |
| 20020161392 | Dubrul | Oct 2002 | A1 |
| 20020161394 | Macoviak et al. | Oct 2002 | A1 |
| 20020161424 | Rapacki et al. | Oct 2002 | A1 |
| 20020161426 | Iancea | Oct 2002 | A1 |
| 20020165479 | Wilk | Nov 2002 | A1 |
| 20020165576 | Boyle et al. | Nov 2002 | A1 |
| 20020165606 | Wolf et al. | Nov 2002 | A1 |
| 20020173842 | Buchanan | Nov 2002 | A1 |
| 20020177766 | Mogul | Nov 2002 | A1 |
| 20020177772 | Altman et al. | Nov 2002 | A1 |
| 20020177840 | Farnholtz | Nov 2002 | A1 |
| 20020177894 | Acosta et al. | Nov 2002 | A1 |
| 20020179098 | Makower et al. | Dec 2002 | A1 |
| 20020183716 | Herweck et al. | Dec 2002 | A1 |
| 20020183781 | Casey et al. | Dec 2002 | A1 |
| 20020186558 | Plank et al. | Dec 2002 | A1 |
| 20020188341 | Elliott | Dec 2002 | A1 |
| 20020188344 | Bolea et al. | Dec 2002 | A1 |
| 20020193782 | Ellis et al. | Dec 2002 | A1 |
| 20020193871 | Beyersdorf et al. | Dec 2002 | A1 |
| 20020198594 | Schreck | Dec 2002 | A1 |
| 20030004541 | Linder et al. | Jan 2003 | A1 |
| 20030004560 | Chobotov et al. | Jan 2003 | A1 |
| 20030009189 | Gilson et al. | Jan 2003 | A1 |
| 20030014104 | Cribier | Jan 2003 | A1 |
| 20030018377 | Berg et al. | Jan 2003 | A1 |
| 20030018379 | Knudson et al. | Jan 2003 | A1 |
| 20030023300 | Bailey et al. | Jan 2003 | A1 |
| 20030023303 | Palmaz et al. | Jan 2003 | A1 |
| 20030027332 | Lafrance et al. | Feb 2003 | A1 |
| 20030028213 | Thill et al. | Feb 2003 | A1 |
| 20030028247 | Cali | Feb 2003 | A1 |
| 20030033001 | Igaki | Feb 2003 | A1 |
| 20030036791 | Philipp et al. | Feb 2003 | A1 |
| 20030036795 | Andersen et al. | Feb 2003 | A1 |
| 20030040736 | Stevens et al. | Feb 2003 | A1 |
| 20030040771 | Hyodoh et al. | Feb 2003 | A1 |
| 20030040772 | Hyodoh et al. | Feb 2003 | A1 |
| 20030040791 | Oktay | Feb 2003 | A1 |
| 20030040792 | Gabbay | Feb 2003 | A1 |
| 20030042186 | Boyle | Mar 2003 | A1 |
| 20030044315 | Boekstegers | Mar 2003 | A1 |
| 20030045828 | Wilk | Mar 2003 | A1 |
| 20030050694 | Yang et al. | Mar 2003 | A1 |
| 20030055371 | Wolf et al. | Mar 2003 | A1 |
| 20030055495 | Pease et al. | Mar 2003 | A1 |
| 20030057156 | Peterson et al. | Mar 2003 | A1 |
| 20030060844 | Borillo et al. | Mar 2003 | A1 |
| 20030065386 | Weadock | Apr 2003 | A1 |
| 20030069492 | Abrams et al. | Apr 2003 | A1 |
| 20030069646 | Stinson | Apr 2003 | A1 |
| 20030070944 | Nigam | Apr 2003 | A1 |
| 20030073973 | Evans et al. | Apr 2003 | A1 |
| 20030074058 | Sherry | Apr 2003 | A1 |
| 20030078561 | Gambale et al. | Apr 2003 | A1 |
| 20030078652 | Sutherland | Apr 2003 | A1 |
| 20030083730 | Stinson | May 2003 | A1 |
| 20030093145 | Lawrence-Brown et al. | May 2003 | A1 |
| 20030100918 | Duane | May 2003 | A1 |
| 20030100919 | Hopkins et al. | May 2003 | A1 |
| 20030100920 | Akin et al. | May 2003 | A1 |
| 20030105514 | Phelps et al. | Jun 2003 | A1 |
| 20030109924 | Cribier | Jun 2003 | A1 |
| 20030109930 | Bluni et al. | Jun 2003 | A1 |
| 20030114912 | Sequin et al. | Jun 2003 | A1 |
| 20030114913 | Spenser et al. | Jun 2003 | A1 |
| 20030120195 | Milo et al. | Jun 2003 | A1 |
| 20030125795 | Pavcnik et al. | Jul 2003 | A1 |
| 20030130726 | Thorpe et al. | Jul 2003 | A1 |
| 20030130727 | Drasler et al. | Jul 2003 | A1 |
| 20030130729 | Paniagua et al. | Jul 2003 | A1 |
| 20030130746 | Ashworth et al. | Jul 2003 | A1 |
| 20030135257 | Taheri | Jul 2003 | A1 |
| 20030139796 | Sequin et al. | Jul 2003 | A1 |
| 20030139798 | Brown et al. | Jul 2003 | A1 |
| 20030139803 | Sequin et al. | Jul 2003 | A1 |
| 20030139804 | Hankh et al. | Jul 2003 | A1 |
| 20030144657 | Bowe et al. | Jul 2003 | A1 |
| 20030144732 | Cosgrove et al. | Jul 2003 | A1 |
| 20030149474 | Becker | Aug 2003 | A1 |
| 20030149475 | Hyodoh et al. | Aug 2003 | A1 |
| 20030149476 | Damm et al. | Aug 2003 | A1 |
| 20030149477 | Gabbay | Aug 2003 | A1 |
| 20030149478 | Figulla et al. | Aug 2003 | A1 |
| 20030153971 | Chandrasekaran | Aug 2003 | A1 |
| 20030153974 | Spenser et al. | Aug 2003 | A1 |
| 20030158573 | Gittings et al. | Aug 2003 | A1 |
| 20030158595 | Randall et al. | Aug 2003 | A1 |
| 20030163198 | Morra et al. | Aug 2003 | A1 |
| 20030165352 | Ibrahim et al. | Sep 2003 | A1 |
| 20030171803 | Shimon | Sep 2003 | A1 |
| 20030171805 | Berg et al. | Sep 2003 | A1 |
| 20030176884 | Berrada et al. | Sep 2003 | A1 |
| 20030181850 | Diamond et al. | Sep 2003 | A1 |
| 20030181938 | Roth et al. | Sep 2003 | A1 |
| 20030181942 | Sutton et al. | Sep 2003 | A1 |
| 20030187495 | Cully et al. | Oct 2003 | A1 |
| 20030191449 | Nash et al. | Oct 2003 | A1 |
| 20030191516 | Weldon et al. | Oct 2003 | A1 |
| 20030191519 | Lombardi et al. | Oct 2003 | A1 |
| 20030191526 | Van Tassel et al. | Oct 2003 | A1 |
| 20030195457 | LaFontaine et al. | Oct 2003 | A1 |
| 20030195458 | Phelps et al. | Oct 2003 | A1 |
| 20030195609 | Berenstein et al. | Oct 2003 | A1 |
| 20030195620 | Huynh et al. | Oct 2003 | A1 |
| 20030198722 | Johnston, Jr. et al. | Oct 2003 | A1 |
| 20030199759 | Richard | Oct 2003 | A1 |
| 20030199913 | Dubrul et al. | Oct 2003 | A1 |
| 20030199963 | Tower et al. | Oct 2003 | A1 |
| 20030199971 | Tower et al. | Oct 2003 | A1 |
| 20030199972 | Zadno-Azizi et al. | Oct 2003 | A1 |
| 20030204160 | Kamm et al. | Oct 2003 | A1 |
| 20030204249 | Letort | Oct 2003 | A1 |
| 20030208224 | Broome | Nov 2003 | A1 |
| 20030212410 | Stenzel et al. | Nov 2003 | A1 |
| 20030212413 | Wilk | Nov 2003 | A1 |
| 20030212429 | Keegan et al. | Nov 2003 | A1 |
| 20030212452 | Zadno-Azizi et al. | Nov 2003 | A1 |
| 20030212454 | Scott et al. | Nov 2003 | A1 |
| 20030216678 | March et al. | Nov 2003 | A1 |
| 20030216679 | Wolf et al. | Nov 2003 | A1 |
| 20030216774 | Larson | Nov 2003 | A1 |
| 20030220661 | Mowry et al. | Nov 2003 | A1 |
| 20030220667 | Van Der Burg et al. | Nov 2003 | A1 |
| 20030225445 | Derus et al. | Dec 2003 | A1 |
| 20030229366 | Reggie et al. | Dec 2003 | A1 |
| 20030229390 | Ashton et al. | Dec 2003 | A1 |
| 20030233117 | Adams et al. | Dec 2003 | A1 |
| 20030236542 | Makower | Dec 2003 | A1 |
| 20030236567 | Elliot | Dec 2003 | A1 |
| 20030236568 | Hojeibane et al. | Dec 2003 | A1 |
| 20030236570 | Cook et al. | Dec 2003 | A1 |
| 20040004926 | Maeda | Jan 2004 | A1 |
| 20040006298 | Wilk | Jan 2004 | A1 |
| 20040006380 | Buck et al. | Jan 2004 | A1 |
| 20040015225 | Kim et al. | Jan 2004 | A1 |
| 20040015228 | Lombardi et al. | Jan 2004 | A1 |
| 20040018651 | Nadeau | Jan 2004 | A1 |
| 20040019348 | Stevens et al. | Jan 2004 | A1 |
| 20040019374 | Hojeibane et al. | Jan 2004 | A1 |
| 20040026389 | Kessler et al. | Feb 2004 | A1 |
| 20040033364 | Spiridigliozzi et al. | Feb 2004 | A1 |
| 20040034411 | Quijano et al. | Feb 2004 | A1 |
| 20040037946 | Morra et al. | Feb 2004 | A1 |
| 20040039343 | Eppstein et al. | Feb 2004 | A1 |
| 20040039436 | Spenser et al. | Feb 2004 | A1 |
| 20040044350 | Martin et al. | Mar 2004 | A1 |
| 20040044361 | Frazier et al. | Mar 2004 | A1 |
| 20040044392 | Von Oepen | Mar 2004 | A1 |
| 20040044400 | Cheng et al. | Mar 2004 | A1 |
| 20040044402 | Jung et al. | Mar 2004 | A1 |
| 20040049204 | Harari et al. | Mar 2004 | A1 |
| 20040049207 | Goldfarb et al. | Mar 2004 | A1 |
| 20040049224 | Buehlmann et al. | Mar 2004 | A1 |
| 20040049226 | Keegan et al. | Mar 2004 | A1 |
| 20040049262 | Obermiller et al. | Mar 2004 | A1 |
| 20040049266 | Anduiza et al. | Mar 2004 | A1 |
| 20040058097 | Weder | Mar 2004 | A1 |
| 20040059280 | Makower et al. | Mar 2004 | A1 |
| 20040059407 | Escamilla et al. | Mar 2004 | A1 |
| 20040059409 | Stenzel | Mar 2004 | A1 |
| 20040059429 | Amin et al. | Mar 2004 | A1 |
| 20040073157 | Knudson et al. | Apr 2004 | A1 |
| 20040073198 | Gilson et al. | Apr 2004 | A1 |
| 20040073238 | Makower | Apr 2004 | A1 |
| 20040073289 | Hartley | Apr 2004 | A1 |
| 20040077987 | Rapacki et al. | Apr 2004 | A1 |
| 20040077988 | Tweden et al. | Apr 2004 | A1 |
| 20040077990 | Knudson et al. | Apr 2004 | A1 |
| 20040078950 | Schreck | Apr 2004 | A1 |
| 20040082904 | Houde et al. | Apr 2004 | A1 |
| 20040082967 | Broome et al. | Apr 2004 | A1 |
| 20040082989 | Cook et al. | Apr 2004 | A1 |
| 20040087982 | Eskuri | May 2004 | A1 |
| 20040088042 | Kim et al. | May 2004 | A1 |
| 20040088045 | Cox | May 2004 | A1 |
| 20040092858 | Wilson et al. | May 2004 | A1 |
| 20040092989 | Wilson et al. | May 2004 | A1 |
| 20040093005 | Durcan | May 2004 | A1 |
| 20040093016 | Root et al. | May 2004 | A1 |
| 20040093060 | Seguin et al. | May 2004 | A1 |
| 20040093063 | Wright et al. | May 2004 | A1 |
| 20040093070 | Hojeibane et al. | May 2004 | A1 |
| 20040093075 | Kuehne | May 2004 | A1 |
| 20040097788 | Mourlas et al. | May 2004 | A1 |
| 20040098022 | Barone | May 2004 | A1 |
| 20040098098 | McGuckin, Jr. et al. | May 2004 | A1 |
| 20040098099 | McCullagh et al. | May 2004 | A1 |
| 20040098112 | DiMatteo et al. | May 2004 | A1 |
| 20040102855 | Shank | May 2004 | A1 |
| 20040106931 | Guiles et al. | Jun 2004 | A1 |
| 20040106976 | Bailey et al. | Jun 2004 | A1 |
| 20040106990 | Spence et al. | Jun 2004 | A1 |
| 20040107004 | Levine et al. | Jun 2004 | A1 |
| 20040111096 | Tu et al. | Jun 2004 | A1 |
| 20040113306 | Rapacki et al. | Jun 2004 | A1 |
| 20040116951 | Rosengart | Jun 2004 | A1 |
| 20040116999 | Ledergerber | Jun 2004 | A1 |
| 20040117004 | Osborne et al. | Jun 2004 | A1 |
| 20040117009 | Cali et al. | Jun 2004 | A1 |
| 20040118415 | Hall et al. | Jun 2004 | A1 |
| 20040122318 | Flaherty et al. | Jun 2004 | A1 |
| 20040122347 | Knudson et al. | Jun 2004 | A1 |
| 20040122468 | Yodfat et al. | Jun 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040122516 | Fogarty et al. | Jun 2004 | A1 |
| 20040127847 | DuBois et al. | Jul 2004 | A1 |
| 20040127912 | Rabkin et al. | Jul 2004 | A1 |
| 20040127936 | Salahieh et al. | Jul 2004 | A1 |
| 20040127979 | Wilson et al. | Jul 2004 | A1 |
| 20040127982 | Machold et al. | Jul 2004 | A1 |
| 20040133154 | Flaherty et al. | Jul 2004 | A1 |
| 20040133225 | Makower | Jul 2004 | A1 |
| 20040133274 | Webler et al. | Jul 2004 | A1 |
| 20040138694 | Tran et al. | Jul 2004 | A1 |
| 20040138742 | Myers et al. | Jul 2004 | A1 |
| 20040138743 | Myers et al. | Jul 2004 | A1 |
| 20040138745 | Macoviak et al. | Jul 2004 | A1 |
| 20040147868 | Bardsley et al. | Jul 2004 | A1 |
| 20040147869 | Wolf et al. | Jul 2004 | A1 |
| 20040148018 | Carpentier et al. | Jul 2004 | A1 |
| 20040148021 | Cartledge et al. | Jul 2004 | A1 |
| 20040153094 | Dunfee et al. | Aug 2004 | A1 |
| 20040153145 | Simionescu et al. | Aug 2004 | A1 |
| 20040153146 | Lashinski et al. | Aug 2004 | A1 |
| 20040158143 | Flaherty et al. | Aug 2004 | A1 |
| 20040158277 | Lowe et al. | Aug 2004 | A1 |
| 20040163094 | Matsui et al. | Aug 2004 | A1 |
| 20040167444 | Laroya et al. | Aug 2004 | A1 |
| 20040167565 | Beulke et al. | Aug 2004 | A1 |
| 20040167573 | Williamson, IV et al. | Aug 2004 | A1 |
| 20040167620 | Ortiz et al. | Aug 2004 | A1 |
| 20040168691 | Sharkawy et al. | Sep 2004 | A1 |
| 20040176791 | Lim et al. | Sep 2004 | A1 |
| 20040181140 | Falwell et al. | Sep 2004 | A1 |
| 20040186507 | Hall et al. | Sep 2004 | A1 |
| 20040186557 | Gambale et al. | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040186563 | Lobbi | Sep 2004 | A1 |
| 20040186565 | Schreck | Sep 2004 | A1 |
| 20040186587 | Ahern | Sep 2004 | A1 |
| 20040193180 | Buzzard et al. | Sep 2004 | A1 |
| 20040193244 | Hartley et al. | Sep 2004 | A1 |
| 20040193252 | Perez et al. | Sep 2004 | A1 |
| 20040193261 | Berreklouw | Sep 2004 | A1 |
| 20040197695 | Aono | Oct 2004 | A1 |
| 20040199245 | Lauterjung | Oct 2004 | A1 |
| 20040204683 | McGuckin, Jr. et al. | Oct 2004 | A1 |
| 20040204755 | Robin | Oct 2004 | A1 |
| 20040206363 | McCarthy et al. | Oct 2004 | A1 |
| 20040210104 | Lau et al. | Oct 2004 | A1 |
| 20040210190 | Kohler et al. | Oct 2004 | A1 |
| 20040210240 | Saint | Oct 2004 | A1 |
| 20040210301 | Obermiller | Oct 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040210306 | Quijano et al. | Oct 2004 | A1 |
| 20040210307 | Khairkhahan | Oct 2004 | A1 |
| 20040215317 | Cummings | Oct 2004 | A1 |
| 20040215331 | Chew et al. | Oct 2004 | A1 |
| 20040215333 | Duran et al. | Oct 2004 | A1 |
| 20040215339 | Drasler et al. | Oct 2004 | A1 |
| 20040219180 | Gambale et al. | Nov 2004 | A1 |
| 20040220598 | Bolduc et al. | Nov 2004 | A1 |
| 20040220655 | Swanson et al. | Nov 2004 | A1 |
| 20040225321 | Krolik et al. | Nov 2004 | A1 |
| 20040225353 | McGuckin, Jr. et al. | Nov 2004 | A1 |
| 20040225354 | Allen et al. | Nov 2004 | A1 |
| 20040225355 | Stevens | Nov 2004 | A1 |
| 20040236411 | Sarac et al. | Nov 2004 | A1 |
| 20040236418 | Stevens | Nov 2004 | A1 |
| 20040243143 | Corcoran et al. | Dec 2004 | A1 |
| 20040243221 | Fawzi et al. | Dec 2004 | A1 |
| 20040249343 | Cioanta | Dec 2004 | A1 |
| 20040254594 | Alfaro | Dec 2004 | A1 |
| 20040254636 | Flagle et al. | Dec 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040260390 | Sarac et al. | Dec 2004 | A1 |
| 20040260393 | Rahdert et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20040267357 | Allen et al. | Dec 2004 | A1 |
| 20050000858 | Roovers | Jan 2005 | A1 |
| 20050004505 | Phelps et al. | Jan 2005 | A1 |
| 20050004558 | Gambale et al. | Jan 2005 | A1 |
| 20050004648 | Boekstegers | Jan 2005 | A1 |
| 20050008589 | Legrand et al. | Jan 2005 | A1 |
| 20050009000 | Wilhelm et al. | Jan 2005 | A1 |
| 20050010246 | Streeter et al. | Jan 2005 | A1 |
| 20050010285 | Lambrecht et al. | Jan 2005 | A1 |
| 20050010287 | Macoviak et al. | Jan 2005 | A1 |
| 20050015112 | Cohn et al. | Jan 2005 | A1 |
| 20050021136 | Xie et al. | Jan 2005 | A1 |
| 20050025857 | Schoenherr et al. | Feb 2005 | A1 |
| 20050027305 | Shiu et al. | Feb 2005 | A1 |
| 20050027348 | Case et al. | Feb 2005 | A1 |
| 20050033220 | Wilk et al. | Feb 2005 | A1 |
| 20050033398 | Seguin | Feb 2005 | A1 |
| 20050033402 | Cully et al. | Feb 2005 | A1 |
| 20050038495 | Greenan | Feb 2005 | A1 |
| 20050038509 | Ashe | Feb 2005 | A1 |
| 20050043585 | Datta et al. | Feb 2005 | A1 |
| 20050043711 | Corcoran et al. | Feb 2005 | A1 |
| 20050043757 | Arad et al. | Feb 2005 | A1 |
| 20050043759 | Chanduszko | Feb 2005 | A1 |
| 20050043760 | Fogarty et al. | Feb 2005 | A1 |
| 20050043781 | Foley | Feb 2005 | A1 |
| 20050043790 | Seguin | Feb 2005 | A1 |
| 20050049674 | Berra et al. | Mar 2005 | A1 |
| 20050049692 | Numamoto et al. | Mar 2005 | A1 |
| 20050049696 | Siess et al. | Mar 2005 | A1 |
| 20050055088 | Liddicoat et al. | Mar 2005 | A1 |
| 20050060016 | Wu et al. | Mar 2005 | A1 |
| 20050060018 | Dittman | Mar 2005 | A1 |
| 20050060029 | Le et al. | Mar 2005 | A1 |
| 20050060030 | Lashinski et al. | Mar 2005 | A1 |
| 20050065594 | DiMatteo et al. | Mar 2005 | A1 |
| 20050070794 | Deal et al. | Mar 2005 | A1 |
| 20050070957 | Das | Mar 2005 | A1 |
| 20050075584 | Cali | Apr 2005 | A1 |
| 20050075662 | Pedersen et al. | Apr 2005 | A1 |
| 20050075712 | Biancucci et al. | Apr 2005 | A1 |
| 20050075717 | Nguyen et al. | Apr 2005 | A1 |
| 20050075719 | Bergheim | Apr 2005 | A1 |
| 20050075720 | Nguyen et al. | Apr 2005 | A1 |
| 20050075724 | Svanidze et al. | Apr 2005 | A1 |
| 20050075725 | Rowe | Apr 2005 | A1 |
| 20050075726 | Svanidze et al. | Apr 2005 | A1 |
| 20050075727 | Wheatley | Apr 2005 | A1 |
| 20050075730 | Myers et al. | Apr 2005 | A1 |
| 20050075731 | Artof et al. | Apr 2005 | A1 |
| 20050075776 | Cho | Apr 2005 | A1 |
| 20050084595 | Shukla et al. | Apr 2005 | A1 |
| 20050085841 | Eversull et al. | Apr 2005 | A1 |
| 20050085842 | Eversull et al. | Apr 2005 | A1 |
| 20050085843 | Opolski et al. | Apr 2005 | A1 |
| 20050085890 | Rasmussen et al. | Apr 2005 | A1 |
| 20050085900 | Case et al. | Apr 2005 | A1 |
| 20050090846 | Pedersen et al. | Apr 2005 | A1 |
| 20050090890 | Wu et al. | Apr 2005 | A1 |
| 20050096568 | Kato | May 2005 | A1 |
| 20050096692 | Linder et al. | May 2005 | A1 |
| 20050096724 | Stenzel et al. | May 2005 | A1 |
| 20050096726 | Sequin et al. | May 2005 | A1 |
| 20050096734 | Majercak et al. | May 2005 | A1 |
| 20050096735 | Hojeibane et al. | May 2005 | A1 |
| 20050096736 | Osse et al. | May 2005 | A1 |
| 20050096738 | Cali et al. | May 2005 | A1 |
| 20050096768 | Huang et al. | May 2005 | A1 |
| 20050098547 | Cali et al. | May 2005 | A1 |
| 20050100580 | Osborne et al. | May 2005 | A1 |
| 20050101903 | Kohler et al. | May 2005 | A1 |
| 20050101904 | Wilk | May 2005 | A1 |
| 20050101968 | Dadourian | May 2005 | A1 |
| 20050107822 | Wasdyke | May 2005 | A1 |
| 20050107871 | Realyvasquez et al. | May 2005 | A1 |
| 20050113902 | Geiser et al. | May 2005 | A1 |
| 20050113904 | Shank et al. | May 2005 | A1 |
| 20050113910 | Paniagua et al. | May 2005 | A1 |
| 20050119688 | Bergheim | Jun 2005 | A1 |
| 20050119728 | Sarac | Jun 2005 | A1 |
| 20050119736 | Zilla et al. | Jun 2005 | A1 |
| 20050125075 | Meade et al. | Jun 2005 | A1 |
| 20050131438 | Cohn | Jun 2005 | A1 |
| 20050137499 | Sheets et al. | Jun 2005 | A1 |
| 20050137609 | Guiraudon | Jun 2005 | A1 |
| 20050137681 | Shoemaker et al. | Jun 2005 | A1 |
| 20050137682 | Justino | Jun 2005 | A1 |
| 20050137683 | Hezi-Yamit et al. | Jun 2005 | A1 |
| 20050137686 | Salahieh et al. | Jun 2005 | A1 |
| 20050137687 | Salahieh et al. | Jun 2005 | A1 |
| 20050137688 | Salahieh et al. | Jun 2005 | A1 |
| 20050137689 | Salahieh et al. | Jun 2005 | A1 |
| 20050137690 | Salahieh et al. | Jun 2005 | A1 |
| 20050137691 | Salahieh et al. | Jun 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137693 | Haug et al. | Jun 2005 | A1 |
| 20050137694 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050137696 | Salahieh et al. | Jun 2005 | A1 |
| 20050137697 | Salahieh et al. | Jun 2005 | A1 |
| 20050137698 | Salahieh et al. | Jun 2005 | A1 |
| 20050137699 | Salahieh et al. | Jun 2005 | A1 |
| 20050137701 | Salahieh et al. | Jun 2005 | A1 |
| 20050137702 | Haug et al. | Jun 2005 | A1 |
| 20050138689 | Aukerman | Jun 2005 | A1 |
| 20050143804 | Haverkost | Jun 2005 | A1 |
| 20050143807 | Pavcnik et al. | Jun 2005 | A1 |
| 20050143809 | Salahieh et al. | Jun 2005 | A1 |
| 20050148997 | Valley et al. | Jul 2005 | A1 |
| 20050149159 | Andreas et al. | Jul 2005 | A1 |
| 20050149166 | Schaeffer et al. | Jul 2005 | A1 |
| 20050149181 | Eberhardt | Jul 2005 | A1 |
| 20050150775 | Zhang et al. | Jul 2005 | A1 |
| 20050159726 | Evans et al. | Jul 2005 | A1 |
| 20050165352 | Henry et al. | Jul 2005 | A1 |
| 20050165477 | Anduiza et al. | Jul 2005 | A1 |
| 20050165479 | Drews et al. | Jul 2005 | A1 |
| 20050171597 | Boatman et al. | Aug 2005 | A1 |
| 20050171598 | Schaeffer | Aug 2005 | A1 |
| 20050177227 | Heim et al. | Aug 2005 | A1 |
| 20050182483 | Osborne et al. | Aug 2005 | A1 |
| 20050182486 | Gabbay | Aug 2005 | A1 |
| 20050186349 | Loper et al. | Aug 2005 | A1 |
| 20050187616 | Realyvasquez | Aug 2005 | A1 |
| 20050192527 | Gharib et al. | Sep 2005 | A1 |
| 20050192665 | Spenser et al. | Sep 2005 | A1 |
| 20050197694 | Pai et al. | Sep 2005 | A1 |
| 20050197695 | Stacchino et al. | Sep 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050203605 | Dolan | Sep 2005 | A1 |
| 20050203614 | Forster et al. | Sep 2005 | A1 |
| 20050203615 | Forster et al. | Sep 2005 | A1 |
| 20050203616 | Cribier | Sep 2005 | A1 |
| 20050203617 | Forster et al. | Sep 2005 | A1 |
| 20050203618 | Sharkawy et al. | Sep 2005 | A1 |
| 20050203818 | Rotman et al. | Sep 2005 | A9 |
| 20050209580 | Freyman | Sep 2005 | A1 |
| 20050214342 | Tweden et al. | Sep 2005 | A1 |
| 20050222664 | Parker | Oct 2005 | A1 |
| 20050222668 | Schaeffer et al. | Oct 2005 | A1 |
| 20050222674 | Paine | Oct 2005 | A1 |
| 20050228334 | Knudson et al. | Oct 2005 | A1 |
| 20050228472 | Case et al. | Oct 2005 | A1 |
| 20050228495 | Macoviak | Oct 2005 | A1 |
| 20050228496 | Mensah et al. | Oct 2005 | A1 |
| 20050234546 | Nugent et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050240262 | White | Oct 2005 | A1 |
| 20050240263 | Fogarty et al. | Oct 2005 | A1 |
| 20050251243 | Seppala et al. | Nov 2005 | A1 |
| 20050251250 | Verhoeven et al. | Nov 2005 | A1 |
| 20050251251 | Cribier | Nov 2005 | A1 |
| 20050251252 | Stobie | Nov 2005 | A1 |
| 20050256532 | Nayak et al. | Nov 2005 | A1 |
| 20050261759 | Lambrecht et al. | Nov 2005 | A1 |
| 20050267523 | Devellian et al. | Dec 2005 | A1 |
| 20050267560 | Bates | Dec 2005 | A1 |
| 20050267567 | Shalev | Dec 2005 | A1 |
| 20050267573 | Macoviak et al. | Dec 2005 | A9 |
| 20050283231 | Haug et al. | Dec 2005 | A1 |
| 20050283962 | Boudjemline | Dec 2005 | A1 |
| 20050288627 | Mogul | Dec 2005 | A1 |
| 20050288685 | Gulles et al. | Dec 2005 | A1 |
| 20050288706 | Widomski et al. | Dec 2005 | A1 |
| 20060004439 | Spenser et al. | Jan 2006 | A1 |
| 20060004442 | Spenser et al. | Jan 2006 | A1 |
| 20060004469 | Sokel | Jan 2006 | A1 |
| 20060009841 | McGuckin, Jr. et al. | Jan 2006 | A1 |
| 20060009842 | Huynh et al. | Jan 2006 | A1 |
| 20060015168 | Gunderson | Jan 2006 | A1 |
| 20060025855 | Lashinski et al. | Feb 2006 | A1 |
| 20060025857 | Bergheim et al. | Feb 2006 | A1 |
| 20060028766 | Khizroev | Feb 2006 | A1 |
| 20060041218 | Phelps et al. | Feb 2006 | A1 |
| 20060047338 | Jenson et al. | Mar 2006 | A1 |
| 20060047343 | Oviatt et al. | Mar 2006 | A1 |
| 20060052736 | Tweden et al. | Mar 2006 | A1 |
| 20060052867 | Revuelta et al. | Mar 2006 | A1 |
| 20060058775 | Stevens et al. | Mar 2006 | A1 |
| 20060058864 | Schaeffer et al. | Mar 2006 | A1 |
| 20060058871 | Zakay et al. | Mar 2006 | A1 |
| 20060058872 | Salahieh et al. | Mar 2006 | A1 |
| 20060064151 | Guterman et al. | Mar 2006 | A1 |
| 20060069424 | Acosta et al. | Mar 2006 | A1 |
| 20060074477 | Berthiaume et al. | Apr 2006 | A1 |
| 20060074484 | Huber | Apr 2006 | A1 |
| 20060074485 | Realyvasquez | Apr 2006 | A1 |
| 20060077447 | Sojian et al. | Apr 2006 | A1 |
| 20060085060 | Campbell | Apr 2006 | A1 |
| 20060089711 | Dolan | Apr 2006 | A1 |
| 20060100685 | Seguin et al. | May 2006 | A1 |
| 20060111770 | Pavcnik et al. | May 2006 | A1 |
| 20060116757 | Lashinski et al. | Jun 2006 | A1 |
| 20060122692 | Gilad et al. | Jun 2006 | A1 |
| 20060135961 | Rosenman et al. | Jun 2006 | A1 |
| 20060135964 | Vesely | Jun 2006 | A1 |
| 20060136034 | Modesitt et al. | Jun 2006 | A1 |
| 20060142846 | Pavcnik et al. | Jun 2006 | A1 |
| 20060142848 | Gabbay | Jun 2006 | A1 |
| 20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
| 20060155312 | Levine et al. | Jul 2006 | A1 |
| 20060155363 | LaDuca et al. | Jul 2006 | A1 |
| 20060155366 | LaDuca et al. | Jul 2006 | A1 |
| 20060161248 | Case et al. | Jul 2006 | A1 |
| 20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
| 20060161265 | Levine et al. | Jul 2006 | A1 |
| 20060167474 | Bloom et al. | Jul 2006 | A1 |
| 20060167543 | Bailey et al. | Jul 2006 | A1 |
| 20060173524 | Salahieh et al. | Aug 2006 | A1 |
| 20060178740 | Stacchino et al. | Aug 2006 | A1 |
| 20060190070 | Dieck et al. | Aug 2006 | A1 |
| 20060193885 | Leonard Neethling et al. | Aug 2006 | A1 |
| 20060195134 | Crittenden | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060195186 | Drews et al. | Aug 2006 | A1 |
| 20060206192 | Tower et al. | Sep 2006 | A1 |
| 20060206202 | Bonhoeffer et al. | Sep 2006 | A1 |
| 20060210597 | Hiles | Sep 2006 | A1 |
| 20060212110 | Osborne et al. | Sep 2006 | A1 |
| 20060212111 | Case et al. | Sep 2006 | A1 |
| 20060217802 | Ruiz et al. | Sep 2006 | A1 |
| 20060224183 | Freudenthal | Oct 2006 | A1 |
| 20060229561 | Huszar | Oct 2006 | A1 |
| 20060229718 | Marquez | Oct 2006 | A1 |
| 20060229719 | Marquez et al. | Oct 2006 | A1 |
| 20060241745 | Solem | Oct 2006 | A1 |
| 20060246584 | Covelli | Nov 2006 | A1 |
| 20060247570 | Pokorney | Nov 2006 | A1 |
| 20060247763 | Slater | Nov 2006 | A1 |
| 20060253191 | Salahieh et al. | Nov 2006 | A1 |
| 20060259134 | Schwammenthal et al. | Nov 2006 | A1 |
| 20060259135 | Navia et al. | Nov 2006 | A1 |
| 20060259136 | Nguyen et al. | Nov 2006 | A1 |
| 20060259137 | Artof et al. | Nov 2006 | A1 |
| 20060265043 | Mandrusov et al. | Nov 2006 | A1 |
| 20060265056 | Nguyen et al. | Nov 2006 | A1 |
| 20060270958 | George | Nov 2006 | A1 |
| 20060271149 | Berez et al. | Nov 2006 | A1 |
| 20060271161 | Meyer et al. | Nov 2006 | A1 |
| 20060271166 | Thill et al. | Nov 2006 | A1 |
| 20060271175 | Woolfson et al. | Nov 2006 | A1 |
| 20060276873 | Sato | Dec 2006 | A1 |
| 20060276874 | Wilson et al. | Dec 2006 | A1 |
| 20060276882 | Case et al. | Dec 2006 | A1 |
| 20060276887 | Brady et al. | Dec 2006 | A1 |
| 20060282161 | Huynh et al. | Dec 2006 | A1 |
| 20060287668 | Fawzi et al. | Dec 2006 | A1 |
| 20060287717 | Rowe et al. | Dec 2006 | A1 |
| 20060287719 | Rowe et al. | Dec 2006 | A1 |
| 20060290027 | O'Connor et al. | Dec 2006 | A1 |
| 20060293745 | Carpentier et al. | Dec 2006 | A1 |
| 20070005129 | Damm et al. | Jan 2007 | A1 |
| 20070005131 | Taylor | Jan 2007 | A1 |
| 20070005132 | Simionescu et al. | Jan 2007 | A1 |
| 20070010876 | Salahieh et al. | Jan 2007 | A1 |
| 20070010877 | Salahieh et al. | Jan 2007 | A1 |
| 20070010878 | Rafiee et al. | Jan 2007 | A1 |
| 20070010887 | Williams et al. | Jan 2007 | A1 |
| 20070016286 | Herrmann et al. | Jan 2007 | A1 |
| 20070016288 | Gurskis et al. | Jan 2007 | A1 |
| 20070020248 | Everaerts et al. | Jan 2007 | A1 |
| 20070021826 | Case et al. | Jan 2007 | A1 |
| 20070027518 | Case et al. | Feb 2007 | A1 |
| 20070027520 | Sherburne | Feb 2007 | A1 |
| 20070027533 | Douk | Feb 2007 | A1 |
| 20070027535 | Purdy, Jr. et al. | Feb 2007 | A1 |
| 20070032856 | Limon | Feb 2007 | A1 |
| 20070038291 | Case et al. | Feb 2007 | A1 |
| 20070038295 | Case et al. | Feb 2007 | A1 |
| 20070043420 | Lostetter | Feb 2007 | A1 |
| 20070043424 | Pryor | Feb 2007 | A1 |
| 20070043431 | Melsheimer | Feb 2007 | A1 |
| 20070043435 | Seguin et al. | Feb 2007 | A1 |
| 20070050014 | Johnson | Mar 2007 | A1 |
| 20070051377 | Douk et al. | Mar 2007 | A1 |
| 20070055340 | Pryor | Mar 2007 | A1 |
| 20070056346 | Spenser et al. | Mar 2007 | A1 |
| 20070060998 | Butterwick et al. | Mar 2007 | A1 |
| 20070061002 | Paul, Jr. et al. | Mar 2007 | A1 |
| 20070061008 | Salahieh et al. | Mar 2007 | A1 |
| 20070073389 | Bolduc et al. | Mar 2007 | A1 |
| 20070073392 | Heyninck-Jantz et al. | Mar 2007 | A1 |
| 20070078504 | Mialhe | Apr 2007 | A1 |
| 20070078509 | Lotfy | Apr 2007 | A1 |
| 20070078510 | Ryan | Apr 2007 | A1 |
| 20070088431 | Bourang et al. | Apr 2007 | A1 |
| 20070093869 | Bloom et al. | Apr 2007 | A1 |
| 20070093887 | Case et al. | Apr 2007 | A1 |
| 20070100427 | Perouse | May 2007 | A1 |
| 20070100435 | Case et al. | May 2007 | A1 |
| 20070100439 | Cangialosi et al. | May 2007 | A1 |
| 20070100440 | Figulla et al. | May 2007 | A1 |
| 20070100449 | O'Neil et al. | May 2007 | A1 |
| 20070112355 | Salahieh et al. | May 2007 | A1 |
| 20070112358 | Abbott et al. | May 2007 | A1 |
| 20070112415 | Bartlett | May 2007 | A1 |
| 20070112422 | Dehdashtian | May 2007 | A1 |
| 20070118214 | Salahieh et al. | May 2007 | A1 |
| 20070123700 | Ueda et al. | May 2007 | A1 |
| 20070123979 | Perier et al. | May 2007 | A1 |
| 20070135889 | Moore et al. | Jun 2007 | A1 |
| 20070142906 | Figulla et al. | Jun 2007 | A1 |
| 20070142907 | Moaddeb et al. | Jun 2007 | A1 |
| 20070155010 | Farnsworth et al. | Jul 2007 | A1 |
| 20070156233 | Kapadia et al. | Jul 2007 | A1 |
| 20070162102 | Ryan et al. | Jul 2007 | A1 |
| 20070162103 | Case et al. | Jul 2007 | A1 |
| 20070162107 | Haug et al. | Jul 2007 | A1 |
| 20070162113 | Sharkawy et al. | Jul 2007 | A1 |
| 20070173918 | Dreher et al. | Jul 2007 | A1 |
| 20070173932 | Cali et al. | Jul 2007 | A1 |
| 20070179592 | Schaeffer | Aug 2007 | A1 |
| 20070179600 | Vardi | Aug 2007 | A1 |
| 20070185513 | Woolfson et al. | Aug 2007 | A1 |
| 20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
| 20070185571 | Kapadia et al. | Aug 2007 | A1 |
| 20070198078 | Berra et al. | Aug 2007 | A1 |
| 20070198097 | Zegdi | Aug 2007 | A1 |
| 20070203391 | Bloom et al. | Aug 2007 | A1 |
| 20070203503 | Salahieh et al. | Aug 2007 | A1 |
| 20070203560 | Forster et al. | Aug 2007 | A1 |
| 20070203576 | Lee et al. | Aug 2007 | A1 |
| 20070208550 | Cao et al. | Sep 2007 | A1 |
| 20070213813 | Von Segesser et al. | Sep 2007 | A1 |
| 20070225681 | House | Sep 2007 | A1 |
| 20070225802 | Forsell | Sep 2007 | A1 |
| 20070232898 | Huynh et al. | Oct 2007 | A1 |
| 20070233222 | Roeder et al. | Oct 2007 | A1 |
| 20070233228 | Eberhardt et al. | Oct 2007 | A1 |
| 20070233237 | Krivoruchko | Oct 2007 | A1 |
| 20070233238 | Huynh et al. | Oct 2007 | A1 |
| 20070238979 | Huynh et al. | Oct 2007 | A1 |
| 20070239254 | Chia et al. | Oct 2007 | A1 |
| 20070239265 | Birdsall | Oct 2007 | A1 |
| 20070239266 | Birdsall | Oct 2007 | A1 |
| 20070239269 | Dolan et al. | Oct 2007 | A1 |
| 20070239271 | Nguyen | Oct 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244543 | Mitchell | Oct 2007 | A1 |
| 20070244544 | Birdsall et al. | Oct 2007 | A1 |
| 20070244545 | Birdsall et al. | Oct 2007 | A1 |
| 20070244546 | Francis | Oct 2007 | A1 |
| 20070244551 | Stobie | Oct 2007 | A1 |
| 20070244552 | Salahieh et al. | Oct 2007 | A1 |
| 20070244553 | Rafiee et al. | Oct 2007 | A1 |
| 20070244554 | Rafiee et al. | Oct 2007 | A1 |
| 20070244555 | Rafiee et al. | Oct 2007 | A1 |
| 20070244556 | Rafiee et al. | Oct 2007 | A1 |
| 20070244557 | Rafiee et al. | Oct 2007 | A1 |
| 20070250151 | Pereira | Oct 2007 | A1 |
| 20070250160 | Rafiee | Oct 2007 | A1 |
| 20070255386 | Tenne | Nov 2007 | A1 |
| 20070255390 | Ducke et al. | Nov 2007 | A1 |
| 20070255394 | Ryan | Nov 2007 | A1 |
| 20070255396 | Douk et al. | Nov 2007 | A1 |
| 20070260301 | Chuter et al. | Nov 2007 | A1 |
| 20070260327 | Case et al. | Nov 2007 | A1 |
| 20070265701 | Gurskis et al. | Nov 2007 | A1 |
| 20070270751 | Stangenes et al. | Nov 2007 | A1 |
| 20070270943 | Solem et al. | Nov 2007 | A1 |
| 20070273813 | Yoshida et al. | Nov 2007 | A1 |
| 20070282436 | Pinchuk | Dec 2007 | A1 |
| 20070287717 | Fanning et al. | Dec 2007 | A1 |
| 20070288000 | Bonan | Dec 2007 | A1 |
| 20070288087 | Fearnot et al. | Dec 2007 | A1 |
| 20070288089 | Gurskis et al. | Dec 2007 | A1 |
| 20080004688 | Spenser et al. | Jan 2008 | A1 |
| 20080004696 | Vesely | Jan 2008 | A1 |
| 20080009934 | Schneider et al. | Jan 2008 | A1 |
| 20080009940 | Cribier | Jan 2008 | A1 |
| 20080015671 | Bonhoeffer | Jan 2008 | A1 |
| 20080021546 | Patz et al. | Jan 2008 | A1 |
| 20080021552 | Gabbay | Jan 2008 | A1 |
| 20080022504 | Melsheimer | Jan 2008 | A1 |
| 20080033534 | Cook et al. | Feb 2008 | A1 |
| 20080033541 | Gelbart et al. | Feb 2008 | A1 |
| 20080039925 | Ishimaru et al. | Feb 2008 | A1 |
| 20080039934 | Styrc | Feb 2008 | A1 |
| 20080045921 | Anderson et al. | Feb 2008 | A1 |
| 20080048656 | Tan et al. | Feb 2008 | A1 |
| 20080065001 | DiNucci et al. | Mar 2008 | A1 |
| 20080065011 | Marchand et al. | Mar 2008 | A1 |
| 20080065206 | Liddicoat | Mar 2008 | A1 |
| 20080071361 | Tuval et al. | Mar 2008 | A1 |
| 20080071362 | Tuval et al. | Mar 2008 | A1 |
| 20080071363 | Tuval et al. | Mar 2008 | A1 |
| 20080071366 | Tuval et al. | Mar 2008 | A1 |
| 20080071368 | Tuval et al. | Mar 2008 | A1 |
| 20080071369 | Tuval et al. | Mar 2008 | A1 |
| 20080077227 | Ouellette et al. | Mar 2008 | A1 |
| 20080077234 | Styrc | Mar 2008 | A1 |
| 20080077236 | Letac et al. | Mar 2008 | A1 |
| 20080082165 | Wilson et al. | Apr 2008 | A1 |
| 20080082166 | Styrc et al. | Apr 2008 | A1 |
| 20080086205 | Gordy et al. | Apr 2008 | A1 |
| 20080097586 | Pavcnik et al. | Apr 2008 | A1 |
| 20080102439 | Tian et al. | May 2008 | A1 |
| 20080109070 | Wagner et al. | May 2008 | A1 |
| 20080125859 | Salahieh et al. | May 2008 | A1 |
| 20080127707 | Kokish et al. | Jun 2008 | A1 |
| 20080133002 | Gelbart et al. | Jun 2008 | A1 |
| 20080133003 | Seguin et al. | Jun 2008 | A1 |
| 20080140188 | Rahdert et al. | Jun 2008 | A1 |
| 20080140189 | Nguyen et al. | Jun 2008 | A1 |
| 20080147105 | Wilson et al. | Jun 2008 | A1 |
| 20080147180 | Ghione et al. | Jun 2008 | A1 |
| 20080147181 | Ghione et al. | Jun 2008 | A1 |
| 20080147182 | Righini et al. | Jun 2008 | A1 |
| 20080154355 | Benichou et al. | Jun 2008 | A1 |
| 20080154356 | Obermiller et al. | Jun 2008 | A1 |
| 20080161909 | Kheradvar et al. | Jul 2008 | A1 |
| 20080161910 | Revuelta et al. | Jul 2008 | A1 |
| 20080161911 | Revuelta et al. | Jul 2008 | A1 |
| 20080172119 | Yamasaki et al. | Jul 2008 | A1 |
| 20080177381 | Navia et al. | Jul 2008 | A1 |
| 20080183273 | Mesana et al. | Jul 2008 | A1 |
| 20080188928 | Salahieh et al. | Aug 2008 | A1 |
| 20080195193 | Purdy et al. | Aug 2008 | A1 |
| 20080195199 | Kheradvar et al. | Aug 2008 | A1 |
| 20080200977 | Paul et al. | Aug 2008 | A1 |
| 20080208209 | Fischer et al. | Aug 2008 | A1 |
| 20080208327 | Rowe | Aug 2008 | A1 |
| 20080208328 | Antocci et al. | Aug 2008 | A1 |
| 20080208332 | Lamphere et al. | Aug 2008 | A1 |
| 20080215143 | Seguin | Sep 2008 | A1 |
| 20080215144 | Ryan et al. | Sep 2008 | A1 |
| 20080221672 | Lamphere et al. | Sep 2008 | A1 |
| 20080221703 | Que et al. | Sep 2008 | A1 |
| 20080228254 | Ryan | Sep 2008 | A1 |
| 20080228263 | Ryan | Sep 2008 | A1 |
| 20080234443 | Kiss et al. | Sep 2008 | A1 |
| 20080234797 | Styrc | Sep 2008 | A1 |
| 20080234814 | Salahieh et al. | Sep 2008 | A1 |
| 20080243246 | Ryan et al. | Oct 2008 | A1 |
| 20080255651 | Dwork | Oct 2008 | A1 |
| 20080255660 | Guyenot et al. | Oct 2008 | A1 |
| 20080255661 | Straubinger et al. | Oct 2008 | A1 |
| 20080262590 | Murray | Oct 2008 | A1 |
| 20080262592 | Jordan et al. | Oct 2008 | A1 |
| 20080262593 | Ryan et al. | Oct 2008 | A1 |
| 20080262602 | Wilk et al. | Oct 2008 | A1 |
| 20080264102 | Berra | Oct 2008 | A1 |
| 20080269878 | Iobbi | Oct 2008 | A1 |
| 20080275549 | Rowe | Nov 2008 | A1 |
| 20080275550 | Kheradvar et al. | Nov 2008 | A1 |
| 20080288054 | Pulnev et al. | Nov 2008 | A1 |
| 20090005863 | Goetz et al. | Jan 2009 | A1 |
| 20090012356 | Dann et al. | Jan 2009 | A1 |
| 20090012600 | Styrc et al. | Jan 2009 | A1 |
| 20090030512 | Thielen et al. | Jan 2009 | A1 |
| 20090048656 | Wen | Feb 2009 | A1 |
| 20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
| 20090054969 | Salahieh et al. | Feb 2009 | A1 |
| 20090054976 | Tuval et al. | Feb 2009 | A1 |
| 20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
| 20090069886 | Suri et al. | Mar 2009 | A1 |
| 20090069887 | Righini et al. | Mar 2009 | A1 |
| 20090069889 | Suri et al. | Mar 2009 | A1 |
| 20090069890 | Suri et al. | Mar 2009 | A1 |
| 20090076598 | Salahieh et al. | Mar 2009 | A1 |
| 20090082844 | Zacharias et al. | Mar 2009 | A1 |
| 20090082858 | Nugent et al. | Mar 2009 | A1 |
| 20090085900 | Weiner | Apr 2009 | A1 |
| 20090093876 | Nitzan et al. | Apr 2009 | A1 |
| 20090093877 | Keidar et al. | Apr 2009 | A1 |
| 20090099640 | Weng | Apr 2009 | A1 |
| 20090099641 | Wu et al. | Apr 2009 | A1 |
| 20090099643 | Hyodoh et al. | Apr 2009 | A1 |
| 20090099653 | Suri et al. | Apr 2009 | A1 |
| 20090112309 | Jaramillo et al. | Apr 2009 | A1 |
| 20090138079 | Tuval et al. | May 2009 | A1 |
| 20090157175 | Benichou | Jun 2009 | A1 |
| 20090163951 | Simmons et al. | Jun 2009 | A1 |
| 20090164004 | Cohn | Jun 2009 | A1 |
| 20090164006 | Seguin et al. | Jun 2009 | A1 |
| 20090171432 | Von Segesser et al. | Jul 2009 | A1 |
| 20090171447 | Von Segesser et al. | Jul 2009 | A1 |
| 20090171456 | Kveen et al. | Jul 2009 | A1 |
| 20090182405 | Arnault De La Menardiere et al. | Jul 2009 | A1 |
| 20090192585 | Bloom et al. | Jul 2009 | A1 |
| 20090192586 | Tabor et al. | Jul 2009 | A1 |
| 20090192591 | Ryan et al. | Jul 2009 | A1 |
| 20090192601 | Rafiee et al. | Jul 2009 | A1 |
| 20090198316 | Laske et al. | Aug 2009 | A1 |
| 20090198323 | Johnson et al. | Aug 2009 | A1 |
| 20090210052 | Forster et al. | Aug 2009 | A1 |
| 20090216310 | Straubinger et al. | Aug 2009 | A1 |
| 20090216312 | Straubinger et al. | Aug 2009 | A1 |
| 20090216313 | Straubinger et al. | Aug 2009 | A1 |
| 20090222076 | Figulla et al. | Sep 2009 | A1 |
| 20090222082 | Lock et al. | Sep 2009 | A1 |
| 20090234407 | Hastings et al. | Sep 2009 | A1 |
| 20090234443 | Ottma et al. | Sep 2009 | A1 |
| 20090240264 | Tuval et al. | Sep 2009 | A1 |
| 20090240320 | Tuval et al. | Sep 2009 | A1 |
| 20090248143 | Laham | Oct 2009 | A1 |
| 20090259306 | Rowe | Oct 2009 | A1 |
| 20090264759 | Byrd | Oct 2009 | A1 |
| 20090264997 | Salahieh et al. | Oct 2009 | A1 |
| 20090276040 | Rowe et al. | Nov 2009 | A1 |
| 20090281619 | Le et al. | Nov 2009 | A1 |
| 20090287290 | MacAulay et al. | Nov 2009 | A1 |
| 20090287296 | Manasse | Nov 2009 | A1 |
| 20090287299 | Tabor et al. | Nov 2009 | A1 |
| 20090299462 | Fawzi et al. | Dec 2009 | A1 |
| 20090319037 | Rowe et al. | Dec 2009 | A1 |
| 20100004739 | Vesely | Jan 2010 | A1 |
| 20100004740 | Seguin et al. | Jan 2010 | A1 |
| 20100011564 | Millwee et al. | Jan 2010 | A1 |
| 20100030328 | Seguin et al. | Feb 2010 | A1 |
| 20100036479 | Hill et al. | Feb 2010 | A1 |
| 20100036485 | Seguin | Feb 2010 | A1 |
| 20100049313 | Alon et al. | Feb 2010 | A1 |
| 20100057051 | Howat et al. | Mar 2010 | A1 |
| 20100057185 | Melsheimer et al. | Mar 2010 | A1 |
| 20100069852 | Kelley | Mar 2010 | A1 |
| 20100069916 | Cully et al. | Mar 2010 | A1 |
| 20100070027 | Bonhoeffer et al. | Mar 2010 | A1 |
| 20100082089 | Quadri et al. | Apr 2010 | A1 |
| 20100082094 | Quadri et al. | Apr 2010 | A1 |
| 20100087913 | Rabkin et al. | Apr 2010 | A1 |
| 20100094399 | Dorn et al. | Apr 2010 | A1 |
| 20100094411 | Tuval et al. | Apr 2010 | A1 |
| 20100100167 | Bortlein et al. | Apr 2010 | A1 |
| 20100121434 | Paul et al. | May 2010 | A1 |
| 20100131054 | Tuval et al. | May 2010 | A1 |
| 20100131057 | Subramanian et al. | May 2010 | A1 |
| 20100137979 | Tuval et al. | Jun 2010 | A1 |
| 20100145439 | Seguin et al. | Jun 2010 | A1 |
| 20100152840 | Seguin et al. | Jun 2010 | A1 |
| 20100160725 | Kiser et al. | Jun 2010 | A1 |
| 20100161045 | Righini | Jun 2010 | A1 |
| 20100168839 | Braido et al. | Jul 2010 | A1 |
| 20100174362 | Straubinger et al. | Jul 2010 | A1 |
| 20100185275 | Richter et al. | Jul 2010 | A1 |
| 20100185277 | Braido et al. | Jul 2010 | A1 |
| 20100191320 | Straubinger et al. | Jul 2010 | A1 |
| 20100191326 | Alkhatib | Jul 2010 | A1 |
| 20100198346 | Keogh et al. | Aug 2010 | A1 |
| 20100210991 | Wilk et al. | Aug 2010 | A1 |
| 20100219092 | Salahieh et al. | Sep 2010 | A1 |
| 20100234932 | Arbefeuille et al. | Sep 2010 | A1 |
| 20100234940 | Dolan | Sep 2010 | A1 |
| 20100239917 | Lee et al. | Sep 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100249915 | Zhang | Sep 2010 | A1 |
| 20100249916 | Zhang | Sep 2010 | A1 |
| 20100249917 | Zhang | Sep 2010 | A1 |
| 20100249918 | Zhang | Sep 2010 | A1 |
| 20100256723 | Murray | Oct 2010 | A1 |
| 20100262231 | Tuval et al. | Oct 2010 | A1 |
| 20100268332 | Tuval et al. | Oct 2010 | A1 |
| 20100280459 | Werner | Nov 2010 | A1 |
| 20100280495 | Paul et al. | Nov 2010 | A1 |
| 20100286768 | Alkhatib | Nov 2010 | A1 |
| 20100292779 | Straubinger et al. | Nov 2010 | A1 |
| 20100292780 | Straubinger et al. | Nov 2010 | A1 |
| 20100292785 | Seguin et al. | Nov 2010 | A1 |
| 20100298931 | Quadri et al. | Nov 2010 | A1 |
| 20110004297 | Sogard et al. | Jan 2011 | A1 |
| 20110015616 | Straubinger et al. | Jan 2011 | A1 |
| 20110022157 | Essinger et al. | Jan 2011 | A1 |
| 20110029066 | Gilad et al. | Feb 2011 | A1 |
| 20110034852 | Hausler et al. | Feb 2011 | A1 |
| 20110040366 | Goetz et al. | Feb 2011 | A1 |
| 20110040374 | Goetz et al. | Feb 2011 | A1 |
| 20110071613 | Wood et al. | Mar 2011 | A1 |
| 20110093007 | Abbott et al. | Apr 2011 | A1 |
| 20110098805 | Dwork et al. | Apr 2011 | A1 |
| 20110106244 | Ferrari et al. | May 2011 | A1 |
| 20110137397 | Chau et al. | Jun 2011 | A1 |
| 20110166637 | Irwin et al. | Jul 2011 | A1 |
| 20110190862 | Bashiri et al. | Aug 2011 | A1 |
| 20110190874 | Celermajer et al. | Aug 2011 | A1 |
| 20110208290 | Straubinger et al. | Aug 2011 | A1 |
| 20110208297 | Tuval et al. | Aug 2011 | A1 |
| 20110224780 | Tabor et al. | Sep 2011 | A1 |
| 20110238159 | Guyenot et al. | Sep 2011 | A1 |
| 20110238167 | Dove et al. | Sep 2011 | A1 |
| 20110257729 | Spenser et al. | Oct 2011 | A1 |
| 20110257733 | Dwork | Oct 2011 | A1 |
| 20110257735 | Salahieh et al. | Oct 2011 | A1 |
| 20110264191 | Rothstein | Oct 2011 | A1 |
| 20110264196 | Savage et al. | Oct 2011 | A1 |
| 20110264203 | Dwork et al. | Oct 2011 | A1 |
| 20110276121 | Levine | Nov 2011 | A1 |
| 20110276129 | Salahieh et al. | Nov 2011 | A1 |
| 20110288626 | Straubinger et al. | Nov 2011 | A1 |
| 20110288634 | Tuval et al. | Nov 2011 | A1 |
| 20110295363 | Girard et al. | Dec 2011 | A1 |
| 20110319989 | Lane et al. | Dec 2011 | A1 |
| 20120016469 | Salahieh et al. | Jan 2012 | A1 |
| 20120016471 | Salahieh et al. | Jan 2012 | A1 |
| 20120022633 | Olson et al. | Jan 2012 | A1 |
| 20120022642 | Haug et al. | Jan 2012 | A1 |
| 20120029627 | Salahieh et al. | Feb 2012 | A1 |
| 20120035719 | Forster et al. | Feb 2012 | A1 |
| 20120035720 | Cali et al. | Feb 2012 | A1 |
| 20120041547 | Duffy et al. | Feb 2012 | A1 |
| 20120041549 | Salahieh et al. | Feb 2012 | A1 |
| 20120041550 | Salahieh et al. | Feb 2012 | A1 |
| 20120046740 | Paul et al. | Feb 2012 | A1 |
| 20120053683 | Salahieh et al. | Mar 2012 | A1 |
| 20120059447 | Zilla et al. | Mar 2012 | A1 |
| 20120065464 | Ellis et al. | Mar 2012 | A1 |
| 20120078347 | Braido et al. | Mar 2012 | A1 |
| 20120078357 | Conklin | Mar 2012 | A1 |
| 20120078360 | Rafiee | Mar 2012 | A1 |
| 20120089224 | Haug et al. | Apr 2012 | A1 |
| 20120100182 | Mooney et al. | Apr 2012 | A1 |
| 20120101571 | Thambar et al. | Apr 2012 | A1 |
| 20120101572 | Kovalsky et al. | Apr 2012 | A1 |
| 20120116496 | Chuter et al. | May 2012 | A1 |
| 20120123515 | Hosford et al. | May 2012 | A1 |
| 20120123529 | Levi et al. | May 2012 | A1 |
| 20120130468 | Khosravi et al. | May 2012 | A1 |
| 20120132547 | Salahieh et al. | May 2012 | A1 |
| 20120136430 | Sochman et al. | May 2012 | A1 |
| 20120165957 | Everland et al. | Jun 2012 | A1 |
| 20120172982 | Stacchino et al. | Jul 2012 | A1 |
| 20120179244 | Schankereli et al. | Jul 2012 | A1 |
| 20120185030 | Igaki et al. | Jul 2012 | A1 |
| 20120197379 | Laske et al. | Aug 2012 | A1 |
| 20120209374 | Bonhoeffer et al. | Aug 2012 | A1 |
| 20120209376 | Hauser et al. | Aug 2012 | A1 |
| 20120221100 | Huber | Aug 2012 | A1 |
| 20120226341 | Schreck et al. | Sep 2012 | A1 |
| 20120283715 | Mihalik et al. | Nov 2012 | A1 |
| 20120283823 | Bonhoeffer et al. | Nov 2012 | A1 |
| 20120303113 | Benichou et al. | Nov 2012 | A1 |
| 20120303116 | Gorman, III et al. | Nov 2012 | A1 |
| 20120305441 | Murray et al. | Dec 2012 | A1 |
| 20120310332 | Murray et al. | Dec 2012 | A1 |
| 20120316637 | Holm et al. | Dec 2012 | A1 |
| 20120330408 | Hillukka et al. | Dec 2012 | A1 |
| 20120330409 | Haug et al. | Dec 2012 | A1 |
| 20130013057 | Salahieh et al. | Jan 2013 | A1 |
| 20130018457 | Gregg et al. | Jan 2013 | A1 |
| 20130030519 | Tran et al. | Jan 2013 | A1 |
| 20130030520 | Lee et al. | Jan 2013 | A1 |
| 20130046373 | Cartledge et al. | Feb 2013 | A1 |
| 20130053949 | Pintor et al. | Feb 2013 | A1 |
| 20130066342 | Dell et al. | Mar 2013 | A1 |
| 20130066419 | Gregg | Mar 2013 | A1 |
| 20130071441 | Iwazawa et al. | Mar 2013 | A1 |
| 20130073037 | Gregg et al. | Mar 2013 | A1 |
| 20130079867 | Hoffman et al. | Mar 2013 | A1 |
| 20130079869 | Straubinger et al. | Mar 2013 | A1 |
| 20130089655 | Gregg | Apr 2013 | A1 |
| 20130090728 | Solem | Apr 2013 | A1 |
| 20130090729 | Gregg et al. | Apr 2013 | A1 |
| 20130096664 | Goetz et al. | Apr 2013 | A1 |
| 20130116778 | Gregg et al. | May 2013 | A1 |
| 20130118949 | Chang et al. | May 2013 | A1 |
| 20130123757 | Crisostomo et al. | May 2013 | A1 |
| 20130123795 | Gamarra et al. | May 2013 | A1 |
| 20130123796 | Sutton et al. | May 2013 | A1 |
| 20130123898 | Tung et al. | May 2013 | A1 |
| 20130138207 | Quadri et al. | May 2013 | A1 |
| 20130144203 | Wilk et al. | Jun 2013 | A1 |
| 20130144276 | Crisostomo et al. | Jun 2013 | A1 |
| 20130158653 | Gamarra et al. | Jun 2013 | A1 |
| 20130158655 | Sutton et al. | Jun 2013 | A1 |
| 20130158656 | Sutton et al. | Jun 2013 | A1 |
| 20130166017 | Cartledge et al. | Jun 2013 | A1 |
| 20130178930 | Straubinger et al. | Jul 2013 | A1 |
| 20130184813 | Quadri et al. | Jul 2013 | A1 |
| 20130190865 | Anderson | Jul 2013 | A1 |
| 20130204359 | Thubrikar et al. | Aug 2013 | A1 |
| 20130231735 | Deem et al. | Sep 2013 | A1 |
| 20130245752 | Goetz et al. | Sep 2013 | A1 |
| 20130253342 | Griswold et al. | Sep 2013 | A1 |
| 20130253635 | Straubinger et al. | Sep 2013 | A1 |
| 20130253640 | Meiri et al. | Sep 2013 | A1 |
| 20130268067 | Forster et al. | Oct 2013 | A1 |
| 20130274865 | Haverkost et al. | Oct 2013 | A1 |
| 20130274870 | Lombardi et al. | Oct 2013 | A1 |
| 20130289698 | Wang et al. | Oct 2013 | A1 |
| 20130296999 | Burriesci et al. | Nov 2013 | A1 |
| 20130304199 | Sutton et al. | Nov 2013 | A1 |
| 20130310917 | Richter et al. | Nov 2013 | A1 |
| 20130310923 | Kheradvar et al. | Nov 2013 | A1 |
| 20130310928 | Morriss et al. | Nov 2013 | A1 |
| 20130325101 | Goetz et al. | Dec 2013 | A1 |
| 20130338755 | Goetz et al. | Dec 2013 | A1 |
| 20130345799 | Lafontaine | Dec 2013 | A1 |
| 20140012368 | Sugimoto et al. | Jan 2014 | A1 |
| 20140012370 | Bonhoeffer et al. | Jan 2014 | A1 |
| 20140018911 | Zhou et al. | Jan 2014 | A1 |
| 20140052239 | Kong et al. | Feb 2014 | A1 |
| 20140058501 | Bonhoeffer et al. | Feb 2014 | A1 |
| 20140083190 | Kaack et al. | Mar 2014 | A1 |
| 20140088680 | Costello et al. | Mar 2014 | A1 |
| 20140094904 | Salahieh et al. | Apr 2014 | A1 |
| 20140114390 | Tobis et al. | Apr 2014 | A1 |
| 20140114405 | Paul et al. | Apr 2014 | A1 |
| 20140114406 | Salahieh et al. | Apr 2014 | A1 |
| 20140114407 | Rajamannan | Apr 2014 | A1 |
| 20140121763 | Duffy et al. | May 2014 | A1 |
| 20140121766 | Salahieh et al. | May 2014 | A1 |
| 20140128969 | Hill et al. | May 2014 | A1 |
| 20140135912 | Salahieh et al. | May 2014 | A1 |
| 20140207229 | Shoemaker et al. | Jul 2014 | A1 |
| 20140222142 | Kovalsky et al. | Aug 2014 | A1 |
| 20140236287 | Clague et al. | Aug 2014 | A1 |
| 20140243962 | Wilson et al. | Aug 2014 | A1 |
| 20140243963 | Sheps et al. | Aug 2014 | A1 |
| 20140243967 | Salahieh et al. | Aug 2014 | A1 |
| 20140249621 | Eidenschink | Sep 2014 | A1 |
| 20140257473 | Rajamannan | Sep 2014 | A1 |
| 20140277414 | Kheradvar | Sep 2014 | A1 |
| 20140296962 | Cartledge et al. | Oct 2014 | A1 |
| 20140309732 | Solem | Oct 2014 | A1 |
| 20140316518 | Kheradvar et al. | Oct 2014 | A1 |
| 20140330371 | Gloss et al. | Nov 2014 | A1 |
| 20140343669 | Lane et al. | Nov 2014 | A1 |
| 20140379068 | Thielen et al. | Dec 2014 | A1 |
| 20150012085 | Salahieh et al. | Jan 2015 | A1 |
| 20150032056 | Okamura et al. | Jan 2015 | A1 |
| 20150073540 | Salahieh et al. | Mar 2015 | A1 |
| 20150073541 | Salahieh et al. | Mar 2015 | A1 |
| 20150088252 | Jenson et al. | Mar 2015 | A1 |
| 20150094804 | Bonhoeffer et al. | Apr 2015 | A1 |
| 20150105857 | Bonhoeffer et al. | Apr 2015 | A1 |
| 20150127092 | Straubinger et al. | May 2015 | A1 |
| 20150127094 | Salahieh et al. | May 2015 | A1 |
| 20150142102 | Lafontaine et al. | May 2015 | A1 |
| 20150209142 | Paul et al. | Jul 2015 | A1 |
| 20150209146 | Hill et al. | Jul 2015 | A1 |
| 20150223933 | Haug et al. | Aug 2015 | A1 |
| 20150238315 | Rabito et al. | Aug 2015 | A1 |
| 20150245909 | Salahieh et al. | Sep 2015 | A1 |
| 20150272731 | Racchini et al. | Oct 2015 | A1 |
| 20150320557 | Sutton et al. | Nov 2015 | A1 |
| 20150335423 | Gregg et al. | Nov 2015 | A1 |
| 20150352252 | Nakamura et al. | Dec 2015 | A1 |
| 20150359997 | Crisostomo et al. | Dec 2015 | A1 |
| 20160022418 | Salahieh et al. | Jan 2016 | A1 |
| 20160045306 | Agrawal et al. | Feb 2016 | A1 |
| 20160045307 | Yohanan et al. | Feb 2016 | A1 |
| 20160051362 | Cooper et al. | Feb 2016 | A1 |
| 20160067040 | Agrawal et al. | Mar 2016 | A1 |
| 20160120645 | Alon | May 2016 | A1 |
| 20160135951 | Salahieh et al. | May 2016 | A1 |
| 20160143731 | Backus et al. | May 2016 | A1 |
| 20160158003 | Wallace et al. | Jun 2016 | A1 |
| 20160166384 | Olson et al. | Jun 2016 | A1 |
| 20160199184 | Ma et al. | Jul 2016 | A1 |
| 20160206423 | O'Connor et al. | Jul 2016 | A1 |
| 20160213467 | Backus et al. | Jul 2016 | A1 |
| 20160220359 | Backus et al. | Aug 2016 | A1 |
| 20160220360 | Lin et al. | Aug 2016 | A1 |
| 20160220365 | Backus et al. | Aug 2016 | A1 |
| 20160250024 | Hill et al. | Sep 2016 | A1 |
| 20160256271 | Backus et al. | Sep 2016 | A1 |
| 20160262878 | Backus et al. | Sep 2016 | A1 |
| 20160346107 | Matthison-Hansen et al. | Dec 2016 | A1 |
| 20160354203 | Tuval et al. | Dec 2016 | A1 |
| 20160374793 | Lafontaine et al. | Dec 2016 | A1 |
| 20160376063 | Salahieh et al. | Dec 2016 | A1 |
| 20170000609 | Gross et al. | Jan 2017 | A1 |
| 20170007400 | Sogard et al. | Jan 2017 | A1 |
| 20170027693 | Paul et al. | Feb 2017 | A1 |
| 20170049563 | Straubinger et al. | Feb 2017 | A1 |
| 20170049568 | Straubinger et al. | Feb 2017 | A1 |
| 20170056172 | Salahieh et al. | Mar 2017 | A1 |
| 20170065410 | Straubinger et al. | Mar 2017 | A1 |
| 20170095595 | Nakamura | Apr 2017 | A1 |
| 20170333230 | Folan et al. | Nov 2017 | A1 |
| 20170348013 | Mottola et al. | Dec 2017 | A1 |
| 20180368976 | Bonhoeffer et al. | Dec 2018 | A1 |
| 20190328522 | Straubinger et al. | Oct 2019 | A1 |
| 20200054449 | Min et al. | Feb 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 757647 | Feb 2003 | AU |
| 776895 | Sep 2004 | AU |
| 777443 | Oct 2004 | AU |
| 778831 | Dec 2004 | AU |
| 2004231189 | Dec 2004 | AU |
| 2004242527 | Jan 2005 | AU |
| 2001281277 | Sep 2005 | AU |
| 2006308187 | May 2007 | AU |
| 2006310681 | May 2007 | AU |
| 2006328896 | Jun 2007 | AU |
| 2002329324 | Jul 2007 | AU |
| 2007294199 | Mar 2008 | AU |
| 2009200985 | Apr 2009 | AU |
| 2006328896 | Aug 2013 | AU |
| 2378589 | Feb 2001 | CA |
| 2381192 | Feb 2001 | CA |
| 2385662 | Mar 2001 | CA |
| 2407987 | Nov 2001 | CA |
| 2418958 | Feb 2002 | CA |
| 2435962 | Aug 2002 | CA |
| 245775 | Feb 2003 | CA |
| 284849 | Jan 2005 | CA |
| 2436258 | Jan 2005 | CA |
| 2848485 | Jan 2005 | CA |
| 2595233 | Jul 2006 | CA |
| 2627409 | May 2007 | CA |
| 2627555 | May 2007 | CA |
| 2634358 | Jun 2007 | CA |
| 2657839 | Mar 2008 | CA |
| 2659690 | Mar 2008 | CA |
| 1338951 | Mar 2002 | CN |
| 1342443 | Apr 2002 | CN |
| 1745727 | Mar 2006 | CN |
| 2762776 | Mar 2006 | CN |
| 1897892 | Jan 2007 | CN |
| 2933337 | Aug 2007 | CN |
| 101011298 | Aug 2007 | CN |
| 101431963 | May 2009 | CN |
| 101605509 | Dec 2009 | CN |
| 101623217 | Jan 2010 | CN |
| 101700199 | May 2010 | CN |
| 101720211 | Jun 2010 | CN |
| 102271626 | Dec 2011 | CN |
| 102413793 | Apr 2012 | CN |
| 2815756 | Oct 1979 | DE |
| 3640745 | Jun 1987 | DE |
| 3920657 | Jan 1991 | DE |
| 3640745 | Mar 1992 | DE |
| 4316971 | Nov 1994 | DE |
| 19532846 | Mar 1997 | DE |
| 19546692 | Jun 1997 | DE |
| 19633901 | Feb 1998 | DE |
| 20003874 | May 2000 | DE |
| 19857887 | Jul 2000 | DE |
| 19907646 | Aug 2000 | DE |
| 10010073 | Sep 2001 | DE |
| 10010074 | Oct 2001 | DE |
| 10034105 | Apr 2002 | DE |
| 10049812 | Apr 2002 | DE |
| 10049813 | Apr 2002 | DE |
| 10049814 | Apr 2002 | DE |
| 10049815 | Apr 2002 | DE |
| 10048814 | May 2002 | DE |
| 10121210 | Nov 2002 | DE |
| 19546692 | Nov 2002 | DE |
| 10301026 | Feb 2004 | DE |
| 10048814 | Apr 2004 | DE |
| 10049812 | Jun 2004 | DE |
| 10302447 | Jul 2004 | DE |
| 10335948 | Feb 2005 | DE |
| 10010074 | Apr 2005 | DE |
| 19857887 | May 2005 | DE |
| 10049815 | Oct 2005 | DE |
| 10010073 | Dec 2005 | DE |
| 102005003632 | Aug 2006 | DE |
| 102005051849 | May 2007 | DE |
| 102005052628 | May 2007 | DE |
| 202007005491 | Jun 2007 | DE |
| 20221871 | Sep 2008 | DE |
| 69937568 | Sep 2008 | DE |
| 0084395 | Jul 1983 | EP |
| 0103546 | Mar 1984 | EP |
| 0103546 | May 1988 | EP |
| 0144167 | Nov 1989 | EP |
| 0402036 | Dec 1990 | EP |
| 0402176 | Dec 1990 | EP |
| 0411118 | Feb 1991 | EP |
| 0458877 | Dec 1991 | EP |
| 0515324 | Nov 1992 | EP |
| 0547135 | Jun 1993 | EP |
| 0579523 | Jan 1994 | EP |
| 0402176 | Apr 1994 | EP |
| 0592410 | Apr 1994 | EP |
| 0597967 | May 1994 | EP |
| 0597967 | Dec 1994 | EP |
| 0458877 | May 1995 | EP |
| 0657147 | Jun 1995 | EP |
| 0592410 | Oct 1995 | EP |
| 0696447 | Feb 1996 | EP |
| 0402036 | Apr 1996 | EP |
| 0729364 | Sep 1996 | EP |
| 0732088 | Sep 1996 | EP |
| 0756498 | Feb 1997 | EP |
| 0409929 | Apr 1997 | EP |
| 0778775 | Jun 1997 | EP |
| 0786970 | Aug 1997 | EP |
| 0792624 | Sep 1997 | EP |
| 0797957 | Oct 1997 | EP |
| 0797958 | Oct 1997 | EP |
| 0799604 | Oct 1997 | EP |
| 0801928 | Oct 1997 | EP |
| 0815798 | Jan 1998 | EP |
| 0826346 | Mar 1998 | EP |
| 0829239 | Mar 1998 | EP |
| 0836834 | Apr 1998 | EP |
| 0850607 | Jul 1998 | EP |
| 0853921 | Jul 1998 | EP |
| 0858779 | Aug 1998 | EP |
| 0871414 | Oct 1998 | EP |
| 0876796 | Nov 1998 | EP |
| 0876803 | Nov 1998 | EP |
| 0778775 | Jan 1999 | EP |
| 0888142 | Jan 1999 | EP |
| 0888750 | Jan 1999 | EP |
| 0895752 | Feb 1999 | EP |
| 0896813 | Feb 1999 | EP |
| 0903122 | Mar 1999 | EP |
| 0876796 | May 1999 | EP |
| 0928615 | Jul 1999 | EP |
| 0657147 | Aug 1999 | EP |
| 0934728 | Aug 1999 | EP |
| 0938877 | Sep 1999 | EP |
| 0943302 | Sep 1999 | EP |
| 0597967 | Dec 1999 | EP |
| 0696447 | Jan 2000 | EP |
| 0971649 | Jan 2000 | EP |
| 0986348 | Mar 2000 | EP |
| 1000590 | May 2000 | EP |
| 1011523 | Jun 2000 | EP |
| 1020166 | Jul 2000 | EP |
| 1027870 | Aug 2000 | EP |
| 1041942 | Oct 2000 | EP |
| 1041943 | Oct 2000 | EP |
| 1051204 | Nov 2000 | EP |
| 1057459 | Dec 2000 | EP |
| 1057460 | Dec 2000 | EP |
| 1078610 | Feb 2001 | EP |
| 1088529 | Apr 2001 | EP |
| 1089676 | Apr 2001 | EP |
| 1093771 | Apr 2001 | EP |
| 1097676 | May 2001 | EP |
| 1112042 | Jul 2001 | EP |
| 1112097 | Jul 2001 | EP |
| 1117446 | Jul 2001 | EP |
| 1158937 | Dec 2001 | EP |
| 0547135 | Jan 2002 | EP |
| 0729364 | Jan 2002 | EP |
| 1164976 | Jan 2002 | EP |
| 1166721 | Jan 2002 | EP |
| 1171061 | Jan 2002 | EP |
| 1206179 | May 2002 | EP |
| 0756498 | Jul 2002 | EP |
| 1233731 | Aug 2002 | EP |
| 0986348 | Sep 2002 | EP |
| 1235537 | Sep 2002 | EP |
| 1248655 | Oct 2002 | EP |
| 1251804 | Oct 2002 | EP |
| 1251805 | Oct 2002 | EP |
| 1255510 | Nov 2002 | EP |
| 1257305 | Nov 2002 | EP |
| 1259193 | Nov 2002 | EP |
| 1259195 | Nov 2002 | EP |
| 0959815 | Dec 2002 | EP |
| 0971649 | Dec 2002 | EP |
| 1262201 | Dec 2002 | EP |
| 1264582 | Dec 2002 | EP |
| 1281357 | Feb 2003 | EP |
| 1281375 | Feb 2003 | EP |
| 0888142 | May 2003 | EP |
| 1112097 | Jun 2003 | EP |
| 1330213 | Jul 2003 | EP |
| 0937439 | Sep 2003 | EP |
| 1017868 | Sep 2003 | EP |
| 1340473 | Sep 2003 | EP |
| 1347785 | Oct 2003 | EP |
| 1354569 | Oct 2003 | EP |
| 1356793 | Oct 2003 | EP |
| 1281375 | Dec 2003 | EP |
| 1340473 | Feb 2004 | EP |
| 1041943 | Mar 2004 | EP |
| 1356793 | Mar 2004 | EP |
| 1395208 | Mar 2004 | EP |
| 1401359 | Mar 2004 | EP |
| 0871414 | Apr 2004 | EP |
| 1406561 | Apr 2004 | EP |
| 1408882 | Apr 2004 | EP |
| 1042045 | May 2004 | EP |
| 1414295 | May 2004 | EP |
| 0819013 | Jun 2004 | EP |
| 1430853 | Jun 2004 | EP |
| 1347785 | Jul 2004 | EP |
| 1435878 | Jul 2004 | EP |
| 1435879 | Jul 2004 | EP |
| 1439800 | Jul 2004 | EP |
| 1441672 | Aug 2004 | EP |
| 0954248 | Sep 2004 | EP |
| 1452153 | Sep 2004 | EP |
| 0987998 | Oct 2004 | EP |
| 1206179 | Oct 2004 | EP |
| 1469797 | Oct 2004 | EP |
| 1087727 | Nov 2004 | EP |
| 1115452 | Nov 2004 | EP |
| 1117446 | Nov 2004 | EP |
| 1472996 | Nov 2004 | EP |
| 1477202 | Nov 2004 | EP |
| 1107710 | Dec 2004 | EP |
| 1233731 | Dec 2004 | EP |
| 1484081 | Dec 2004 | EP |
| 1494616 | Jan 2005 | EP |
| 1499366 | Jan 2005 | EP |
| 1143879 | Mar 2005 | EP |
| 1516599 | Mar 2005 | EP |
| 1518518 | Mar 2005 | EP |
| 1229864 | Apr 2005 | EP |
| 1253875 | Apr 2005 | EP |
| 1519697 | Apr 2005 | EP |
| 1521414 | Apr 2005 | EP |
| 1522278 | Apr 2005 | EP |
| 1088529 | Jun 2005 | EP |
| 1093771 | Jun 2005 | EP |
| 1251803 | Jun 2005 | EP |
| 1430853 | Jun 2005 | EP |
| 1539047 | Jun 2005 | EP |
| 1547533 | Jun 2005 | EP |
| 1059894 | Jul 2005 | EP |
| 1551274 | Jul 2005 | EP |
| 1551336 | Jul 2005 | EP |
| 1000590 | Aug 2005 | EP |
| 1027013 | Aug 2005 | EP |
| 1078610 | Aug 2005 | EP |
| 1560542 | Aug 2005 | EP |
| 1562515 | Aug 2005 | EP |
| 1570809 | Sep 2005 | EP |
| 1576937 | Sep 2005 | EP |
| 0943302 | Oct 2005 | EP |
| 1267753 | Oct 2005 | EP |
| 1582178 | Oct 2005 | EP |
| 1582179 | Oct 2005 | EP |
| 1011523 | Nov 2005 | EP |
| 1067869 | Nov 2005 | EP |
| 1469797 | Nov 2005 | EP |
| 1589902 | Nov 2005 | EP |
| 1598031 | Nov 2005 | EP |
| 1600110 | Nov 2005 | EP |
| 1600121 | Nov 2005 | EP |
| 0786970 | Dec 2005 | EP |
| 1156757 | Dec 2005 | EP |
| 1603493 | Dec 2005 | EP |
| 1605871 | Dec 2005 | EP |
| 1021141 | Jan 2006 | EP |
| 1614400 | Jan 2006 | EP |
| 1616531 | Jan 2006 | EP |
| 1616536 | Jan 2006 | EP |
| 1041942 | Jun 2006 | EP |
| 1441672 | Jun 2006 | EP |
| 1663070 | Jun 2006 | EP |
| 1667614 | Jun 2006 | EP |
| 1494616 | Jul 2006 | EP |
| 1690515 | Aug 2006 | EP |
| 1702247 | Sep 2006 | EP |
| 1051204 | Dec 2006 | EP |
| 1734902 | Dec 2006 | EP |
| 1395208 | Jan 2007 | EP |
| 1251805 | Mar 2007 | EP |
| 1255510 | Apr 2007 | EP |
| 1499366 | Jul 2007 | EP |
| 1600121 | Jul 2007 | EP |
| 1835948 | Sep 2007 | EP |
| 1112042 | Nov 2007 | EP |
| 1251797 | Nov 2007 | EP |
| 1616531 | Dec 2007 | EP |
| 1863545 | Dec 2007 | EP |
| 1878407 | Jan 2008 | EP |
| 1886649 | Feb 2008 | EP |
| 1406561 | Mar 2008 | EP |
| 1893132 | Mar 2008 | EP |
| 1900343 | Mar 2008 | EP |
| 1901681 | Mar 2008 | EP |
| 1435878 | Apr 2008 | EP |
| 1886649 | Apr 2008 | EP |
| 1251804 | Jul 2008 | EP |
| 1605871 | Jul 2008 | EP |
| 1968491 | Sep 2008 | EP |
| 1259195 | Oct 2008 | EP |
| 1980220 | Oct 2008 | EP |
| 1994913 | Nov 2008 | EP |
| 1994913 | Dec 2008 | EP |
| 2000115 | Dec 2008 | EP |
| 1560542 | Jan 2009 | EP |
| 1408882 | Feb 2009 | EP |
| 1255510 | Mar 2009 | EP |
| 1330213 | Mar 2009 | EP |
| 2033593 | Mar 2009 | EP |
| 2047824 | Apr 2009 | EP |
| 2059192 | May 2009 | EP |
| 2074964 | Jul 2009 | EP |
| 1401359 | Aug 2009 | EP |
| 1968491 | Jul 2010 | EP |
| 1259193 | Nov 2010 | EP |
| 2257242 | Dec 2010 | EP |
| 2266503 | Dec 2010 | EP |
| 2266504 | Dec 2010 | EP |
| 1893132 | Mar 2011 | EP |
| 2266503 | Apr 2011 | EP |
| 2266504 | Apr 2011 | EP |
| 2059192 | Jul 2011 | EP |
| 1441672 | Sep 2011 | EP |
| 2364669 | Sep 2011 | EP |
| 2387977 | Nov 2011 | EP |
| 1603493 | Dec 2011 | EP |
| 1281375 | Feb 2012 | EP |
| 2364669 | Mar 2012 | EP |
| 2047824 | May 2012 | EP |
| 2474287 | Jul 2012 | EP |
| 2387977 | Nov 2013 | EP |
| 1551274 | Dec 2014 | EP |
| 2874812 | May 2015 | EP |
| 2749254 | Jun 2015 | EP |
| 1702247 | Aug 2015 | EP |
| 2926766 | Oct 2015 | EP |
| 1519697 | Nov 2015 | EP |
| 1863545 | Nov 2015 | EP |
| 1835948 | Feb 2016 | EP |
| 1734902 | Jun 2016 | EP |
| 3028668 | Jun 2016 | EP |
| 1539047 | Nov 2016 | EP |
| 1667614 | Dec 2016 | EP |
| 3181096 | Jun 2017 | EP |
| 2659861 | Mar 2019 | EP |
| 1667614 | Apr 2020 | EP |
| S5286296 | Jul 1977 | JP |
| S54137896 | Sep 1979 | JP |
| S62227352 | Oct 1987 | JP |
| S6449571 | Feb 1989 | JP |
| H0447576 | Aug 1992 | JP |
| H04505866 | Oct 1992 | JP |
| H06505187 | Jun 1994 | JP |
| H06343703 | Dec 1994 | JP |
| H07504091 | May 1995 | JP |
| H07505803 | Jun 1995 | JP |
| H07265339 | Oct 1995 | JP |
| H0833715 | Feb 1996 | JP |
| H1049571 | Feb 1998 | JP |
| H10507673 | Jul 1998 | JP |
| 2001000460 | Jan 2001 | JP |
| 2001504016 | Mar 2001 | JP |
| 2001526574 | Dec 2001 | JP |
| 2002525168 | Aug 2002 | JP |
| 2002525169 | Aug 2002 | JP |
| 2002536115 | Oct 2002 | JP |
| 2003515386 | May 2003 | JP |
| 2003518984 | Jun 2003 | JP |
| 2003523262 | Aug 2003 | JP |
| 2003524504 | Aug 2003 | JP |
| 2004504111 | Feb 2004 | JP |
| 2004130068 | Apr 2004 | JP |
| 2004514467 | May 2004 | JP |
| 2004255186 | Sep 2004 | JP |
| 2004267750 | Sep 2004 | JP |
| 2004283461 | Oct 2004 | JP |
| 2005505343 | Feb 2005 | JP |
| 2005118585 | May 2005 | JP |
| 2007521125 | Aug 2007 | JP |
| 2007296375 | Nov 2007 | JP |
| 2007298375 | Nov 2007 | JP |
| 2007534381 | Nov 2007 | JP |
| 2007536003 | Dec 2007 | JP |
| 2008506497 | Mar 2008 | JP |
| 2008514345 | May 2008 | JP |
| 2008535572 | Sep 2008 | JP |
| 2008539985 | Nov 2008 | JP |
| 2008541865 | Nov 2008 | JP |
| 2009034529 | Feb 2009 | JP |
| 2009061293 | Mar 2009 | JP |
| 2009509635 | Mar 2009 | JP |
| 4246433 | Apr 2009 | JP |
| 2009520535 | May 2009 | JP |
| 2009131397 | Jun 2009 | JP |
| 4295460 | Jul 2009 | JP |
| 2009528905 | Aug 2009 | JP |
| 2009534157 | Sep 2009 | JP |
| 2010525896 | Jul 2010 | JP |
| 2010526609 | Aug 2010 | JP |
| 4636794 | Feb 2011 | JP |
| 2011509805 | Mar 2011 | JP |
| 4739223 | Aug 2011 | JP |
| 2012500665 | Jan 2012 | JP |
| 4904362 | Mar 2012 | JP |
| 4912395 | Apr 2012 | JP |
| 2012518446 | Aug 2012 | JP |
| 2013520260 | Jun 2013 | JP |
| 2013521884 | Jun 2013 | JP |
| 2013526388 | Jun 2013 | JP |
| 5341455 | Nov 2013 | JP |
| 2013540495 | Nov 2013 | JP |
| 6144009 | Jun 2017 | JP |
| 6449571 | Jan 2019 | JP |
| WO-8402266 | Jun 1984 | WO |
| WO-9009102 | Aug 1990 | WO |
| WO-9014804 | Dec 1990 | WO |
| WO-9117720 | Nov 1991 | WO |
| WO-9203990 | Mar 1992 | WO |
| WO-9212690 | Aug 1992 | WO |
| WO-9214419 | Sep 1992 | WO |
| WO-9217118 | Oct 1992 | WO |
| WO-9301768 | Feb 1993 | WO |
| WO-9315693 | Aug 1993 | WO |
| WO-9320757 | Oct 1993 | WO |
| WO-9504556 | Feb 1995 | WO |
| WO-9504556 | Apr 1995 | WO |
| WO-9511055 | Apr 1995 | WO |
| WO-9524873 | Sep 1995 | WO |
| WO-9528183 | Oct 1995 | WO |
| WO-9528899 | Nov 1995 | WO |
| WO-9529640 | Nov 1995 | WO |
| WO-9529713 | Nov 1995 | WO |
| WO-9613227 | May 1996 | WO |
| WO-9614032 | May 1996 | WO |
| WO-9624306 | Aug 1996 | WO |
| WO-9630072 | Oct 1996 | WO |
| WO-9632972 | Oct 1996 | WO |
| WO-9635469 | Nov 1996 | WO |
| WO-9639962 | Dec 1996 | WO |
| WO-9639964 | Dec 1996 | WO |
| WO-9639965 | Dec 1996 | WO |
| WO-9640012 | Dec 1996 | WO |
| WO-9713463 | Apr 1997 | WO |
| WO-9713471 | Apr 1997 | WO |
| WO-9724082 | Jul 1997 | WO |
| WO-9727893 | Aug 1997 | WO |
| WO-9727897 | Aug 1997 | WO |
| WO-9727898 | Aug 1997 | WO |
| WO-9728839 | Aug 1997 | WO |
| WO-9732551 | Sep 1997 | WO |
| WO-9732615 | Sep 1997 | WO |
| WO-9743961 | Nov 1997 | WO |
| WO-9748350 | Dec 1997 | WO |
| WO-9803118 | Jan 1998 | WO |
| WO-9806356 | Feb 1998 | WO |
| WO-9808456 | Mar 1998 | WO |
| WO-9810714 | Mar 1998 | WO |
| WO-9811846 | Mar 1998 | WO |
| WO-9814137 | Apr 1998 | WO |
| WO-9816161 | Apr 1998 | WO |
| WO-9819633 | May 1998 | WO |
| WO-9824373 | Jun 1998 | WO |
| WO-9825533 | Jun 1998 | WO |
| WO-9825549 | Jun 1998 | WO |
| WO-9829057 | Jul 1998 | WO |
| WO-9836790 | Aug 1998 | WO |
| WO-9838916 | Sep 1998 | WO |
| WO-9838925 | Sep 1998 | WO |
| WO-9838939 | Sep 1998 | WO |
| WO-9838941 | Sep 1998 | WO |
| WO-9839038 | Sep 1998 | WO |
| WO-9843556 | Oct 1998 | WO |
| WO-9844869 | Oct 1998 | WO |
| WO-9846115 | Oct 1998 | WO |
| WO-9846119 | Oct 1998 | WO |
| WO-9846165 | Oct 1998 | WO |
| WO-9849964 | Nov 1998 | WO |
| WO-9850103 | Nov 1998 | WO |
| WO-9853759 | Dec 1998 | WO |
| WO-9853761 | Dec 1998 | WO |
| WO-9855027 | Dec 1998 | WO |
| WO-9855047 | Dec 1998 | WO |
| WO-9857590 | Dec 1998 | WO |
| WO-9857591 | Dec 1998 | WO |
| WO-9857592 | Dec 1998 | WO |
| WO-9857599 | Dec 1998 | WO |
| WO-9907296 | Feb 1999 | WO |
| WO-9908624 | Feb 1999 | WO |
| WO-9915112 | Apr 1999 | WO |
| WO-9915220 | Apr 1999 | WO |
| WO-9917671 | Apr 1999 | WO |
| WO-9917683 | Apr 1999 | WO |
| WO-9921490 | May 1999 | WO |
| WO-9921510 | May 1999 | WO |
| WO-9922655 | May 1999 | WO |
| WO-9922656 | May 1999 | WO |
| WO-9922658 | May 1999 | WO |
| WO-9925273 | May 1999 | WO |
| WO-9927985 | Jun 1999 | WO |
| WO-9933414 | Jul 1999 | WO |
| WO-9935977 | Jul 1999 | WO |
| WO-9935979 | Jul 1999 | WO |
| WO-9935980 | Jul 1999 | WO |
| WO-9936000 | Jul 1999 | WO |
| WO-9936001 | Jul 1999 | WO |
| WO-9937337 | Jul 1999 | WO |
| WO-9938459 | Aug 1999 | WO |
| WO-9940853 | Aug 1999 | WO |
| WO-9940868 | Aug 1999 | WO |
| WO-9940963 | Aug 1999 | WO |
| WO-9940964 | Aug 1999 | WO |
| WO-9942058 | Aug 1999 | WO |
| WO-9944524 | Sep 1999 | WO |
| WO-9944540 | Sep 1999 | WO |
| WO-9944542 | Sep 1999 | WO |
| WO-9947071 | Sep 1999 | WO |
| WO-9947075 | Sep 1999 | WO |
| WO-9948545 | Sep 1999 | WO |
| WO-9948549 | Sep 1999 | WO |
| WO-9949793 | Oct 1999 | WO |
| WO-9949910 | Oct 1999 | WO |
| WO-9951162 | Oct 1999 | WO |
| WO-9951165 | Oct 1999 | WO |
| WO-9953863 | Oct 1999 | WO |
| WO-9953987 | Oct 1999 | WO |
| WO-9955406 | Nov 1999 | WO |
| WO-9960941 | Dec 1999 | WO |
| WO-9962430 | Dec 1999 | WO |
| WO-9966863 | Dec 1999 | WO |
| WO-0002503 | Jan 2000 | WO |
| WO-0009059 | Feb 2000 | WO |
| WO-0009195 | Feb 2000 | WO |
| WO-0010623 | Mar 2000 | WO |
| WO-0012029 | Mar 2000 | WO |
| WO-0013722 | Mar 2000 | WO |
| WO-0015146 | Mar 2000 | WO |
| WO-0015147 | Mar 2000 | WO |
| WO-0015148 | Mar 2000 | WO |
| WO-0015149 | Mar 2000 | WO |
| WO-0015275 | Mar 2000 | WO |
| WO-0016848 | Mar 2000 | WO |
| WO-0018302 | Apr 2000 | WO |
| WO-0018323 | Apr 2000 | WO |
| WO-0018325 | Apr 2000 | WO |
| WO-0018326 | Apr 2000 | WO |
| WO-0018330 | Apr 2000 | WO |
| WO-0018331 | Apr 2000 | WO |
| WO-0018333 | Apr 2000 | WO |
| WO-0018445 | Apr 2000 | WO |
| WO-0018462 | Apr 2000 | WO |
| WO-0021436 | Apr 2000 | WO |
| WO-0021461 | Apr 2000 | WO |
| WO-0021463 | Apr 2000 | WO |
| WO-0021464 | Apr 2000 | WO |
| WO-0024449 | May 2000 | WO |
| WO-0025702 | May 2000 | WO |
| WO-0028922 | May 2000 | WO |
| WO-0028924 | May 2000 | WO |
| WO-0033725 | Jun 2000 | WO |
| WO-0035376 | Jun 2000 | WO |
| WO-0036997 | Jun 2000 | WO |
| WO-0041632 | Jul 2000 | WO |
| WO-0041633 | Jul 2000 | WO |
| WO-0041652 | Jul 2000 | WO |
| WO-0043051 | Jul 2000 | WO |
| WO-0044211 | Jul 2000 | WO |
| WO-0044308 | Aug 2000 | WO |
| WO-0044311 | Aug 2000 | WO |
| WO-0044313 | Aug 2000 | WO |
| WO-0044331 | Aug 2000 | WO |
| WO-0045711 | Aug 2000 | WO |
| WO-0045874 | Aug 2000 | WO |
| WO-0045886 | Aug 2000 | WO |
| WO-0047136 | Aug 2000 | WO |
| WO-0047139 | Aug 2000 | WO |
| WO-0048531 | Aug 2000 | WO |
| WO-0049952 | Aug 2000 | WO |
| WO-0049954 | Aug 2000 | WO |
| WO-0049956 | Aug 2000 | WO |
| WO-0049970 | Aug 2000 | WO |
| WO-0053122 | Sep 2000 | WO |
| WO-0053125 | Sep 2000 | WO |
| WO-0054660 | Sep 2000 | WO |
| WO-0054661 | Sep 2000 | WO |
| WO-0056224 | Sep 2000 | WO |
| WO-0056225 | Sep 2000 | WO |
| WO-0056387 | Sep 2000 | WO |
| WO-0060995 | Oct 2000 | WO |
| WO-0062714 | Oct 2000 | WO |
| WO-0066007 | Nov 2000 | WO |
| WO-0066009 | Nov 2000 | WO |
| WO-0066035 | Nov 2000 | WO |
| WO-0067661 | Nov 2000 | WO |
| WO-0069345 | Nov 2000 | WO |
| WO-0069367 | Nov 2000 | WO |
| WO-0069504 | Nov 2000 | WO |
| WO-0071195 | Nov 2000 | WO |
| WO-0078226 | Dec 2000 | WO |
| WO-0105331 | Jan 2001 | WO |
| WO-0106959 | Feb 2001 | WO |
| WO-0108566 | Feb 2001 | WO |
| WO-0108596 | Feb 2001 | WO |
| WO-0108602 | Feb 2001 | WO |
| WO-0110209 | Feb 2001 | WO |
| WO-0110320 | Feb 2001 | WO |
| WO-0110340 | Feb 2001 | WO |
| WO-0110341 | Feb 2001 | WO |
| WO-0110343 | Feb 2001 | WO |
| WO-0110347 | Feb 2001 | WO |
| WO-0110348 | Feb 2001 | WO |
| WO-0110349 | Feb 2001 | WO |
| WO-0110350 | Feb 2001 | WO |
| WO-0117440 | Mar 2001 | WO |
| WO-0117456 | Mar 2001 | WO |
| WO-0135864 | May 2001 | WO |
| WO-0135870 | May 2001 | WO |
| WO-0136870 | May 2001 | WO |
| WO-0139700 | Jun 2001 | WO |
| WO-0141679 | Jun 2001 | WO |
| WO-0149185 | Jul 2001 | WO |
| WO-0149187 | Jul 2001 | WO |
| WO-0149213 | Jul 2001 | WO |
| WO-0151104 | Jul 2001 | WO |
| WO-0154625 | Aug 2001 | WO |
| WO-0158503 | Aug 2001 | WO |
| WO-0162189 | Aug 2001 | WO |
| WO-0047139 | Sep 2001 | WO |
| WO-0164137 | Sep 2001 | WO |
| WO-0176510 | Oct 2001 | WO |
| WO-0182837 | Nov 2001 | WO |
| WO-0197715 | Dec 2001 | WO |
| WO-0211647 | Feb 2002 | WO |
| WO-0219926 | Mar 2002 | WO |
| WO-0222054 | Mar 2002 | WO |
| WO-0224118 | Mar 2002 | WO |
| WO-0236048 | May 2002 | WO |
| WO-0241789 | May 2002 | WO |
| WO-0243620 | Jun 2002 | WO |
| WO-0247575 | Jun 2002 | WO |
| WO-0249540 | Jun 2002 | WO |
| WO-02051489 | Jul 2002 | WO |
| WO-02056798 | Jul 2002 | WO |
| WO-02056955 | Jul 2002 | WO |
| WO-02058745 | Aug 2002 | WO |
| WO-02060509 | Aug 2002 | WO |
| WO-02067782 | Sep 2002 | WO |
| WO-02069842 | Sep 2002 | WO |
| WO-02076349 | Oct 2002 | WO |
| WO-02100297 | Dec 2002 | WO |
| WO-02100301 | Dec 2002 | WO |
| WO-02102286 | Dec 2002 | WO |
| WO-03003943 | Jan 2003 | WO |
| WO-03003949 | Jan 2003 | WO |
| WO-03007795 | Jan 2003 | WO |
| WO-03009785 | Feb 2003 | WO |
| WO-03011195 | Feb 2003 | WO |
| WO-03013239 | Feb 2003 | WO |
| WO-03015851 | Feb 2003 | WO |
| WO-03028592 | Apr 2003 | WO |
| WO-03030776 | Apr 2003 | WO |
| WO-03032869 | Apr 2003 | WO |
| WO-03032870 | Apr 2003 | WO |
| WO-03037222 | May 2003 | WO |
| WO-03037227 | May 2003 | WO |
| WO-03047460 | Jun 2003 | WO |
| WO-03047468 | Jun 2003 | WO |
| WO-03047648 | Jun 2003 | WO |
| WO-03051231 | Jun 2003 | WO |
| WO-03063729 | Aug 2003 | WO |
| WO-03079928 | Oct 2003 | WO |
| WO-03079932 | Oct 2003 | WO |
| WO-03079933 | Oct 2003 | WO |
| WO-03088873 | Oct 2003 | WO |
| WO-03015851 | Nov 2003 | WO |
| WO-03063729 | Nov 2003 | WO |
| WO-03092554 | Nov 2003 | WO |
| WO-03094793 | Nov 2003 | WO |
| WO-03094797 | Nov 2003 | WO |
| WO-03096932 | Nov 2003 | WO |
| WO-03096935 | Nov 2003 | WO |
| WO-03101195 | Dec 2003 | WO |
| WO-03103949 | Dec 2003 | WO |
| WO-03003949 | Jan 2004 | WO |
| WO-2004004597 | Jan 2004 | WO |
| WO-2004006803 | Jan 2004 | WO |
| WO-2004006804 | Jan 2004 | WO |
| WO-2004014256 | Feb 2004 | WO |
| WO-2004016200 | Feb 2004 | WO |
| WO-2004016201 | Feb 2004 | WO |
| WO-2004019811 | Mar 2004 | WO |
| WO-2004019817 | Mar 2004 | WO |
| WO-2004019825 | Mar 2004 | WO |
| WO-2004021922 | Mar 2004 | WO |
| WO-2004023980 | Mar 2004 | WO |
| WO-2004019811 | Apr 2004 | WO |
| WO-2004026117 | Apr 2004 | WO |
| WO-2004026173 | Apr 2004 | WO |
| WO-2004028399 | Apr 2004 | WO |
| WO-2004030515 | Apr 2004 | WO |
| WO-2004041126 | May 2004 | WO |
| WO-2004043293 | May 2004 | WO |
| WO-2004043301 | May 2004 | WO |
| WO-2004047681 | Jun 2004 | WO |
| WO-2004058106 | Jul 2004 | WO |
| WO-2004062980 | Jul 2004 | WO |
| WO-2004058106 | Aug 2004 | WO |
| WO-2004064671 | Aug 2004 | WO |
| WO-2004066876 | Aug 2004 | WO |
| WO-2004082527 | Sep 2004 | WO |
| WO-2004082528 | Sep 2004 | WO |
| WO-2004082536 | Sep 2004 | WO |
| WO-2004089250 | Oct 2004 | WO |
| WO-2004089253 | Oct 2004 | WO |
| WO-2004093728 | Nov 2004 | WO |
| WO-2004096100 | Nov 2004 | WO |
| WO-2004103162 | Dec 2004 | WO |
| WO-2004105651 | Dec 2004 | WO |
| WO-2005002466 | Jan 2005 | WO |
| WO-2005004753 | Jan 2005 | WO |
| WO-2005007343 | Jan 2005 | WO |
| WO-2005009285 | Feb 2005 | WO |
| WO-2005011534 | Feb 2005 | WO |
| WO-2005011535 | Feb 2005 | WO |
| WO-2005021063 | Mar 2005 | WO |
| WO-2005023155 | Mar 2005 | WO |
| WO-2005027790 | Mar 2005 | WO |
| WO-2005027797 | Mar 2005 | WO |
| WO-2005032622 | Apr 2005 | WO |
| WO-2005034812 | Apr 2005 | WO |
| WO-2005010215 | May 2005 | WO |
| WO-2005046528 | May 2005 | WO |
| WO-2005046529 | May 2005 | WO |
| WO-2005048883 | Jun 2005 | WO |
| WO-2005062980 | Jul 2005 | WO |
| WO-2005063980 | Jul 2005 | WO |
| WO-2005065585 | Jul 2005 | WO |
| WO-2005065594 | Jul 2005 | WO |
| WO-2005070343 | Aug 2005 | WO |
| WO-2005072654 | Aug 2005 | WO |
| WO-2005076890 | Aug 2005 | WO |
| WO-2005084595 | Sep 2005 | WO |
| WO-2005087140 | Sep 2005 | WO |
| WO-2005096993 | Oct 2005 | WO |
| WO-2005102015 | Nov 2005 | WO |
| WO-2005110240 | Nov 2005 | WO |
| WO-2005112779 | Dec 2005 | WO |
| WO-2006005015 | Jan 2006 | WO |
| WO-2006009690 | Jan 2006 | WO |
| WO-2006026371 | Mar 2006 | WO |
| WO-2006027499 | Mar 2006 | WO |
| WO-2005062980 | May 2006 | WO |
| WO-2006058163 | Jun 2006 | WO |
| WO-2006065949 | Jun 2006 | WO |
| WO-2006066327 | Jun 2006 | WO |
| WO-2006068944 | Jun 2006 | WO |
| WO-2006070372 | Jul 2006 | WO |
| WO-2006076890 | Jul 2006 | WO |
| WO-2006083763 | Aug 2006 | WO |
| WO-2006086135 | Aug 2006 | WO |
| WO-2006086736 | Aug 2006 | WO |
| WO-2006089517 | Aug 2006 | WO |
| WO-2006093795 | Sep 2006 | WO |
| WO-2006102063 | Sep 2006 | WO |
| WO-2006108090 | Oct 2006 | WO |
| WO-2006118766 | Nov 2006 | WO |
| WO-2006124649 | Nov 2006 | WO |
| WO-2006127756 | Nov 2006 | WO |
| WO-2006127765 | Nov 2006 | WO |
| WO-2006129441 | Dec 2006 | WO |
| WO-2006132948 | Dec 2006 | WO |
| WO-2006133959 | Dec 2006 | WO |
| WO-2006138173 | Dec 2006 | WO |
| WO-2006138391 | Dec 2006 | WO |
| WO-2007009117 | Jan 2007 | WO |
| WO-2007009609 | Jan 2007 | WO |
| WO-2007013999 | Feb 2007 | WO |
| WO-2007033093 | Mar 2007 | WO |
| WO-2007035471 | Mar 2007 | WO |
| WO-2005102015 | Apr 2007 | WO |
| WO-2006138391 | Apr 2007 | WO |
| WO-2007044285 | Apr 2007 | WO |
| WO-2007047488 | Apr 2007 | WO |
| WO-2007047945 | Apr 2007 | WO |
| WO-2007048529 | May 2007 | WO |
| WO-2007051620 | May 2007 | WO |
| WO-2007053243 | May 2007 | WO |
| WO-2007058847 | May 2007 | WO |
| WO-2007059252 | May 2007 | WO |
| WO-2006086736 | Jun 2007 | WO |
| WO-2007071436 | Jun 2007 | WO |
| WO-2007092354 | Aug 2007 | WO |
| WO-2007097983 | Aug 2007 | WO |
| WO-2007098232 | Aug 2007 | WO |
| WO-2007053243 | Sep 2007 | WO |
| WO-2007120543 | Oct 2007 | WO |
| WO-2007071436 | Nov 2007 | WO |
| WO-2007123658 | Nov 2007 | WO |
| WO-2007123956 | Nov 2007 | WO |
| WO-2007033093 | Jan 2008 | WO |
| WO-2007071436 | Jan 2008 | WO |
| WO-2008028569 | Mar 2008 | WO |
| WO-2008031103 | Mar 2008 | WO |
| WO-2008035337 | Mar 2008 | WO |
| WO-2008040555 | Apr 2008 | WO |
| WO-2008045949 | Apr 2008 | WO |
| WO-2008047354 | Apr 2008 | WO |
| WO-2008051554 | May 2008 | WO |
| WO-2008070442 | Jun 2008 | WO |
| WO-2008070797 | Jun 2008 | WO |
| WO-2008079962 | Jul 2008 | WO |
| WO-2008098191 | Aug 2008 | WO |
| WO-2008100599 | Aug 2008 | WO |
| WO-2008101083 | Aug 2008 | WO |
| WO-2008125153 | Oct 2008 | WO |
| WO-2008137603 | Nov 2008 | WO |
| WO-2008138584 | Nov 2008 | WO |
| WO-2008150529 | Dec 2008 | WO |
| WO-2009002548 | Dec 2008 | WO |
| WO-2009024859 | Feb 2009 | WO |
| WO-2009029199 | Mar 2009 | WO |
| WO-2009042196 | Apr 2009 | WO |
| WO-2009045334 | Apr 2009 | WO |
| WO-2009045338 | Apr 2009 | WO |
| WO-2009053497 | Apr 2009 | WO |
| WO-2009054397 | Apr 2009 | WO |
| WO-2007044285 | May 2009 | WO |
| WO-2009061389 | May 2009 | WO |
| WO-2009085206 | Jul 2009 | WO |
| WO-2009091509 | Jul 2009 | WO |
| WO-2009094188 | Jul 2009 | WO |
| WO-2009094501 | Jul 2009 | WO |
| WO-2009100198 | Aug 2009 | WO |
| WO-2009106545 | Sep 2009 | WO |
| WO-2009108615 | Sep 2009 | WO |
| WO-2009111241 | Sep 2009 | WO |
| WO-2009149462 | Dec 2009 | WO |
| WO-2009155561 | Dec 2009 | WO |
| WO-2010022138 | Feb 2010 | WO |
| WO-2010042950 | Apr 2010 | WO |
| WO-2010043950 | Apr 2010 | WO |
| WO-2010044851 | Apr 2010 | WO |
| WO-2010045238 | Apr 2010 | WO |
| WO-2010045297 | Apr 2010 | WO |
| WO-2010049160 | May 2010 | WO |
| WO-2010083558 | Jul 2010 | WO |
| WO-2010086460 | Aug 2010 | WO |
| WO-2010098857 | Sep 2010 | WO |
| WO-2010104638 | Sep 2010 | WO |
| WO-2010045238 | Oct 2010 | WO |
| WO-2010141626 | Dec 2010 | WO |
| WO-2011008812 | Jan 2011 | WO |
| WO-2011008853 | Jan 2011 | WO |
| WO-2011051043 | May 2011 | WO |
| WO-2011057087 | May 2011 | WO |
| WO-2011060386 | May 2011 | WO |
| WO-2011102968 | Aug 2011 | WO |
| WO-2011104269 | Sep 2011 | WO |
| WO-2011120050 | Sep 2011 | WO |
| WO-2011133368 | Oct 2011 | WO |
| WO-2011144351 | Nov 2011 | WO |
| WO-2011147849 | Dec 2011 | WO |
| WO-2012002228 | Jan 2012 | WO |
| WO-2012023980 | Feb 2012 | WO |
| WO-2012036742 | Mar 2012 | WO |
| WO-2012038550 | Mar 2012 | WO |
| WO-2012039748 | Mar 2012 | WO |
| WO-2012082952 | Jun 2012 | WO |
| WO-2012106491 | Aug 2012 | WO |
| WO-2012116368 | Aug 2012 | WO |
| WO-2012142189 | Oct 2012 | WO |
| WO-2012145546 | Oct 2012 | WO |
| WO-2012162228 | Nov 2012 | WO |
| WO-2013009975 | Jan 2013 | WO |
| WO-2013028387 | Feb 2013 | WO |
| WO-2013033791 | Mar 2013 | WO |
| WO-2013074671 | May 2013 | WO |
| WO-2013096545 | Jun 2013 | WO |
| WO-2013134214 | Sep 2013 | WO |
| WO-2014056644 | Apr 2014 | WO |
| WO-2014072439 | May 2014 | WO |
| WO-2014072439 | Jul 2014 | WO |
| WO-2015028209 | Mar 2015 | WO |
| WO-2016093877 | Jun 2016 | WO |
| WO-2016126511 | Aug 2016 | WO |
| Entry |
|---|
| US 6,331,185 B1, 12/2001, Gambale et al. (withdrawn) |
| US 8,062,356 B2, 11/2011, Salahieh et al. (withdrawn) |
| US 8,062,357 B2, 11/2011, Salahieh et al. (withdrawn) |
| US 8,075,614 B2, 12/2011, Salahieh et al. (withdrawn) |
| US 8,133,271 B2, 03/2012, Salahieh et al. (withdrawn) |
| US 8,211,170 B2, 07/2012, Paul et al. (withdrawn) |
| Ahmed, et al., Silent left coronary artery-cameral fistula: probable cause of myocardial ischemia, American Heart Journal, vol. 104, No. 4, Part 1, pp. 869-870 (Oct. 1982). |
| Akins C.W., et al., “Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses,” The Annals of Thoracic Surgery, 65:545-1552 (Jan. 1998). Retreived from the Internet: URL: http://ats.ctsnetjournals.org/cgi/contenUfull/65/6/1545 (Jan. 1998). |
| Allen et al., “What are the characteristics of the ideal endovascular graft for abdominal aortic aneurysm exclusion?”, J. Endovasc. Surg., vol. 4(2), May 1997, pp. 195-202. |
| Anabtawi I.N., et al., “Experimental evaluation of myocardial tunnelization as a method of myocardial revascularization,” Journal of Thoracic and Cardiovascular Surgery, 58(5):638-646 (Nov. 1969). |
| Andersen et al., “Transluminal implantation of artificial heart valves, Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs,” Euro. Heart J., vol. 13, May 1992, pp. 704-708. |
| “Aortenklappenbioprothese erfolgreich in der Entwicklung,” May 16, 2003, 1 page (with English Translation). |
| Archie J.P., et al., “Intramyocardial Pressure: Effect of Preload on Transmural Distribution of Systolic Coronary Blood Flow,” The American Journal of Cardiology, 35(6):904-911 (Jun. 1975). |
| Baba H., et al., “Hemodynamic effects of venous valves in aorta-coronary bypass grafts,” The Journal of Thoracic and Cardiovascular Surgery, 71(5):774-778 (May 1976). |
| Block et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, 7(2):108-113 ( Mar. 2005). |
| Blum et al., “Endoluminal Stent—Grafts for Intrarenal Abdominal Aortic Aneurysms.” New Engl. J. Med., 336:13-20 (Jan. 1997). |
| Bonhoeffer et al., “Percutaneous Insertion of the Pulmonary Valve,” J. Am. Coll. Cardiol., vol. 39, May 15, 2002, pp. 1664-1669. |
| Bonhoeffer et al., “Percutaneous Mitral Valve Dilatation with the Multi-Track System,” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiograhy & Interventions, United States (Oct. 1999), pp. 178-183. |
| Bonhoeffer et al., “Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary-artery prosthetic conduit with valve dysfunction”, The Lancet, Oct. 21, 2000, vol. 356, pp. 1403-1405. |
| Bonhoeffer et al., “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation, vol. 102, Aug. 15, 2000, pp. 813-816. |
| Bonhoeffer P., et al., “Technique and Results of Percutaneous Mitral Valvuloplasty With the Multi-Track System,” Journal of Interventional Cadiology, 13(4):263-268 (Aug. 2000). |
| Boudjemline et al., “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal, vol. 22, p. 630, Abstract Only (Sep. 2001). |
| Boudjemline et al., “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study.” Med Sci. Monit., 8:4:BR113-116 (Apr. 2002). |
| Boudjemline et al., “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs.” Euro. Heart J., Jul. 2002, 23, pp. 1045-1049. |
| Boudjemline et al., “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study.” Journal of the American College of Cardiology, 43(6):1082-1087 (Mar. 2004). |
| Boudjemline et al., “Percutaneous Valve Insertion: A New Approach?”, J. of Thoracic and Cardio. Surg, 125(3): 741-743, Mar. 2003. |
| Boudjemline et al., “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal, vol. 22, p. 355, Abstract Only (Sep. 2001). |
| Boudjemline et al., “Steps Toward Percutaneous Aortic Valve Replacement.” Circulation, Feb. 12, 2002, vol. 105, pp. 775-778. |
| Boudjemline et al., “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology, 14:89-93, (Nov. 2001). |
| Boudjemline Y., et al., “Images in Cardiovascular Medicine, Percutaneous Aortic Valve Replacement in Animals,” Circulation, vol. 109: e161, United States, Mar. 16, 2004, 1 page. |
| Boudjemline Y., et al., “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research, Poland, Mar. 2004, pp. BR61-BR66. |
| Boudjemline Y., et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery, United States, vol. 129, No. 4, Apr. 2005, pp. 831-837. |
| Boudjemline Y., et al., “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart, British Cardiac Society, England, Dec. 2001, pp. 705-706. |
| Boudjemline Y., et al., “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young, England, Jun. 2003, pp. 308-311. |
| Bruce C.J., et al., “Right-sided Valve Disease Deserves Little More Respect,” Circulation, 119(2):2726-2734 (May 2009). |
| Coats L., et al., “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery, vol. 27, England, Apr. 2005, pp. 536-543. |
| Commeau P et al., “Percutaneous Balloon Dilatation of calcific aortic Valve Stenosis: Anatomical and Haemodynamic Evaluation,” British Heart Journal, 59:227-238 (Feb. 1988). |
| Cribier et al., “Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenosis”, J. of Am. Coll. of Cardio, Feb. 18, 2004, 43(4), pp. 698-703. |
| Cribier et al., “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case”, Circulation, 106(24):3006-3008 (Dec. 2002). |
| Cribier et al., “Percutaneous Transluminal Valvuloplasty of Acquired Aortic Stenosis in Elderly Patients: An Alternative to Valve Replacement?”, The Lancet, Jan. 11, 1986, pp. 63-67. |
| Cunanan et al., “Tissue Characterization and Calcification Potential of Commercial Bioprosthetic Heart Valves.” Ann. Thorac. Surg., May 15, 2001, pp. S417-S421. |
| Cunliffe et al., “Glutaraldehyde Inactivation of Exotic Animal Viruses in Swine Heart Tissue,” Applied and Environmental Microbiology, Greenport, New York, vol. 37, No. 5, May 1979, pp. 1044-1046. |
| Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms.” New Engl. J. of Med., 331(26):1729-34 (Dec. 1994). |
| Dalby et al., “Non-Surgical Aortic Valve Replacement” Br. J. Cardiol., 10(6):450-452 (Nov. 2003). |
| Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15:123-129 (Jan. 2006). |
| Dewey et al., “Transapical aortic valve implantation: An Animal Feasibility Study”, The annals of thoracic surgery, 82:110-116 (Feb. 2006). |
| Dhasmana et al., “Factors Associated With Periprosthetic Leakage Following Primary Mitral Valve Replacement: With Special Consideration of Suture Technique.” Annals of Thorac. Surg., (Feb. 1983), 35(2), pp. 170-178. |
| Dotter, “Transluminally-Placed Coilspring Endarterial Tube Grafts,” Investigative Radiology, pp. 329-332 (Oct. 1969). |
| Emery et al., “Replacement of the Aortic Valve in Patients Under 50 Years of Age: Long-Term Follow-Up of the St. Jude Medical Prosthesis.” Ann. Thorac. Surg., 75:1815-1819 (Jun. 2003). |
| European Search Report dated Aug. 10, 2011 for EP Application No. 06824992.9. |
| European Search Report for EP Patent Appl. Serial No. 12179049.7 (1257), dated Oct. 30, 2012, 4 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179075.2 (1257), dated Oct. 29, 2012, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179141.2 (1257), dated Nov. 2, 2012, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179146.1 (1257), dated Nov. 7, 2012, 8 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179330.1 (1257), dated Nov. 22, 2012, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179338.4 (1257), dated Nov. 2, 2012, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179339.2 (1257), dated Oct. 29, 2012, 4 pages. |
| European Search Report for EP Patent Appl. Serial No. 12179914.2 (1257), dated Nov. 7, 2012, 6 pages. |
| European Search Report for EP Patent Appl. Serial No. 13150337.7 (1257), dated Jul. 9, 2013, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 13183134.9 (1651), dated Nov. 19, 2013, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 14159630.4 (1651), dated May 22, 2014, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 14161991.6 (1651), dated Jun. 3, 2014, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 15167832.3 (1651), dated Jul. 23, 2015, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 15167847.1 (1651), dated Jul. 23, 2015, 3 pages. |
| European Search Report for EP Patent Appl. Serial No. 17196833.2, dated Mar. 6, 2018, 4 pages. |
| European Search Report for EP Patent Appl. Serial No. 18164490.7, dated Sep. 17, 2018 5 pages. |
| European Search Report from EP Patent Office for EP Application No. 15177718.2, dated Jan. 18, 2016, 4 pages. |
| European Search Report from EP Patent Office for EP Application No. 15177731.5, dated Apr. 14, 2016, 4 pages. |
| European Search Report from EP Patent Office for EP Application No. 16151726.3, dated Feb. 25, 2016, 4 pages. |
| Extended European Search Report dated Apr. 11, 2008 in EP Patent Appl. Serial No. 081630410, 5 pages. |
| Extended EP Search Report dated Sep. 24, 2020 in EP Patent Appl. Serial No. 20165841.6 (JVT-0280). |
| Extended European Search Report for Application No. 10183946.2.4-2320 dated Feb. 14, 2012, 7 pages. |
| Extended European Search Report dated Aug. 9, 2018 in EP Patent Appl. Serial No. 18158901.1 (1113). |
| Extended European Search Report dated Jun. 12, 2018 in EP Patent Appl. Serial No. 17209326.2 (1113). |
| Extended European Search Report dated May 16, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257). |
| Extended European Search Report for Application No. 11178076.3-1257 dated Feb. 29, 2012, 5 pages. |
| Extended European Search Report from EP Patent Office for EP Application No. 17162616.1, dated Jul. 27, 2017, 7 pages. |
| Extended European Search Report dated Apr. 9, 2014 in EP Patent Appl. Serial No. 14164683.6. |
| Extended European Search Report dated May 9, 2013 in EP Patent Appl. Serial No. 130178309.4,4 pages. |
| Extended European Search Report dated Aug. 19, 2011 in EP Patent Appl. Serial No. 07827132.7. |
| Extended European Search Report dated Feb. 27, 2017 in EP Patent Appl. Serial No. 16186773,6 pages. |
| Extended European Search Report dated Sep. 29, 2014 in EP Patent Appl. Serial No. 14164680, 5 pages. |
| Extended European Search Report for Application No. 07116242.4-2310 dated Mar. 31, 2008, 10 pages. |
| Extended European Search Report for Application No. 09154935.2, dated May 29, 2009, 7 pages. |
| Extended European Search Report for Application No. 10012198 dated Mar. 23, 2011, 7 pages. |
| Extended European Search Report for Application No. 10168525.3-1257 dated Feb. 3, 2011, 13 pages. |
| Extended European Search Report for Application No. 11153142.2-1257 dated Aug. 3, 2011, 10 pages. |
| Extended European Search Report for Application No. 11165093.3-1257 dated Aug. 30, 2011, 6 pages. |
| Extended European Search Report for Application No. 11178073.0-1257 dated Oct. 14, 2011, 5 pages. |
| Extended European Search Report for Application No. 11178145.6-1257 dated Feb. 29, 2012, 5 pages. |
| Extended European Search Report for Application No. 13188858.8-1651 dated Jan. 13, 2014, 6 pages. |
| Extended European Search Report for Application No. 19195062 dated Jan. 2, 2020, 7 pages. |
| ExtendedEuropean Search Report for EP Patent Appl. Serial No. 06827630.2 dated Jun. 7, 2010, 5 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 07110318.8, dated May 29, 2008, 10 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Mar. 22, 2011, 9 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 10184842.2, dated Mar. 23, 2011, 7 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 11162971.3, dated Jun. 30, 2011, 5 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 13163918.9, dated Jul. 24, 2013, 8 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 14179639.1, dated Mar. 9, 2015, 7 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 16201320.5, dated May 19, 2017, 6 pages. |
| Extended European Search Report for EP Patent Appl. Serial No. 18200191.7, dated May 6, 2019, 8 pages. |
| Ferrari, “Entwicklung eines Verfahrens zum transvaskularen Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultat der Friedrich-Schiller-Universitat Jena, Sep. 2003, pp. 1-159. (With English Translation). |
| Ferrari, “Entwicklung eines Verfahrens zum transvaskulären Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultät der Friedrich-Schiller-Universität Jena, Sep. 2003, pp. 49-52. (With English Translation). |
| Ferrari et al., “Percutaneous Transvascular Aortic Valve Replacement with Self-Expanding Stent-Valve Device.” Poster from the presentation given at SMIT 2000, 12th International Conference, Sep. 5, 2000. |
| Ferrari M.W., “Transarterial Aortic Valve Replacement with a Self Expanding Stent in Pigs,” Heart, vol. 90, No. 11, doi:10.1136/hrt.2003.028951, ISSN 1355-6037, XP055137208, Nov. 2004, pp. 1326-1331. |
| Filsoufi F., et al., “Long-term Outcomes of Tricuspid Valve Replacement in the Current Era,” Ann. Thorac. Surg., 8(3):845-850 (Sep. 2005). |
| Fluency Vascular Stent Graft Instructions for Use, May 2014, 20 pages. |
| Greeenberg, “Abdominal Aortic Endografting: Fixation and Sealing.” J. Am. Coll. Surg., 194(1):S79-S87 (Jan. 2002). |
| Grossi A.E. et al., “Impact of Minimally Invasive Valvular Heart Surgery: A Case-Control Study”, Ann. Thorac. Surg., 71:807-810 (Mar. 2001). |
| Gummert J.F. et al., Cardiac Surgery in Germany During 2006: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery, Thorac. Cardiov. Surg., vol. 55, (Sep. 2007), pp. 343-350. |
| Gummert J.F. et al., “Cardiac Surgery in Germany During 2007: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 56, (Sep. 2008), pp. 328-336. |
| Hanzel et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards.TM. percutaneous heart valve,” Eurolntervention Supplements I (Supplement A):A3-A8 (May 19, 2006). |
| Heinrich R.S., et al., “Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery”, Ann Biomed Eng., Nov.-Dec. 1996, vol. 24(6), pp. 685-694. |
| Hijazi Z.M., “Transcatheter Valve Replacement: A New Era of Percutaneous Cardiac Intervention Begins”, J. of Am. College of Cardio., Nov. 6, 2004, vol. 43, No. 6, pp. 1088-1089. |
| Hourihan M., et al., “Transcatheter Umbrella Closure of Valvular and Paravalvular Leaks”, JACC, Boston, Massachusetts, 20(6):1371-1377 (Nov. 1992). |
| Huber C.H., et al., “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” European Journal of Cardio-thoracic Surgery, vol. 29, Jan. 19, 2006, pp. 380-385. |
| Huber H.C., et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal of the American College of Cardiology, vol. 46, No. 2, Jul. 19, 2005, pp. 366-370. |
| Huber H.C., et al., “Do Valved Stents Compromise Coronary Flow?”, European Journal of Cardio-thoracic Surgery, Jan. 23, 2004, vol. 25; pp. 754-759. |
| Ing F., “Stents: What's Available to the Pediatric Interventional Cardiologist?” Catheterization and Cardiovascular Interventions, 57:374-386 (Jun. 2002). |
| International Search Report dated Dec. 29, 2003 in Intl PCT Patent Appl. U.S. Appl. No. PCT/DE2003/002669. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2009/052230 dated Jun. 29, 2009, 12 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2010/052429 dated Jun. 14, 2010, 12 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2011/002524 dated Apr. 23, 2012, 15 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2011/052674 dated Jul. 5, 2011, 12 pages. |
| International Search Report for PCT Application No. PCT/US1999/020736 dated Jan. 28, 2000, 3 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2009/050762 dated Jun. 23, 2009, 12 pages. |
| International Search Report & Written Opinion dated Jul. 18, 2016 for PCT Patent Appl No. PCT/EP2016/059839, 10 pages. |
| International Search Report and Written Opinion for Appl. No. PCT/EP2016/055783, dated May 30, 2016, 15 pages. |
| International Search Report and Written Opinion for Application No. PCT/EP2013/057431 dated Jul. 26, 2013, 9 pages. |
| International Search Report and Written Opinion for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 11 pages. |
| International Search Report and Written Opinion for International Application No. PCT/EP2010/063306, dated Nov. 17, 2010, 9 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/EP2006/010519 dated Mar. 1, 2007, 13 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US06/36286 dated Jul. 9, 2007, 4 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2004/041513 dated Jun. 10, 2005, 4 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2004/043607 dated Mar. 20, 2006, 4 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2005/020947 dated Oct. 6, 2005, 5 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2006/038352 dated May 19, 2008, 4 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2006/043484 dated Jun. 25, 2008, 4 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2007/003992 dated Jan. 10, 2008, 5 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2007/02970 dated Oct. 19, 2007, 7 pages. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2009/060531 dated May 13, 2010, 6 pages. |
| International Search Report and Written Opinion for PCT/DE2006/000056 dated Jun. 7, 2006, 11 pages. |
| International Search Report and Written Opinion for PCT/EP2007/061117 dated May 20, 2008, 16 pages. |
| International Search Report and Written Opinion for PCT/EP2008/003803 dated Aug. 20, 2008, 10 pages. |
| International Search Report and Written Opinion for PCT/EP2009/055958 dated Oct. 21, 2009, 8 pages. |
| International Search Report and Written Opinion for PCT/EP2010/056558 dated Oct. 7, 2010, 14 pages. |
| International Search Report and Written Opinion for PCT/EP2012/067617 dated Dec. 19, 2012, 10 pages. |
| International Search Report and Written Opinion for PCT/IL2007/001149 dated May 1, 2008, 4 pages. |
| International Search Report and Written Opinion for PCT/US2011/027730 dated May 25, 2011, 9 pages. |
| International Search Report and Written Opinion of the International Search Authority for International Application No. PCT/EP2008/064558, date of completion of report is Mar. 18, 2009, 14 pages. |
| International Search Report for Application No. PCT/DE2001/000837, dated Aug. 7, 2001, 4 pages. |
| International Search Report for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 5 pages. |
| International Search Report for Application No. PCT/EP2010/057798, dated Sep. 12, 2010, 6 pages. |
| International Search Report for Application No. PCT/EP2011/058506, dated Nov. 3, 2011, 4 pages. |
| International Search Report for Application No. PCT/EP2011/066677, dated Feb. 17, 2012, 7 pages. |
| International Search Report for Application No. PCT/EP2012/067617 dated Dec. 19, 2012, 3 pages. |
| International Search Report for Application No. PCT/EP2012/067714 dated Dec. 18, 2012, 3 pages. |
| International Search Report for Application No. PCT/EP2013/073318, dated Apr. 17, 2014, 5 pages. |
| International Search Report for Application No. PCT/EP2014/065817, dated Jan. 7, 2015, 6 pages. |
| International Search Report for Application No. PCT/EP2016/055783, dated May 30, 2016, 5 pages. |
| International Search Report for Application No. PCT/EP2016/058532, dated Jul. 11, 2016, 4 pages. |
| International Search Report for Application No. PCT/IB2008/002180, dated Apr. 15, 2009, 7 pages. |
| International Search Report for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 3 pages. |
| International Search Report for PCT/DE2001/000836 dated Jun. 13, 2001, 6 pages. |
| International Search Report for PCT/EP2006/010023 dated Mar. 30, 2007, 6 pages. |
| International Search Report for PCT/EP2007/007413, dated Jan. 28, 2008, 4 pages. |
| International Search Report for PCT/IB2017/052718, dated Sep. 5, 2017, 4 pages. |
| Kato et al., “Traumatic Thoracic Aortic Aneurysm: Treatment with Endovascular Stent-Grafts.” Radiol., 205:657-662 (Dec. 1997). |
| Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548. |
| Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408. |
| Klein A.L., et al., “Age-related Prevalence of Valvular Regurgitation in Normal Subjects: A Comprehensive Color Flow Examination of 118 Volunteers,” Journal of the American Society of Echocardiography, vol. 3, No. 1, (Jan. 1990), pp. 54-63. |
| Knudsen et al., “Catheter-implanted prosthetic heart valves”, Intl J. of Art. Organs, 16(5): 253-262, May 1993. |
| Kort et al., “Minimally Invasive Aortic Valve Replacement: Echocardiographic and Clinical Results.” Am. Heart J., Sep. 2001, vol. 142(3), pp. 476-481. |
| Kuzela L., et al., “Experimental evaluation of direct transventricular revascularization,” Journal of Thoracic and Cardiovascular Surgery, 57(6):770-773 (Jun. 1969). |
| Laborde et al., “Percutaneous Implantation of the Corevalve Aortic Valve Prosthesis for Patients Presenting High Risk for Surgical Valve Replacement,” EuroIntervention, 1(4):472-474 (Feb. 2006). |
| Lary B.G., et al., “A method for creating a coronary-myocardial artery,” Surgery, 59(6):1061-1064 (Jun. 1966). |
| Lawrence et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Radiology, May 1987, vol. 163(2), pp. 357-360. |
| Levi et al., “Future of Interventional Cardiology in Pediactrics.” Current Opinion in Cardiol., 18:79-90 (Mar. 2003). |
| Levy, “Mycobacterium chelonei Infection of Porcine Heart Valves.” The New England Journal of Medicine, Washington DC, 297(12), Sep. 22, 1977, pp. 667-668. |
| Lichtenstein et al., “Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience”, circulation, American Heart Association vol. 114, Jul. 31, 2006, pp. 591-596. |
| Lichtenstein, S.V., “Closed heart surgery: Back to the future” The Journal of Thoracic and Cardiovascular Surgery, vol. 131(5), May 2006, pp. 941-943. |
| Liu et al., “Effect of Fiber Orientation on the Stress Distribution within a Leaflet of a Polymer Composite Heart Valve in be Closed Position”, Journal of Biomechanics, 4:1099-1106 (Jan. 2007). |
| Lonescu et al., “Prevalence and Clinical Significance of Incidental Paraprosthetic Valvar Regurgitation: A prospective study using transesophageal echocardiography.” Heart, 89:1316-21 (Oct. 2003). |
| Love S.C. et al., The Autogenous Tissue Heart Valve: Current Status, Journal of Cardiac Surgery, Mar. 1991, vol. 6(4), pp. 499-507. |
| Lutter et al., “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation.” J. of Thoracic and Cardio. Surg., Apr. 2002, vol. 123(4), pp. 768-776. |
| Lutter et al., “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery, Netherlands Dec. 2004, pp. 2199-2206. |
| Ma L., et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, vol. 28, No. 2, Jun. 13, 2005, pp. 194-198. |
| Mack, M.J., “Minimally invasive cardiac surgery”, Surg Endosc, 20:S488-S492 (Mar. 2006). |
| Magovern et al., “Twenty-five-Year Review of the Magovern-Cromie Sutureless Aortic Valve”, Ann. Thorac. Surg., 48:S33-S334 (Jan. 1989). |
| Maraj et al., Evaluation of Hemolysis in Patients with Prosthetic Heart Valves, Clin. Cardiol. 21:387-392 (Jun. 1998). |
| Marcus RH et al., “Assessment of small-diameter aortic mechanical prostheses: physiological relevance of the Doppler gradient, utility of flow augmentation, and limitations of orifice area estimation,” Circulation, 98(9):866-872 (Sep. 1998). |
| McKay G. R. et al., “The Mansfield Scientific Aortic Valvuloplasty Registry: Overview of Acute Hemodynamic Results and Procedural Complications.” J. Am. Coll. Cardiol., 17(2):485-491 (Feb. 1991). |
| Mills N.L., et al., “Valvulotomy of valves in the saphenous vein graft before coronary artery bypass,” The Journal of Thoracic and Cardiovascular Surgery, 71(6):878-879 (Jun. 1976). |
| Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study”, Radiology, 170:1033-1037 (Mar. 1989). |
| Moazami N et al. “Transluminal Aortic Valve Placement: a Fesibility Study with a Newly Designed Collapsible Aortic Valve”, ASAIO Journal, vol. 42, No. 2, Mar.-Apr. 1996. |
| Moulopoulos et al., “Catheter-Mounted Aortic Valves,” Annals of Thoracic Surg., vol. 11, No. 5, May 1971, pp. 423-430. |
| Munro I., et al., “The possibility of myocardial revascularization by creation of a left ventriculocoronary artery fistula,” The Journal of Thoracic and Cardiovascular Surgery, 58(1):25-32 (Jul. 1969). |
| Nath J., et al., Impact of Tricuspid Regurgitation on Long-term Survival, Journal of the American College of Cardiology, 43(3):405-406 (Feb. 2004). |
| Nietlispach F., et al., “Current Balloon-Expandable Transcatheter Heart Valve and Delivery Systems”, Catheterization and Cardiovascular Interventions, 75:295-300 (Sep. 2009). |
| Palacios., “Percutaneous Valve Replacement and Repair, Fiction or Reality?,” Journal of American College of Cardiology, 44(8):1662-1663 (Oct. 2004). |
| Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents: Early Experience in the Dog,” American Journal of Roentgenology, 145 (4):821-825 (Oct. 1985). |
| Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents in Dogs with Chronic Portal Hypertension,” American Journal of Roentgenology, 147(6):1251-1254 (Dec. 1986). |
| Paniagua et al., “Percutaneous Heart Valve in the Chronic in Vitro Testing Model.” Circulation, Sep. 17, 2002, vol. 106: e51-e52. |
| Parodi J.C., et al., “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms”, Ann. Vasc. Surg., 5(6):491-499 (Nov. 1991). |
| Partial European Search Report dated Feb. 28, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257). |
| Partial European Search Report for Application No. 10168525.3-269 dated Sep. 20, 2010, 5 pages. |
| Partial European Search Report for Application No. 07116242.4-2310 dated Jan. 14, 2008, 5 pages. |
| Partial European Search Report for Application No. 11153142.2-1257 dated Apr. 4, 2011, 5 pages. |
| Partial European Search Report for EP Patent Appl. Serial No. 07110318.8, dated Mar. 10, 2008, 6 pages. |
| Partial European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Nov. 2, 2010, 6 pages. |
| Partial International Search Report for International Application No. PCT/EP2014/055044, filed Mar. 13, 2014, 7 pages. |
| Pavcnik D., et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement.” Radiology, 183:151-154 (Apr. 1992). |
| Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Technol, 9(3/4):287-292 (Jan. 2000). |
| Pavcnik et al., “Percutaneous Bioprosthetic Venous Valve: A Long-term Study in Sheep,” Jounal of Vascular Surg., vol. 35, No. 3, Mar. 2002, pp. 598-603. |
| Pawelec-Wojtalk M., “Closure of left ventricle perforation with the use of muscular VSD occluder,” European Journal of Cardia-Thoracic Surgery, 27(4):714-716 (Apr. 2005). |
| Pelton A.R., et al., “Medical Uses of Nitinol”, Materials Science Forum, 327-328:63-70 (Jan. 2000). |
| Phillips et al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic Insufficiency”, Annals of Thoracic Surg., Feb. 1976, 21(2), pp. 134-136. |
| Phillips S.J., et al., “Improvement in Forward Coronary Blood Flow by Using a Reversed Saphenous Vein with a Competent Valve,” The Annals of Thoracic Surgery, vol. 21 (1), Jan. 1976, pp. 12-15. |
| Preliminary Search Report (Rapport De Recherche Preliminaire) dated Jul. 10, 2002 in French Patent Application No. 0110444 (2 pages). |
| Raillat et al., “Treatment of Iliac Artery Stenosis with the Wallstent Endoprosthesis.” AJR, Mar. 1990, vol. 154(3), pp. 613-616. |
| Remadi et al., “Preliminary results of 130 aortic valve replacements with a new mechanical bileaflet prosthesis: The Edwards MIRA valve,” Interactive Cardiovasc. and Thorac. Surg., 2:80-83 (Mar. 2003). |
| Rogers J.H., et al., “The Tricuspid Valve: Current Perspective and Evolving Management of Tricuspid Regurgitation,” Circulation, 119(20):2718-2725 (May 2009). |
| Ruiz C.E.,“Transcatheter Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, 26(3):289-294 (Jun. 2005). |
| Schurink et al., “Stent Attachment Site—related Endoleakage after Stent Graft Treatment: An in vitro study of the effects of graft size, stent type, and atherosclerotic wall changes”, J. Vasc. Surg., vol. 30(4), Oct. 1999, pp. 658-667. |
| Search Report dated Oct. 15, 2003 from the European Patent Office for European Patent Application No. EP 02291953.4, 2 pages. |
| Search Report from the European Patent Office for European Patent Application No. EP 02291954.4, 4 pages. |
| Sochman et al., “Percutaneous Transcatheter Aortic Disc Valve Prosthesis Implantation: A Feasibility Study.” Cardiovasc. Intervent. Radiol., Sep. 2000, 23: 384-388. |
| Stanley et al., “Evaluation of Patient Selection Guidelines for Endoluminal AAA Repair With the Zenith Stent Graft: The Australasian Experience.” J. Endovasc. Ther., 8:457-464 (Oct. 2001). |
| Stassano., “Mid-term Results of the Valve-on-Valve Technique for Bioprosthetic Failure”, European Journal of Cardiothoracic Surgery, Oct. 2000, vol. 18, pp. 453-457. |
| Stein D.P., et al., “Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves”, Circulation Research by American Heart Association, 39:58-65 (Jul. 1976). |
| Steinhoff et al., “Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits.” Circulation102 [suppl. III], pp. III-50-III-55 (Nov. 2000). |
| Supplemental Search Report from EP Patent Office for EP Application No. 04813777.2, dated Aug. 19, 2011. |
| Supplemental Search Report from EP Patent Office for EP Application No. 04815634.3, dated Aug. 19, 2011. |
| Supplemental Search Report from EP Patent Office for EP Application No. 05758878.2, dated Oct. 24, 2011. |
| Supplementary European Search Report dated Jan. 2, 2012 in EP Patent Appl. Serial No. 09820051.2. |
| Thompson et al., “Endoluminal stent grafting of the thoracic aorta: Initial experience with the Gore Excluder,” Journal of Vascular Surgery, Jun. 2002, pp. 1163-1170. |
| Topol, Eric., Textbook of Interventional Cardiology, 4th Ed; Chapter 24: “Endovascular Options for Peripheral Arterial Occlusive and Aneurysmal Disease,”. Saunders, pp. 499-503, 949-953 (Dec. 2003). |
| Triennial Review of the National Nanotechnology Initiative: “A Matter of Size”, The National Academies Press, Washington DC, V-13, Retrived from the Interent: URL: http://www.nap.edu/catalog/11752/a-matter-of-size-triennial-review-of-the-national-nanotechnology, 200 pages (Mar. 2006) (Parts 1-5). |
| Vahanian et al., “Percutaneous Approaches to Valvular Disease”, Circulation, Apr. 6, 2004, 109: 1572-1579. |
| Van Herwerden et al., “Percutaneous Valve Implantation: Back to the Future?”, Euro. Heart J., Sep. 2002, 23(18): 1415-1416. |
| Walther et al., “Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results”, European Journal of Cardiao-thoriacic Surgery 29, 703-708 (May 2006). |
| Webb et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery”, Circulation, American Hea Association, vol. 113, Feb. 6, 2006, pp. 842-850. |
| Weerasinghe A., et al., “First Redo Heart Valve Replacement: A 10-Year Analysis,” Circulation, 99(5):655-658 (Feb. 1999). |
| Weyman AB et al., “Aortic Stenosis: Physics and Physiology—What Do the Numbers Really Mean?”, Rev Cardiovasc Med., 6(1):23-32 (Jan. 2005). |
| White et al., “Endoleak as a Complication of Endoluminal Grafting of Abdominal Aortic Aneurysms: Classification, Incidence, Diagnosis, and Management,” J. Endovac. Surg., 4:152-168 (May 1997). |
| Written Opinion for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 11 pages. |
| Written Opinion for Application No. PCT/EP2007/007413, dated Jan. 28, 2008, 5 pages. |
| Written Opinion for Application No. PCT/EP2011/058506, dated Nov. 3, 2011, 5 pages. |
| Written Opinion for Application No. PCT/EP2014/065817, dated Jan. 7, 2015, 7 pages. |
| Written Opinion for PCT/EP2006/010023 dated Mar. 30, 2007, 10 Pages. |
| Written Opinion for PCT/EP2012/067714 dated Dec. 18, 2012, 5 Pages. |
| Yonga G.O., et al., “Percutaneous Transvenous Mitral Commissurotomy in Juvenile Mitral Stenosis”, East African Medical Journal, 80(4):172-174 (Apr. 2003). |
| Yoshioka et al., “Self-Expanding Endovascular Graft: An Experimental Study in Dogs.” AJR 151, Oct. 1988, pp. 673-676. |
| Zhou et al., “Self-expandable Valved Stent of Large Size: Off-Bypass Implantation in Pulmonary Position”, Eur. J. Cardiothorac, Aug. 2003, 24: 212-216. |
| U.S. Appl. No. 12/071,814 / U.S. Pat. No. 9,044,318, filed Feb. 26, 2008 / Dec. 18, 2018. |
| U.S. Appl. No. 12/285,544 / U.S. Pat. No. 9,168,130, filed Oct. 8, 2008 / Jun. 5, 2018. |
| U.S. Appl. No. 12/392,467 / U.S. Pat. No. 8,317,858, filed Feb. 25, 2009 / Nov. 27, 2012. |
| U.S. Appl. No. 12/713,058 / U.S. Pat. No. 8,398,704, filed Feb. 25, 2010 / Mar. 19, 2013. |
| U.S. Appl. No. 13/033,023 / U.S. Pat. No. 8,465,540, filed Feb. 23, 2011 / Jun. 18, 2013. |
| U.S. Appl. No. 13/896,905 / U.S. Pat. No. 8,790,395, filed May 17, 2013 / Jul. 29, 2014. |
| U.S. Appl. No. 14/312,180 / U.S. Pat. No. 9,439,759, filed Jun. 23, 2014 / Sep. 13, 2016. |
| U.S. Appl. No. 15/221,860 / U.S. Pat. No. 9,987,133, filed Jul. 28, 2016 / Jun. 5, 2018. |
| U.S. Appl. No. 15/229,270 / U.S. Pat. No. 9,867,699, filed May 5, 2016 / Jan. 16, 2018. |
| U.S. Appl. No. 15/266,295 / U.S. Pat. No. 10,154,901, filed Sep. 15, 2016 / Sep. 15, 2016. |
| U.S. Appl. No. 16/199,763 / U.S. Pat. No. 10,702,382, filed Nov. 26, 2018 / Jul. 7, 2020. |
| U.S. Appl. No. 16/919,014 / U.S. Pat. No. 10,993,805, filed Jul. 1, 2020 / May 4, 2021. |
| Number | Date | Country | |
|---|---|---|---|
| 20210236281 A1 | Aug 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16919014 | Jul 2020 | US |
| Child | 17238055 | US | |
| Parent | 16199763 | Nov 2018 | US |
| Child | 16919014 | US | |
| Parent | 15266295 | Sep 2016 | US |
| Child | 16199763 | US | |
| Parent | 15221860 | Jul 2016 | US |
| Child | 15266295 | US | |
| Parent | 14312180 | Jun 2014 | US |
| Child | 15221860 | US | |
| Parent | 13896905 | May 2013 | US |
| Child | 14312180 | US | |
| Parent | 13033023 | Feb 2011 | US |
| Child | 13896905 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12713058 | Feb 2010 | US |
| Child | 13033023 | US | |
| Parent | 12392467 | Feb 2009 | US |
| Child | 12713058 | US | |
| Parent | 12285544 | Oct 2008 | US |
| Child | 12392467 | US | |
| Parent | 12071814 | Feb 2008 | US |
| Child | 12285544 | US |
